pathwayRes	pathway	pathwayTitle	TotalGenesinPW	GenesInPWs.rectum_Ensembl_BridgeDb_UC	probabilities.rectum_Ensembl_BridgeDb_UC	GenesInPWs.rectum_Ensembl_Hs_UC	probabilities.rectum_Ensembl_Hs_UC	GenesInPWs.rectum_Ensembl_PriID_BridgeDb_UC	probabilities.rectum_Ensembl_PriID_BridgeDb_UC	GenesInPWs.rectum_ENTREZ_BridgeDb_UC	probabilities.rectum_ENTREZ_BridgeDb_UC	GenesInPWs.rectum_ENTREZ_Hs_UC	probabilities.rectum_ENTREZ_Hs_UC	GenesInPWs.rectum_ENTREZ_PriID_BridgeDb_UC	probabilities.rectum_ENTREZ_PriID_BridgeDb_UC	GenesInPWs.rectum_HGNC_PriID_BridgeDb_UC	probabilities.rectum_HGNC_PriID_BridgeDb_UC	GenesInPWs.rectum_HGNC_UC	probabilities.rectum_HGNC_UC
<https://identifiers.org/wikipathways/WP100_r107114>	WP100	Glutathione metabolism	37	5	2.74357362893039e-80	5	4.56942111088807e-80	5	3.99410987383192e-81	5	1.24165681738008e-79	5	2.65548575123283e-80	5	1.85862346295606e-80	5	2.32951371004393e-82	5	2.32951371004393e-82
<https://identifiers.org/wikipathways/WP106_r114258>	WP106	Alanine and aspartate metabolism	40	3	4.55368402357911e-93	3	8.21134465925397e-93	4	7.69183408183581e-91	3	2.60717025569596e-92	3	4.38513248148084e-93	4	4.33537665159409e-90	4	3.14796870974093e-92	3	1.83930394960025e-95
<https://identifiers.org/wikipathways/WP107_r117851>	WP107	Translation factors	50	15	2.7115771269937e-80	15	4.73668123226912e-80	15	3.29679860591448e-81	15	1.41315721393626e-79	15	2.61652311440253e-80	15	1.7712834642901e-80	15	1.47416227911142e-82	15	1.47416227911142e-82
<https://identifiers.org/wikipathways/WP111_r117097>	WP111	Electron transport chain: OXPHOS system in mitochondria	104	25	7.97708914374426e-158	25	2.7963729930388e-157	33	3.11084738857607e-141	25	3.26580967062504e-156	25	7.36197761694248e-158	33	9.32794351094378e-140	33	5.79072785856404e-144	25	6.42383121881756e-163
<https://identifiers.org/wikipathways/WP117_r117743>	WP117	GPCRs, other	114	22	2.3208670910205e-182	22	9.98489729601402e-182	27	9.73670284147356e-173	22	1.74173896036609e-180	22	2.11402399311006e-182	27	6.24869493194892e-171	27	4.43699746078371e-176	22	2.75026599796589e-188
<https://identifiers.org/wikipathways/WP12_r116896>	WP12	Osteoclast signaling	16	7	5.02472675720555e-25	7	5.80155998276729e-25	7	2.91936375048472e-25	7	7.68941721995219e-25	7	4.97873024641623e-25	7	4.50249723800548e-25	7	1.31090184546314e-25	7	1.31090184546314e-25
<https://identifiers.org/wikipathways/WP127_r120669>	WP127	IL-5 signaling pathway	40	17	4.69571590562352e-54	17	6.77734667074928e-54	17	1.17418356033852e-54	17	1.39105518230053e-53	17	4.58677504176628e-54	17	3.54854803062228e-54	17	1.52081412325075e-55	17	1.52081412325075e-55
<https://identifiers.org/wikipathways/WP129_r117774>	WP129	Matrix metalloproteinases	31	16	1.15508311322459e-36	16	1.46761985495712e-36	16	4.67484888932938e-37	16	2.34649980832518e-36	16	1.13752305791728e-36	16	9.62103699458382e-37	16	1.23169753809056e-37	16	1.23169753809056e-37
<https://identifiers.org/wikipathways/WP134_r118339>	WP134	Pentose phosphate metabolism	7	4	1.04038272276242e-09	4	1.09147711746456e-09	4	8.68052619849782e-10	4	1.19899959392901e-09	4	1.0371967961983e-09	4	1.00299490585005e-09	4	6.6464028831477e-10	4	6.6464028831477e-10
<https://identifiers.org/wikipathways/WP136_r118346>	WP136	Phase I biotransformations, non P450	8	3	9.66693715085535e-16	3	1.04709344410267e-15	3	7.14878285688919e-16	3	1.2245620981219e-15	3	9.61765804688458e-16	3	9.09500010121972e-16	3	4.5813779726248e-16	3	4.5813779726248e-16
<https://identifiers.org/wikipathways/WP138_r122133>	WP138	Androgen receptor signaling pathway	88	33	9.2311048265877e-111	33	2.21455312986948e-110	35	1.12308393080244e-107	33	1.23017147400653e-109	33	8.72854497410874e-111	35	1.42728752247408e-106	35	1.02239658541791e-109	33	2.58270663370922e-114
<https://identifiers.org/wikipathways/WP1403_r121114>	WP1403	AMP-activated protein kinase (AMPK) signaling	68	26	2.87062372954783e-89	26	5.60408906506057e-89	26	2.29325988835539e-90	26	2.07881463381653e-88	26	2.75036565849714e-89	26	1.72260811209057e-89	26	5.5190303079525e-92	26	5.5190303079525e-92
<https://identifiers.org/wikipathways/WP1422_r118359>	WP1422	Sphingolipid pathway	36	11	5.50168012493545e-61	11	8.19748747845264e-61	12	6.35724865971749e-59	11	1.79085769716883e-60	11	5.36310596420498e-61	12	2.01570076300064e-58	12	7.53505364069078e-60	11	1.32309984911161e-62
<https://identifiers.org/wikipathways/WP1423_r117518>	WP1423	Ganglio sphingolipid metabolism	18	6	5.30772381186324e-33	6	6.42880132072716e-33	6	2.57367627871572e-33	6	9.35876465930646e-33	6	5.24305649273788e-33	6	4.58541997331669e-33	6	8.85190056388581e-34	6	8.85190056388581e-34
<https://identifiers.org/wikipathways/WP1425_r116437>	WP1425	Bone morphogenic protein (BMP) signaling and regulation	12	3	9.66293607154925e-27	3	1.11568461207063e-26	3	5.61416105862447e-27	3	1.47873408076005e-26	3	9.57448124310812e-27	3	8.6586485346259e-27	3	2.52096508742914e-27	3	2.52096508742914e-27
<https://identifiers.org/wikipathways/WP143_r116506>	WP143	Fatty acid beta-oxidation	34	15	5.54528253501659e-46	15	7.50952173024769e-46	15	1.76393852593275e-46	15	1.36043284519509e-45	15	5.43875351979114e-46	15	4.39941874856918e-46	15	3.25817596999598e-47	15	3.25817596999598e-47
<https://identifiers.org/wikipathways/WP1433_r122867>	WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	41	18	1.06957973405869e-53	18	1.5437289638929e-53	18	2.67452922077111e-54	18	3.16851458190679e-53	18	1.04476542618009e-53	18	8.08280384752852e-54	18	3.46407661407123e-55	18	3.46407661407123e-55
<https://identifiers.org/wikipathways/WP1434_r117813>	WP1434	Osteopontin signaling	13	6	3.61008360998001e-20	6	4.03723548982462e-20	6	2.36629065287588e-20	6	5.02644420012132e-20	6	3.58434992057519e-20	6	3.31468968956627e-20	6	1.26934368977921e-20	6	1.26934368977921e-20
<https://identifiers.org/wikipathways/WP1455_r117827>	WP1455	Serotonin transporter activity	11	5	8.15184649007405e-18	5	8.97197948469494e-18	5	5.6754571197438e-18	5	1.08261875079541e-17	5	8.10200941662318e-18	5	7.5766157019585e-18	5	3.32763330366732e-18	5	3.32763330366732e-18
<https://identifiers.org/wikipathways/WP1471_r120934>	WP1471	Target of rapamycin (TOR) signaling	36	11	5.50168012493545e-61	11	8.19748747845264e-61	11	1.21981106358505e-61	11	1.79085769716883e-60	11	5.36310596420498e-61	11	4.05777707700175e-61	11	1.32309984911161e-62	11	1.32309984911161e-62
<https://identifiers.org/wikipathways/WP1495_r117738>	WP1495	Glycine metabolism	5	2	2.97252206503549e-10	2	3.11850604989874e-10	2	2.48015034242795e-10	2	3.42571312551149e-10	2	2.96341941770944e-10	2	2.86569973100015e-10	2	1.89897225232792e-10	2	1.89897225232792e-10
<https://identifiers.org/wikipathways/WP15_r121694>	WP15	Selenium micronutrient network	89	36	6.71765240310828e-106	36	1.56132408244876e-105	40	1.96954837625037e-98	36	8.15114600492903e-105	36	6.36481526434806e-106	40	2.06762193752708e-97	40	2.552819031007e-100	36	2.52759155839437e-109
<https://identifiers.org/wikipathways/WP1528_r121714>	WP1528	Physiological and pathological hypertrophy of the heart	24	10	2.95431743316258e-36	10	3.69430263902516e-36	10	1.26990412503651e-36	10	5.72491430679887e-36	10	2.91237395246178e-36	10	2.49087708397952e-36	10	3.65665135085334e-37	10	3.65665135085334e-37
<https://identifiers.org/wikipathways/WP1530_r118120>	WP1530	miRNA regulation of DNA damage response	96	30	5.11417341057312e-132	30	1.46011521376597e-131	31	1.97299721118087e-131	30	1.14063197503899e-130	30	4.78220684675072e-132	31	4.44514263438258e-130	31	6.23096731882761e-134	30	2.8095998092169e-136
<https://identifiers.org/wikipathways/WP1531_r118354>	WP1531	Vitamin D metabolism	11	7	6.68665495202244e-12	7	7.12801382834039e-12	7	5.25236395316088e-12	7	8.07922337980158e-12	7	6.65936947799904e-12	7	6.36822162444463e-12	7	3.67920647742978e-12	7	3.67920647742978e-12
<https://identifiers.org/wikipathways/WP1533_r121695>	WP1533	Vitamin B12 metabolism	57	23	1.07813777305122e-74	23	1.85363872636387e-74	23	1.39193216570267e-75	23	5.36066258793539e-74	23	1.0414019381563e-74	23	7.12867874329108e-75	23	6.80031764388235e-77	23	6.80031764388235e-77
<https://identifiers.org/wikipathways/WP1539_r118358>	WP1539	Angiogenesis	24	9	5.02520400265779e-39	9	6.38489913416021e-39	9	2.03379904714365e-39	9	1.02084777225371e-38	9	4.94880875524508e-39	9	4.18564457062599e-39	9	5.35851604755747e-40	9	5.35851604755747e-40
<https://identifiers.org/wikipathways/WP1541_r117711>	WP1541	Energy metabolism	47	11	1.2802845999123e-84	11	2.27226460747493e-84	11	1.46591204686648e-85	11	6.99351969945363e-84	11	1.23414930895578e-84	11	8.26237382873815e-85	11	5.99940821093022e-87	11	5.99940821093022e-87
<https://identifiers.org/wikipathways/WP1544_r121713>	WP1544	MicroRNAs in cardiomyocyte hypertrophy	104	35	6.5316751308206e-135	35	1.95534886589113e-134	35	1.03739440768095e-136	35	1.67617219241235e-133	35	6.08920128169255e-135	35	2.82801628370956e-135	35	2.30303183647685e-139	35	2.30303183647685e-139
<https://identifiers.org/wikipathways/WP1545_r118363>	WP1545	miRNAs involved in DNA damage response	69	7	5.73747227381566e-140	7	1.53767754325216e-139	7	1.3842904841008e-141	7	1.06123030267248e-138	7	5.38679870159619e-140	7	2.70313053206393e-140	7	5.695371710905e-144	7	5.695371710905e-144
<https://identifiers.org/wikipathways/WP1559_r117836>	WP1559	Transcription factors regulate miRNAs related to cardiac hypertrophy	14	3	5.09610867949464e-32	3	6.07479706499433e-32	3	2.62456105481452e-32	3	8.57122155480596e-32	3	5.03915985135365e-32	3	4.45654869302096e-32	3	9.86581923958582e-33	3	9.86581923958582e-33
<https://identifiers.org/wikipathways/WP1584_r122869>	WP1584	Type II diabetes mellitus	22	10	1.84885712779902e-31	10	2.23936579338662e-31	10	8.96497237085973e-32	10	3.25996968965845e-31	10	1.82633134497037e-31	10	1.59725462403867e-31	10	3.08341202975359e-32	10	3.08341202975359e-32
<https://identifiers.org/wikipathways/WP1589_r122870>	WP1589	Folate-alcohol and cancer pathway hypotheses	9	4	2.17506085894246e-15	4	2.355960249231e-15	4	1.60847614280008e-15	4	2.75526472077428e-15	4	2.16397306054903e-15	4	2.04637502277443e-15	4	1.03081004384058e-15	4	1.03081004384058e-15
<https://identifiers.org/wikipathways/WP1591_r118366>	WP1591	Heart development	47	16	1.74327709692547e-71	16	2.85763057673763e-71	16	2.69498307010639e-72	16	7.52690498824777e-71	16	1.68902279334435e-71	16	1.19539809552056e-71	16	1.7174226688988e-73	16	1.7174226688988e-73
<https://identifiers.org/wikipathways/WP1600_r119518>	WP1600	Nicotine metabolism in liver cells	6	3	5.94504413007102e-10	3	6.23701209979749e-10	3	4.96030068485593e-10	3	6.85142625102298e-10	3	5.92683883541888e-10	3	5.73139946200029e-10	3	3.79794450465585e-10	3	3.79794450465585e-10
<https://identifiers.org/wikipathways/WP1601_r120496>	WP1601	Fluoropyrimidine activity	34	15	5.54528253501659e-46	15	7.50952173024769e-46	15	1.76393852593275e-46	15	1.36043284519509e-45	15	5.43875351979114e-46	15	4.39941874856918e-46	15	3.25817596999598e-47	15	3.25817596999598e-47
<https://identifiers.org/wikipathways/WP1602_r117165>	WP1602	Nicotine effect on dopaminergic neurons	21	6	2.08555897343506e-40	6	2.64985932445385e-40	6	8.44066798221658e-41	6	4.23672000342444e-40	6	2.05385343597129e-40	6	1.73712521705823e-40	6	2.22389005926303e-41	6	2.22389005926303e-41
<https://identifiers.org/wikipathways/WP1603_r117164>	WP1603	Nicotine effect on chromaffin cells	4	2	3.48795739111272e-07	2	3.60125078642309e-07	2	3.09125938680219e-07	2	3.83405813007207e-07	2	3.48083244804143e-07	2	3.4038781404818e-07	2	2.5871597965717e-07	2	2.5871597965717e-07
<https://identifiers.org/wikipathways/WP1604_r118374>	WP1604	Codeine and morphine metabolism	17	8	1.06775443590619e-24	8	1.23283149633803e-24	8	6.2036479697801e-25	8	1.63400115923983e-24	8	1.05798017736345e-24	8	9.56780663076162e-25	8	2.78566642160919e-25	8	2.78566642160919e-25
<https://identifiers.org/wikipathways/WP167_r120547>	WP167	Eicosanoid synthesis	28	13	1.43903569167021e-37	13	1.82840293387314e-37	13	5.82406090772946e-38	13	2.92333680236283e-37	13	1.41715887082017e-37	13	1.19861639977014e-37	13	1.53448414089145e-38	13	1.53448414089145e-38
<https://identifiers.org/wikipathways/WP170_r116552>	WP170	Nuclear receptors	38	17	1.04301729327747e-49	17	1.45820009431791e-49	17	2.94157459075944e-50	17	2.81187894550233e-49	17	1.02089722097495e-49	17	8.07606812710646e-50	17	4.54970964596966e-51	17	4.54970964596966e-51
<https://identifiers.org/wikipathways/WP1742_r116592>	WP1742	TP53 network	22	6	7.80311180536929e-43	6	1.00737696799698e-42	6	2.97349392488012e-43	6	1.66175503789159e-42	6	7.67665232609053e-43	6	6.42082573509422e-43	6	7.16858334121406e-44	6	7.16858334121406e-44
<https://identifiers.org/wikipathways/WP176_r121696>	WP176	Folate metabolism	75	26	1.14029677909569e-102	26	2.4875142715827e-102	26	5.98840462786077e-104	26	1.1469780680444e-101	26	1.08479399464289e-102	26	6.2865969318942e-103	26	7.76183691840957e-106	26	7.76183691840957e-106
<https://identifiers.org/wikipathways/WP1772_r120736>	WP1772	Apoptosis modulation and signaling	97	33	5.32792025389888e-127	33	1.47379888937808e-126	33	1.14067264334828e-128	33	1.08216703715752e-125	33	4.99216688029082e-127	33	2.45028806064973e-127	33	3.93434841563782e-131	33	3.93434841563782e-131
<https://identifiers.org/wikipathways/WP179_r122978>	WP179	Cell cycle	120	46	1.08097640540546e-138	46	3.50191761160688e-138	46	1.27396529614605e-140	46	3.50412965238446e-137	46	1.0026703966352e-138	46	4.40649604320702e-139	46	1.82097186898357e-143	46	1.82097186898357e-143
<https://identifiers.org/wikipathways/WP183_r117060>	WP183	Proteasome degradation	65	30	3.62507402615283e-74	30	6.33241073408151e-74	31	8.90589131442442e-73	30	1.88923245446852e-73	30	3.49799748877704e-74	31	4.56108707504093e-72	31	4.35099434672574e-74	30	1.97078937388221e-76
<https://identifiers.org/wikipathways/WP185_r116785>	WP185	Integrin-mediated cell adhesion	101	40	1.15687316731318e-118	40	3.05183289158069e-118	41	4.54587205817799e-118	40	2.04195305269731e-117	40	1.08726495570247e-118	41	8.06913855163894e-117	41	2.23109675093789e-120	40	1.3315133448101e-122
<https://identifiers.org/wikipathways/WP186_r118416>	WP186	Homologous recombination	13	3	2.13854560657372e-29	3	2.50889118784261e-29	4	1.82460234405296e-26	3	3.43093754236663e-29	3	2.11680707755789e-29	4	2.81406077375342e-26	4	8.19313653414472e-27	3	4.80606337242684e-30
<https://identifiers.org/wikipathways/WP1941_r107124>	WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	4	2	3.48795739111272e-07	2	3.60125078642309e-07	2	3.09125938680219e-07	2	3.83405813007207e-07	2	3.48083244804143e-07	2	3.4038781404818e-07	2	2.5871597965717e-07	2	2.5871597965717e-07
<https://identifiers.org/wikipathways/WP1946_r122878>	WP1946	Cori cycle	23	9	1.23096559715107e-36	9	1.53929276626046e-36	9	5.2912671876521e-37	9	2.38538096116616e-36	9	1.21348914685908e-36	9	1.03786545165814e-36	9	1.52360472952219e-37	9	1.52360472952219e-37
<https://identifiers.org/wikipathways/WP195_r120702>	WP195	IL-1 signaling pathway	55	23	1.17475492745723e-70	23	1.9565540027935e-70	23	1.71021481093568e-71	23	5.31657852753399e-70	23	1.13703708847402e-70	23	7.9583323311299e-71	23	9.97461005090681e-73	23	9.97461005090681e-73
<https://identifiers.org/wikipathways/WP197_r120482>	WP197	Cholesterol biosynthesis pathway	15	13	6.10392543444724e-06	13	6.30218887624041e-06	13	5.40970392690382e-06	13	6.70960172762611e-06	13	6.09145678407249e-06	13	5.95678674584315e-06	13	4.52752964400048e-06	13	4.52752964400048e-06
<https://identifiers.org/wikipathways/WP1971_r117762>	WP1971	Integrated cancer pathway	49	21	3.43803114060639e-63	21	5.37313394730429e-63	22	1.81020332632079e-61	21	1.28894287555612e-62	21	3.3412158461138e-63	22	6.62811825124255e-61	22	1.64441296257656e-62	21	5.29136831602814e-65
<https://identifiers.org/wikipathways/WP1982_r116442>	WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	69	36	1.86595734367605e-68	36	3.15754827762316e-68	36	2.55813325722479e-69	36	8.85152436141604e-68	36	1.80421135436878e-68	36	1.24883785834365e-68	36	1.36552111603771e-70	36	1.36552111603771e-70
<https://identifiers.org/wikipathways/WP1991_r117830>	WP1991	SRF and miRs in smooth muscle differentiation and proliferation	17	3	1.02431087759606e-39	3	1.28087602767669e-39	3	4.40296832756565e-40	3	1.9849227885718e-39	3	1.00976837683301e-39	3	8.63628418271777e-40	3	1.26782170128746e-40	3	1.26782170128746e-40
<https://identifiers.org/wikipathways/WP1992_r105839>	WP1992	Genes targeted by miRNAs in adipocytes	13	3	2.13854560657372e-29	3	2.50889118784261e-29	3	1.16980435586016e-29	3	3.43093754236663e-29	3	2.11680707755789e-29	3	1.89307821981393e-29	3	4.80606337242684e-30	3	4.80606337242684e-30
<https://identifiers.org/wikipathways/WP1995_r116455>	WP1995	Effects of nitric oxide	8	4	1.41838135345931e-12	4	1.51200293328433e-12	4	1.11413780824625e-12	4	1.71377465632155e-12	4	1.41259352563617e-12	4	1.35083489003371e-12	4	7.80437737636619e-13	4	7.80437737636619e-13
<https://identifiers.org/wikipathways/WP2007_r106626>	WP2007	Iron metabolism in placenta	12	3	9.66293607154925e-27	3	1.11568461207063e-26	3	5.61416105862447e-27	3	1.47873408076005e-26	3	9.57448124310812e-27	3	8.6586485346259e-27	3	2.52096508742914e-27	3	2.52096508742914e-27
<https://identifiers.org/wikipathways/WP2011_r118441>	WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	18	9	2.13550887181237e-24	9	2.46566299267609e-24	9	1.24072959395602e-24	9	3.2680023184797e-24	9	2.11596035472688e-24	9	1.91356132615233e-24	9	5.57133284321839e-25	9	5.57133284321839e-25
<https://identifiers.org/wikipathways/WP2018_r120672>	WP2018	RANKL/RANK signaling pathway	55	21	1.70907804875918e-75	21	2.93841226672953e-75	21	2.20650900954111e-76	21	8.49779219766691e-75	21	1.65084392452098e-75	21	1.13004744489514e-75	21	1.07799521547759e-77	21	1.07799521547759e-77
<https://identifiers.org/wikipathways/WP2023_r117676>	WP2023	Cell differentiation - expanded index	68	5	5.89231386458575e-144	5	1.60434973435554e-143	5	1.33917927370939e-145	5	1.14209029560102e-142	5	5.52658174413897e-144	5	2.74276346412041e-144	5	5.04474388524771e-148	5	5.04474388524771e-148
<https://identifiers.org/wikipathways/WP2029_r120346>	WP2029	Cell differentiation - index	58	4	2.50521371959002e-127	4	5.91560739240025e-127	4	9.75292475785605e-129	4	3.18568696744131e-126	4	2.37122610408458e-127	4	1.30009284099603e-127	4	8.12821366943404e-131	4	8.12821366943404e-131
<https://identifiers.org/wikipathways/WP2032_r122774>	WP2032	Thyroid stimulating hormone (TSH) signaling pathway	64	24	3.32936925081549e-86	24	6.29655942549845e-86	24	2.99867891173897e-87	24	2.19481984064999e-85	24	3.19637827707749e-86	24	2.04690649309269e-86	24	8.61350017900154e-89	24	8.61350017900154e-89
<https://identifiers.org/wikipathways/WP2034_r120670>	WP2034	Leptin signaling pathway	76	27	3.20972426708422e-102	27	7.00189202371446e-102	27	1.6856250063608e-103	27	3.22853085819928e-101	27	3.05349420714298e-102	27	1.7695606178666e-102	27	2.18481335481144e-105	27	2.18481335481144e-105
<https://identifiers.org/wikipathways/WP2035_r120721>	WP2035	Follicle stimulating hormone (FSH) signaling pathway	27	6	1.07272857407607e-54	6	1.49973822867297e-54	6	3.02536797483791e-55	6	2.89197783308539e-54	6	1.04997839172294e-54	6	8.30612215345807e-55	6	4.67931219591277e-56	6	4.67931219591277e-56
<https://identifiers.org/wikipathways/WP2036_r120940>	WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	42	13	1.10563125524784e-68	13	1.75564464459479e-68	13	1.92745952935175e-69	13	4.34489986037617e-68	13	1.07340367692738e-68	13	7.76786713127503e-69	13	1.46647896670953e-70	13	1.46647896670953e-70
<https://identifiers.org/wikipathways/WP2037_r122570>	WP2037	Prolactin signaling pathway	76	36	8.25165200427422e-82	36	1.56056638027516e-81	36	7.43205483926576e-83	36	5.43973592976632e-81	36	7.92204145274784e-82	36	5.07314112489991e-82	36	2.13480694574409e-84	36	2.13480694574409e-84
<https://identifiers.org/wikipathways/WP2038_r117173>	WP2038	Microtubule cytoskeleton regulation	46	15	5.93456032995903e-72	15	9.72810409102197e-72	15	9.17441045142595e-73	15	2.56235063429712e-71	15	5.74986482840627e-72	15	4.06944032517634e-72	15	5.84654525582569e-74	15	5.84654525582569e-74
<https://identifiers.org/wikipathways/WP205_r120718>	WP205	IL-7 signaling pathway	25	14	6.24049308460976e-28	14	7.43895616414989e-28	14	3.21393363893687e-28	14	1.0495978834723e-27	14	6.17075580258889e-28	14	5.45731322644826e-28	14	1.2081291944651e-28	14	1.2081291944651e-28
<https://identifiers.org/wikipathways/WP2059_r119468>	WP2059	Alzheimer's disease and miRNA effects	280	87	1.85285818748486e-296	87	3.85442302455937e-295	87	1.93236496502742e-301	87	1.47272740125493e-292	87	1.5258436344602e-296	87	1.82563533723283e-297	87	8.56584905931846e-309	87	8.56584905931846e-309
<https://identifiers.org/wikipathways/WP206_r117723>	WP206	Fatty acid omega-oxidation	15	5	2.24547288690242e-28	5	2.63433574723475e-28	5	1.22829457365318e-28	5	3.60248441948495e-28	5	2.22264743143579e-28	5	1.98773213080464e-28	5	5.04636654104818e-29	5	5.04636654104818e-29
<https://identifiers.org/wikipathways/WP2064_r117162>	WP2064	Neural crest differentiation	101	29	3.34183890527324e-143	29	1.04896911412163e-142	29	4.43757143668854e-145	29	9.86670181262616e-142	29	3.10602378908133e-143	29	1.39550730550704e-143	29	7.56410812827662e-148	29	7.56410812827662e-148
<https://identifiers.org/wikipathways/WP2112_r117960>	WP2112	IL-17 signaling pathway	32	7	3.08217373945953e-63	7	4.59242995991739e-63	7	6.83367542624676e-64	7	1.00328162306377e-62	7	3.00454115641739e-63	7	2.27326446890851e-63	7	7.4123240846591e-65	7	7.4123240846591e-65
<https://identifiers.org/wikipathways/WP2113_r105848>	WP2113	Type III interferon signaling	10	5	4.35012171788489e-15	5	4.71192049846199e-15	5	3.21695228560015e-15	5	5.51052944154852e-15	5	4.32794612109808e-15	5	4.09275004554889e-15	5	2.06162008768117e-15	5	2.06162008768117e-15
<https://identifiers.org/wikipathways/WP2118_r119252>	WP2118	Arrhythmogenic right ventricular cardiomyopathy	74	25	3.95302883419858e-103	25	8.62338280815341e-103	25	2.07598027099176e-104	25	3.97619063588756e-102	25	3.76061918142867e-103	25	2.17935360305671e-103	25	2.69077013171533e-106	25	2.69077013171533e-106
<https://identifiers.org/wikipathways/WP2197_r117710>	WP2197	Endothelin pathways	33	12	1.28584398412583e-51	12	1.79768622343596e-51	12	3.62640774583902e-52	12	3.46651742925842e-51	12	1.25857409887853e-51	12	9.95627175461194e-52	12	5.60893555216746e-53	12	5.60893555216746e-53
<https://identifiers.org/wikipathways/WP22_r120719>	WP22	IL-9 signaling pathway	17	10	4.09142809131064e-19	10	4.5755335551346e-19	10	2.68179607325935e-19	10	5.69663676013752e-19	10	4.06226324331855e-19	10	3.75664831484179e-19	10	1.4385895150831e-19	10	1.4385895150831e-19
<https://identifiers.org/wikipathways/WP2203_r120724>	WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	47	22	1.35836619056113e-56	22	2.02396169632074e-56	23	8.18925012778804e-55	22	4.42163210637207e-56	22	1.32415219582739e-56	23	2.5965757538449e-54	23	9.70646930659109e-56	22	3.26673681667536e-58
<https://identifiers.org/wikipathways/WP2249_r107453>	WP2249	Metastatic brain tumor	22	3	4.60123090081095e-52	3	6.23106996214099e-52	3	1.46363839919809e-52	3	1.12882717990695e-51	3	4.51283782190241e-52	3	3.65044366336572e-52	3	2.70349073446816e-53	3	2.70349073446816e-53
<https://identifiers.org/wikipathways/WP2253_r112071>	WP2253	Pilocytic astrocytoma	11	2	2.41573401788731e-27	2	2.78921153017656e-27	2	1.40354026465612e-27	2	3.69683520190006e-27	2	2.39362031077702e-27	2	2.16466213365647e-27	2	6.30241271857283e-28	2	6.30241271857283e-28
<https://identifiers.org/wikipathways/WP2261_r118379>	WP2261	Glioblastoma signaling pathways	83	34	2.47722402031127e-99	34	5.40397045523387e-99	34	1.30094375950476e-100	34	2.49173870611401e-98	34	2.35664766390886e-99	34	1.365724187878e-99	34	1.68621092407814e-102	34	1.68621092407814e-102
<https://identifiers.org/wikipathways/WP2267_r117179>	WP2267	Synaptic vesicle pathway	51	18	9.82729273944337e-75	18	1.66296144808948e-74	18	1.34727219089191e-75	18	4.6617636456028e-74	18	9.50209992918631e-75	18	6.57715743590604e-75	18	7.19168409431943e-77	18	7.19168409431943e-77
<https://identifiers.org/wikipathways/WP2272_r118427>	WP2272	Pathogenic Escherichia coli infection	71	23	3.60580332849196e-102	23	7.7422078155394e-102	23	2.01052143361814e-103	23	3.46070399353276e-101	23	3.43377528922568e-102	23	2.01212996950126e-102	23	2.84667739776987e-105	23	2.84667739776987e-105
<https://identifiers.org/wikipathways/WP2276_r117054>	WP2276	Glial cell differentiation	8	2	4.94051302428728e-19	2	5.4375633240575e-19	2	3.43967098166293e-19	2	6.56132576239643e-19	2	4.91030873734739e-19	2	4.59188830421729e-19	2	2.01674745676809e-19	2	2.01674745676809e-19
<https://identifiers.org/wikipathways/WP2289_r120498>	WP2289	Drug induction of bile acid pathway	17	8	1.06775443590619e-24	8	1.23283149633803e-24	8	6.2036479697801e-25	8	1.63400115923983e-24	8	1.05798017736345e-24	8	9.56780663076162e-25	8	2.78566642160919e-25	8	2.78566642160919e-25
<https://identifiers.org/wikipathways/WP229_r116612>	WP229	Irinotecan pathway	13	8	2.2216693059198e-14	8	2.40644511171452e-14	8	1.64294348871722e-14	8	2.814306107648e-14	8	2.21034391184653e-14	8	2.0902259161196e-14	8	1.05289883049431e-14	8	1.05289883049431e-14
<https://identifiers.org/wikipathways/WP2290_r79988>	WP2290	RalA downstream regulated genes	12	2	4.93510524593939e-30	2	5.78974889502136e-30	2	2.6995485135235e-30	2	7.91754817469217e-30	2	4.88493940974894e-30	2	4.36864204572446e-30	2	1.10909154748312e-30	2	1.10909154748312e-30
<https://identifiers.org/wikipathways/WP2291_r117696>	WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	16	9	2.40672240665333e-19	9	2.69149032654974e-19	9	1.57752710191726e-19	9	3.3509628000809e-19	9	2.38956661371681e-19	9	2.20979312637752e-19	9	8.46229126519476e-20	9	8.46229126519476e-20
<https://identifiers.org/wikipathways/WP23_r120701>	WP23	B cell receptor signaling pathway	97	37	4.1466717084777e-118	37	1.07672256719232e-117	37	1.12752613220104e-119	37	6.98436790366691e-117	37	3.90111600803605e-118	37	2.0014123725625e-118	37	5.5338554582193e-122	37	5.5338554582193e-122
<https://identifiers.org/wikipathways/WP231_r120699>	WP231	TNF-alpha signaling pathway	93	34	1.37718583305392e-117	34	3.51985440726318e-117	34	3.97544778682785e-119	34	2.21352247701733e-116	34	1.29694452916916e-117	34	6.7278460846912e-118	34	2.13107714149334e-121	34	2.13107714149334e-121
<https://identifiers.org/wikipathways/WP2324_r120674>	WP2324	AGE/RAGE pathway	66	28	1.01298551726762e-80	28	1.85589095156085e-80	28	1.02867778999973e-81	28	6.07887782460215e-80	28	9.74499860748982e-81	28	6.3807046448324e-81	28	3.52689658049439e-83	28	3.52689658049439e-83
<https://identifiers.org/wikipathways/WP2328_r120805>	WP2328	Allograft rejection	102	40	1.99124304869959e-120	40	5.33665275057815e-120	41	7.37168441866679e-120	40	3.6830983443877e-119	40	1.86953852801155e-120	41	1.37243977366543e-118	41	3.31254539440562e-122	40	1.97663165726437e-124
<https://identifiers.org/wikipathways/WP2332_r120725>	WP2332	Interleukin-11 signaling pathway	44	22	2.85004719430901e-50	22	4.04850233181267e-50	23	2.0569930753811e-48	22	8.05429736163666e-50	22	2.78676330766957e-50	23	5.64745706804432e-48	23	3.18153456524722e-49	22	1.0712237593425e-51
<https://identifiers.org/wikipathways/WP2333_r72015>	WP2333	Trans-sulfuration pathway	10	4	3.70538476821545e-18	4	4.07817249304314e-18	4	2.57975323624717e-18	4	4.92099432179726e-18	4	3.68273155301054e-18	4	3.44391622816294e-18	4	1.51256059257606e-18	4	1.51256059257606e-18
<https://identifiers.org/wikipathways/WP2338_r117159>	WP2338	miRNA biogenesis	6	1	1.03574326616307e-16	1	1.12188583296715e-16	1	7.65941020380987e-17	1	1.31203081941631e-16	1	1.0304633621662e-16	1	9.74464296559259e-17	1	4.90861925638373e-17	1	4.90861925638373e-17
<https://identifiers.org/wikipathways/WP2355_r120664>	WP2355	Corticotropin-releasing hormone signaling pathway	92	31	1.51477813843909e-122	31	3.99598666210955e-122	32	7.62630846626039e-122	31	2.67367757446439e-121	31	1.42363504671314e-122	32	1.35370593066048e-120	32	3.74296324730795e-124	31	1.74344721854225e-126
<https://identifiers.org/wikipathways/WP2359_r119918>	WP2359	Parkin-ubiquitin proteasomal system pathway	73	30	1.33176957078276e-89	30	2.64149497786496e-89	31	2.02726895091548e-88	30	1.01079845363001e-88	30	1.27468344553025e-89	31	1.52280600989398e-87	31	4.87888827571906e-90	30	2.20731956432126e-92
<https://identifiers.org/wikipathways/WP236_r105873>	WP236	Adipogenesis	131	54	1.5569661396179e-140	54	5.28845643771624e-140	54	1.5343506144176e-142	54	5.80608092777838e-139	54	1.43981192502807e-140	54	6.12151272352794e-141	54	1.68427765835323e-145	54	1.68427765835323e-145
<https://identifiers.org/wikipathways/WP2361_r117731>	WP2361	Gastric cancer network 1	29	16	4.29203572407738e-32	16	5.28217058723902e-32	16	1.95948010334215e-32	16	7.9337065996738e-32	16	4.23541910584316e-32	16	3.66307534807385e-32	16	6.16645425715293e-33	16	6.16645425715293e-33
<https://identifiers.org/wikipathways/WP2363_r117737>	WP2363	Gastric cancer network 2	32	17	2.17427409548156e-36	17	2.76257855050754e-36	17	8.79971555638451e-37	17	4.41694081567093e-36	17	2.14121987372667e-36	17	1.81101872839223e-36	17	2.31848948346462e-37	17	2.31848948346462e-37
<https://identifiers.org/wikipathways/WP2366_r105116>	WP2366	Butyrate-induced histone acetylation	3	1	1.74397869555636e-07	1	1.80062539321155e-07	1	1.54562969340109e-07	1	1.91702906503603e-07	1	1.74041622402071e-07	1	1.7019390702409e-07	1	1.29357989828585e-07	1	1.29357989828585e-07
<https://identifiers.org/wikipathways/WP2369_r118380>	WP2369	Histone modifications	67	9	2.09236229002286e-130	9	5.26375733818173e-130	11	2.30370223613579e-126	9	3.20914022800131e-129	9	1.97244752014058e-130	11	3.37859528069794e-125	11	1.6092007402316e-128	9	3.75432670248878e-134
<https://identifiers.org/wikipathways/WP2371_r119919>	WP2371	Parkinson's disease pathway	47	13	2.85635597716697e-79	13	4.910923434742e-79	15	6.88703547703277e-75	13	1.4202230000059e-78	13	2.75903017688331e-79	15	3.20482063142234e-74	15	4.01677572027219e-76	13	1.80163689968549e-81
<https://identifiers.org/wikipathways/WP2374_r120781>	WP2374	Oncostatin M signaling pathway	65	33	2.27198552267132e-67	33	3.78399125194015e-67	33	3.30756926426731e-68	33	1.02823058345018e-66	33	2.19903891728718e-67	33	1.53914790381614e-67	33	1.92909764413632e-69	33	1.92909764413632e-69
<https://identifiers.org/wikipathways/WP2380_r120727>	WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	144	50	5.27336613146423e-170	50	2.34124777758256e-169	51	2.341679631698e-170	50	4.34368914018437e-168	50	4.79372616582692e-170	51	1.99806787954167e-168	51	6.30079460584405e-174	50	4.65508510644712e-176
<https://identifiers.org/wikipathways/WP24_r113974>	WP24	Peptide GPCRs	75	20	4.40679860197874e-117	20	1.05719627499062e-116	21	4.83551060979451e-116	20	5.87266425166321e-116	20	4.16688365171867e-117	21	6.44587432225423e-115	21	4.02997710051693e-118	20	1.2329475394938e-120
<https://identifiers.org/wikipathways/WP2406_r119249>	WP2406	Cardiac progenitor differentiation	53	13	1.11762133168942e-91	13	2.11366436103872e-91	13	1.00661334510306e-92	13	7.36769426378497e-91	13	1.07297817619222e-91	13	6.87117044795665e-92	13	2.89142801994847e-94	13	2.89142801994847e-94
<https://identifiers.org/wikipathways/WP241_r120901>	WP241	One-carbon metabolism	29	14	2.98085964703116e-37	14	3.78740607730872e-37	14	1.20641261660113e-37	14	6.05548337632307e-37	14	2.93554337527037e-37	14	2.48284825666674e-37	14	3.1785742918466e-38	14	3.1785742918466e-38
<https://identifiers.org/wikipathways/WP2431_r120812>	WP2431	Spinal cord injury	117	46	1.34247786704708e-133	46	4.14788129060099e-133	47	2.53644389274584e-133	46	3.7826803979802e-132	46	1.2490078172343e-133	47	7.25186221221848e-132	47	5.15617439584701e-136	46	3.52238657855831e-138
<https://identifiers.org/wikipathways/WP2435_r120750>	WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	17	4	1.5052248346274e-36	4	1.85246695502739e-36	4	6.8719328172481e-37	4	2.7823655188805e-36	4	1.48536928232135e-36	4	1.28464727217928e-36	4	2.16258686697106e-37	4	2.16258686697106e-37
<https://identifiers.org/wikipathways/WP2436_r107129>	WP2436	Dopamine metabolism	13	6	3.61008360998001e-20	6	4.03723548982462e-20	6	2.36629065287588e-20	6	5.02644420012132e-20	6	3.58434992057519e-20	6	3.31468968956627e-20	6	1.26934368977921e-20	6	1.26934368977921e-20
<https://identifiers.org/wikipathways/WP244_r120686>	WP244	Alpha 6 beta 4 signaling pathway	33	15	9.59496975103017e-44	15	1.27882737700394e-43	15	3.24149644412583e-44	15	2.24551444918673e-43	15	9.42024102295596e-44	15	7.70545254344955e-44	15	6.54318397739187e-45	15	6.54318397739187e-45
<https://identifiers.org/wikipathways/WP2446_r116593>	WP2446	Retinoblastoma gene in cancer	90	42	1.1590192631107e-94	42	2.48859052469991e-94	43	9.43367693220022e-94	42	1.1123797464867e-93	42	1.10372400900483e-94	43	9.00052365689887e-93	43	1.45912522602383e-95	42	9.15012173239361e-98
<https://identifiers.org/wikipathways/WP2447_r113794>	WP2447	Amyotrophic lateral sclerosis (ALS)	38	13	4.95856554849943e-60	13	7.38824832993868e-60	13	1.09939381756446e-60	13	1.61406789885857e-59	13	4.83367114466172e-60	13	3.65720164760541e-60	13	1.19248614605826e-61	13	1.19248614605826e-61
<https://identifiers.org/wikipathways/WP2453_r117835>	WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	16	5	6.11533041539365e-31	5	7.28975647799305e-31	5	3.14947326577743e-31	5	1.02854658657672e-30	5	6.04699182162429e-31	5	5.34785843162519e-31	5	1.18389830875028e-31	5	1.18389830875028e-31
<https://identifiers.org/wikipathways/WP2456_r119185>	WP2456	HIF1A and PPARG regulation of glycolysis	8	5	1.66461235641988e-09	5	1.7463633879433e-09	5	1.38888419175966e-09	5	1.91839935028643e-09	5	1.65951487391729e-09	5	1.60479184936009e-09	5	1.06342446130364e-09	5	1.06342446130364e-09
<https://identifiers.org/wikipathways/WP247_r118104>	WP247	Small ligand GPCRs	19	10	4.05746685644352e-24	10	4.68475968608457e-24	10	2.35738622851644e-24	10	6.20920440511143e-24	10	4.02032467398112e-24	10	3.63576651968942e-24	10	1.05855324021149e-24	10	1.05855324021149e-24
<https://identifiers.org/wikipathways/WP2485_r117161>	WP2485	NAD biosynthesis II (from tryptophan)	8	5	1.66461235641988e-09	5	1.7463633879433e-09	5	1.38888419175966e-09	5	1.91839935028643e-09	5	1.65951487391729e-09	5	1.60479184936009e-09	5	1.06342446130364e-09	5	1.06342446130364e-09
<https://identifiers.org/wikipathways/WP2491_r117698>	WP2491	Diclofenac metabolic pathway	5	2	2.97252206503549e-10	2	3.11850604989874e-10	2	2.48015034242795e-10	2	3.42571312551149e-10	2	2.96341941770944e-10	2	2.86569973100015e-10	2	1.89897225232792e-10	2	1.89897225232792e-10
<https://identifiers.org/wikipathways/WP2507_r110715>	WP2507	Nanomaterial induced apoptosis	21	7	1.75157160068925e-37	7	2.19029800732716e-37	7	7.52907584013723e-38	7	3.39421796845774e-37	7	1.72670392438444e-37	7	1.47680459524476e-37	7	2.16797510920157e-38	7	2.16797510920157e-38
<https://identifiers.org/wikipathways/WP2509_r101755>	WP2509	Nanoparticle triggered autophagic cell death	23	7	2.56387959319274e-42	7	3.30995289484716e-42	7	9.77005146746331e-43	7	5.46005226735805e-42	7	2.52232862142971e-42	7	2.10969988438809e-42	7	2.35539166925604e-43	7	2.35539166925604e-43
<https://identifiers.org/wikipathways/WP2513_r119820>	WP2513	Nanoparticle triggered regulated necrosis	14	2	2.60182539797213e-35	2	3.15137319643485e-35	2	1.26160601897829e-35	2	4.5876297349542e-35	2	2.57012573173424e-35	2	2.24775488888076e-35	2	4.33916694308129e-36	2	4.33916694308129e-36
<https://identifiers.org/wikipathways/WP2516_r116808>	WP2516	ATM signaling pathway	41	17	3.26977500221748e-56	17	4.79501662641451e-56	18	2.67452922077111e-54	17	1.01536874620477e-55	17	3.19066468802885e-56	18	8.08280384752852e-54	18	3.46407661407123e-55	17	9.12532987754724e-58
<https://identifiers.org/wikipathways/WP2525_r116582>	WP2525	Trans-sulfuration and one-carbon metabolism	31	13	1.908090575489e-44	13	2.54312262472374e-44	14	2.87636765432587e-42	13	4.4655116887237e-44	13	1.87334338524697e-44	14	6.51679892666186e-42	14	6.34521548489418e-43	13	1.30120135914047e-45
<https://identifiers.org/wikipathways/WP2526_r121697>	WP2526	PDGF pathway	41	14	6.52878189531233e-64	14	1.00424665144948e-63	14	1.28354073356996e-64	14	2.33510746346104e-63	14	6.35139198904221e-64	14	4.69972606871705e-64	14	1.16598560481456e-65	14	1.16598560481456e-65
<https://identifiers.org/wikipathways/WP2533_r120261>	WP2533	Glycerophospholipid biosynthetic pathway	44	9	8.54049445310967e-84	9	1.49188453419338e-83	10	6.50436973006716e-82	9	4.45093787923184e-83	9	8.24110843926619e-84	10	3.33116536679995e-81	10	3.17772527480748e-83	9	4.64308193279892e-86
<https://identifiers.org/wikipathways/WP2536_r117685>	WP2536	Colchicine metabolic pathway	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
<https://identifiers.org/wikipathways/WP254_r118382>	WP254	Apoptosis	87	36	3.00244170424597e-102	36	6.76065129332795e-102	36	1.39879401653991e-103	36	3.31704080172279e-101	36	2.85051453525506e-102	36	1.61570623525638e-102	36	1.51940079916841e-105	36	1.51940079916841e-105
<https://identifiers.org/wikipathways/WP2542_r117834>	WP2542	Sulindac metabolic pathway	6	2	3.03938861455565e-13	2	3.24000628560928e-13	2	2.38743816052768e-13	2	3.67237426354619e-13	2	3.02698612636321e-13	2	2.89464619292938e-13	2	1.6723665806499e-13	2	1.6723665806499e-13
<https://identifiers.org/wikipathways/WP2572_r119251>	WP2572	Primary focal segmental glomerulosclerosis (FSGS)	73	32	4.68357877211149e-85	32	8.99939817751945e-85	32	3.97281362224726e-86	32	3.23606921139628e-84	32	4.49192997961099e-85	32	2.84479197723307e-85	32	1.04453948677971e-87	32	1.04453948677971e-87
<https://identifiers.org/wikipathways/WP2583_r117181>	WP2583	T cell receptor and co-stimulatory signaling	32	8	2.26886514395966e-60	8	3.32721550596023e-60	8	5.34222576446847e-61	8	7.04554519796534e-60	8	2.21397126463498e-60	8	1.69386618739547e-60	8	6.3319778493199e-62	8	6.3319778493199e-62
<https://identifiers.org/wikipathways/WP2586_r121728>	WP2586	Aryl hydrocarbon receptor pathway	48	12	5.12113839964903e-84	12	9.08905842989956e-84	12	5.86364818746608e-85	12	2.7974078797813e-83	12	4.93659723582309e-84	12	3.30494953149529e-84	12	2.39976328437206e-86	12	2.39976328437206e-86
<https://identifiers.org/wikipathways/WP2596_r122782>	WP2596	Gastric acid production	14	1	8.85426373310216e-39	1	1.08968644413377e-38	1	4.04231342191063e-39	1	1.63668559934149e-38	1	8.73746636659638e-39	1	7.55674865987813e-39	1	1.27210992174768e-39	1	1.27210992174768e-39
<https://identifiers.org/wikipathways/WP2597_r117821>	WP2597	Secretion of hydrochloric acid in parietal cells	5	1	1.01312953818522e-13	1	1.08000209520309e-13	1	7.95812720175891e-14	1	1.22412475451539e-13	1	1.0089953754544e-13	1	9.6488206430979e-14	1	5.57455526883299e-14	1	5.57455526883299e-14
<https://identifiers.org/wikipathways/WP26_r118660>	WP26	S1P receptor signal transduction	25	14	6.24049308460976e-28	14	7.43895616414989e-28	14	3.21393363893687e-28	14	1.0495978834723e-27	14	6.17075580258889e-28	14	5.45731322644826e-28	14	1.2081291944651e-28	14	1.2081291944651e-28
<https://identifiers.org/wikipathways/WP262_r116630>	WP262	Ebstein-Barr virus LMP1 signaling	24	8	7.69163877957834e-42	8	9.9298586845417e-42	9	2.03379904714365e-39	8	1.63801568020741e-41	8	7.56698586428915e-42	9	4.18564457062599e-39	9	5.35851604755747e-40	8	7.06617500776819e-43
<https://identifiers.org/wikipathways/WP2636_r116781>	WP2636	Common pathways underlying drug addiction	41	10	1.30012275513086e-74	10	2.13119907622666e-74	10	2.00989780701954e-75	10	5.6135082989318e-74	10	1.25966030955985e-74	10	8.91518777001899e-75	10	1.28084072001581e-76	10	1.28084072001581e-76
<https://identifiers.org/wikipathways/WP2637_r117962>	WP2637	Interleukin-1 (IL-1) structural pathway	51	18	9.82729273944337e-75	18	1.66296144808948e-74	18	1.34727219089191e-75	18	4.6617636456028e-74	18	9.50209992918631e-75	18	6.57715743590604e-75	18	7.19168409431943e-77	18	7.19168409431943e-77
<https://identifiers.org/wikipathways/WP2640_r117652>	WP2640	Aripiprazole metabolic pathway	2	1	0.000341005967604384	1	0.000346500346500379	1	0.000321027287319477	1	0.000357525920629227	1	0.00034065746891505	1	0.000336870473303061	1	0.000293685756240802	1	0.000293685756240802
<https://identifiers.org/wikipathways/WP2643_r110709>	WP2643	Nanoparticle-mediated activation of receptor signaling	28	12	3.18154149518922e-40	12	4.10735063769672e-40	12	1.21237456846249e-40	12	6.77542849540332e-40	12	3.12998051659227e-40	12	2.61794576562702e-40	12	2.92282693503135e-41	12	2.92282693503135e-41
<https://identifiers.org/wikipathways/WP2645_r95179>	WP2645	Heroin metabolism	3	2	0.000511508951406576	2	0.000519750519750568	2	0.000481540930979215	2	0.000536288880943841	2	0.000510986203372576	2	0.000505305709954593	2	0.000440528634361202	2	0.000440528634361202
<https://identifiers.org/wikipathways/WP2646_r106722>	WP2646	Lidocaine metabolism	2	1	0.000341005967604384	1	0.000346500346500379	1	0.000321027287319477	1	0.000357525920629227	1	0.00034065746891505	1	0.000336870473303061	1	0.000293685756240802	1	0.000293685756240802
<https://identifiers.org/wikipathways/WP268_r117167>	WP268	Notch signaling	46	14	1.50981012465035e-74	14	2.51458833991609e-74	14	2.19799004586159e-75	14	6.83293502479219e-74	14	1.46133467343432e-74	14	1.02281509513479e-74	14	1.28194969795916e-76	14	1.28194969795916e-76
<https://identifiers.org/wikipathways/WP272_r120902>	WP272	Blood clotting cascade	23	9	1.23096559715107e-36	9	1.53929276626046e-36	9	5.2912671876521e-37	9	2.38538096116616e-36	9	1.21348914685908e-36	9	1.03786545165814e-36	9	1.52360472952219e-37	9	1.52360472952219e-37
<https://identifiers.org/wikipathways/WP2795_r117670>	WP2795	Cardiac hypertrophic response	54	17	2.17329449878343e-83	17	3.91895223365638e-83	17	2.34344733058751e-84	17	1.24429994368428e-82	17	2.0928514690723e-83	17	1.3856386847894e-83	17	8.7782752043368e-86	17	8.7782752043368e-86
<https://identifiers.org/wikipathways/WP2805_r106523>	WP2805	exRNA mechanism of action and biogenesis	6	2	3.03938861455565e-13	2	3.24000628560928e-13	2	2.38743816052768e-13	2	3.67237426354619e-13	2	3.02698612636321e-13	2	2.89464619292938e-13	2	1.6723665806499e-13	2	1.6723665806499e-13
<https://identifiers.org/wikipathways/WP2806_r116569>	WP2806	Complement system	136	51	6.40985755911297e-155	51	2.46986854435554e-154	51	3.92184741187264e-157	51	3.47167119337557e-153	51	5.87990813210419e-155	51	2.28879152804507e-155	51	2.13051209456243e-160	51	2.13051209456243e-160
<https://identifiers.org/wikipathways/WP2813_r102405>	WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	20	6	5.83857200229747e-38	6	7.30099335775709e-38	6	2.50969194671241e-38	6	1.13140598948591e-37	6	5.75567974794809e-38	6	4.92268198414912e-38	6	7.2265836973384e-39	6	7.2265836973384e-39
<https://identifiers.org/wikipathways/WP2814_r102407>	WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	14	6	8.60714757147815e-23	6	9.78046320428196e-23	6	5.3115390636944e-23	6	1.25638669526333e-22	6	8.53707024294871e-23	6	7.8071426066501e-23	6	2.60683756152388e-23	6	2.60683756152388e-23
<https://identifiers.org/wikipathways/WP2815_r102408>	WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	12	5	1.6661924353754e-20	5	1.86333945684214e-20	5	1.09213414748118e-20	5	2.31989732313294e-20	5	1.65431534795778e-20	5	1.52985677979982e-20	5	5.85850933744251e-21	5	5.85850933744251e-21
<https://identifiers.org/wikipathways/WP2816_r117724>	WP2816	Felbamate metabolism	4	1	1.1890088260142e-10	1	1.2474024199595e-10	1	9.92060136971183e-11	1	1.37028525020459e-10	1	1.18536776708378e-10	1	1.14627989240006e-10	1	7.5958890093117e-11	1	7.5958890093117e-11
<https://identifiers.org/wikipathways/WP2817_r102410>	WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	38	13	4.95856554849943e-60	13	7.38824832993868e-60	13	1.09939381756446e-60	13	1.61406789885857e-59	13	4.83367114466172e-60	13	3.65720164760541e-60	13	1.19248614605826e-61	13	1.19248614605826e-61
<https://identifiers.org/wikipathways/WP2826_r106727>	WP2826	Cocaine metabolism	6	3	5.94504413007102e-10	3	6.23701209979749e-10	3	4.96030068485593e-10	3	6.85142625102298e-10	3	5.92683883541888e-10	3	5.73139946200029e-10	3	3.79794450465585e-10	3	3.79794450465585e-10
<https://identifiers.org/wikipathways/WP2828_r119245>	WP2828	Bladder cancer	40	15	3.68350583602808e-59	15	5.48841304509746e-59	16	3.19224700555807e-57	15	1.19902186772348e-58	15	3.5907271360344e-59	16	1.01216974027815e-56	16	3.78367336386103e-58	15	8.85846851357598e-61
<https://identifiers.org/wikipathways/WP2839_r117746>	WP2839	Hair follicle development: organogenesis - part 2 of 3	32	15	1.71023066895637e-41	15	2.24337323802298e-41	15	6.13625099589524e-42	15	3.81805502254144e-41	15	1.68079936797469e-41	15	1.39025043768788e-41	15	1.35364597011078e-42	15	1.35364597011078e-42
<https://identifiers.org/wikipathways/WP2840_r120866>	WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	88	29	7.37349934505665e-120	29	1.88454190739808e-119	30	4.46126921646855e-119	29	1.18512739114976e-118	29	6.94388470087446e-120	30	7.19821939816898e-118	30	2.61209700970208e-121	29	1.14098588076687e-123
<https://identifiers.org/wikipathways/WP2846_r116729>	WP2846	PCSK9-mediated LDL receptor degradation	2	2	1	2	1	2	1	2	1	2	1	2	1	2	1	2	1
<https://identifiers.org/wikipathways/WP2848_r120814>	WP2848	Pluripotent stem cell differentiation pathway	50	17	3.46845626097993e-75	17	5.86927569913927e-75	17	4.75507832079489e-76	17	1.64532834550687e-74	17	3.35368232794817e-75	17	2.32134968326095e-75	17	2.53824144505391e-77	17	2.53824144505391e-77
<https://identifiers.org/wikipathways/WP2849_r117150>	WP2849	Hematopoietic stem cell differentiation	94	22	3.03255385218336e-147	22	9.51887693578326e-147	22	4.02687703869657e-149	22	8.9535448710623e-146	22	2.81856327415686e-147	22	1.26635399701274e-147	22	6.86405475935495e-152	22	6.86405475935495e-152
<https://identifiers.org/wikipathways/WP2853_r116557>	WP2853	Endoderm differentiation	145	45	4.33097579308096e-182	45	2.11307955747321e-181	45	1.08598670112227e-184	45	4.7161466582875e-180	45	3.91335977147167e-182	45	1.29145214449411e-182	45	1.58128671304282e-188	45	1.58128671304282e-188
<https://identifiers.org/wikipathways/WP2854_r106431>	WP2854	Gene regulatory network modelling somitogenesis 	12	2	4.93510524593939e-30	2	5.78974889502136e-30	2	2.6995485135235e-30	2	7.91754817469217e-30	2	4.88493940974894e-30	2	4.36864204572446e-30	2	1.10909154748312e-30	2	1.10909154748312e-30
<https://identifiers.org/wikipathways/WP2855_r117704>	WP2855	Dopaminergic neurogenesis	30	9	5.184854774701e-53	9	7.24873477191939e-53	9	1.4622611878383e-53	9	1.39778928599127e-52	9	5.07489555999405e-53	9	4.0146257075048e-53	9	2.26166756135788e-54	9	2.26166756135788e-54
<https://identifiers.org/wikipathways/WP2857_r118395>	WP2857	Mesodermal commitment pathway	153	53	3.02130629192973e-178	53	1.47409287591513e-177	53	7.57588730533649e-181	53	3.290003050839e-176	53	2.72997566022432e-178	53	9.00922257778298e-179	53	1.1031120291859e-184	53	1.1031120291859e-184
<https://identifiers.org/wikipathways/WP2858_r116763>	WP2858	Ectoderm differentiation	142	57	1.80717321039126e-152	57	6.96346248787e-152	57	1.10571218043708e-154	57	9.78791044589645e-151	57	1.65776109030579e-152	57	6.45294017145959e-153	57	6.0066925765519e-158	57	6.0066925765519e-158
<https://identifiers.org/wikipathways/WP286_r120663>	WP286	IL-3 signaling pathway	49	28	1.41515366448617e-46	28	1.97846883299864e-46	29	8.60149569043354e-45	28	3.81512446578451e-46	28	1.38514140910043e-46	29	2.2508246735198e-44	29	1.45384624347651e-45	28	6.17299283467331e-48
<https://identifiers.org/wikipathways/WP2864_r108133>	WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	53	26	1.8035028074988e-59	26	2.77411879329409e-59	27	8.21537314052027e-58	26	6.4504725899744e-59	26	1.75450083452589e-59	27	2.86720174622187e-57	27	8.15485307404845e-59	26	3.22090452017713e-61
<https://identifiers.org/wikipathways/WP2865_r120807>	WP2865	IL1 and megakaryocytes in obesity	24	18	2.3749046107749e-15	18	2.61383668987445e-15	18	1.65344984088536e-15	18	3.15402929398394e-15	18	2.36038541004289e-15	18	2.20732070783723e-15	18	9.69450502468421e-16	18	9.69450502468421e-16
<https://identifiers.org/wikipathways/WP2868_r117183>	WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	5	3	5.81326231852119e-07	3	6.00208464403848e-07	3	5.15209897800365e-07	3	6.39009688345344e-07	3	5.80138741340239e-07	3	5.67313023413633e-07	3	4.31193299428616e-07	3	4.31193299428616e-07
<https://identifiers.org/wikipathways/WP2870_r106411>	WP2870	Extracellular vesicle-mediated signaling in recipient cells	30	15	5.96171929406223e-37	15	7.57481215461733e-37	15	2.41282523320223e-37	15	1.21109667526463e-36	15	5.87108675054079e-37	15	4.96569651333346e-37	15	6.35714858369324e-38	15	6.35714858369324e-38
<https://identifiers.org/wikipathways/WP2873_r120645>	WP2873	Aryl hydrocarbon receptor pathway	46	17	7.58077463813491e-67	17	1.20375996356386e-66	17	1.32156505587087e-67	17	2.97908606603149e-66	17	7.35980584115127e-67	17	5.32604788998795e-67	17	1.00549315202727e-68	17	1.00549315202727e-68
<https://identifiers.org/wikipathways/WP2874_r116465>	WP2874	Liver X receptor pathway	10	6	4.2551440603779e-12	6	4.53600879985298e-12	6	3.34241342473874e-12	6	5.14132396896464e-12	6	4.23778057690848e-12	6	4.05250467010112e-12	6	2.34131321290986e-12	6	2.34131321290986e-12
<https://identifiers.org/wikipathways/WP2875_r117690>	WP2875	Constitutive androstane receptor pathway	32	16	6.2861666025826e-39	16	8.11540268854818e-39	17	8.79971555638451e-37	16	1.33870554227862e-38	16	6.18429117454184e-39	17	1.81101872839223e-36	17	2.31848948346462e-37	16	5.77499211998508e-40
<https://identifiers.org/wikipathways/WP2876_r116466>	WP2876	Pregnane X receptor pathway	33	17	1.22025586991311e-38	17	1.5753428748358e-38	17	4.64996978960264e-39	17	2.59866369971729e-38	17	1.20048005152869e-38	17	1.00409304497552e-38	17	1.12102788211474e-39	17	1.12102788211474e-39
<https://identifiers.org/wikipathways/WP2877_r119905>	WP2877	Vitamin D receptor pathway	186	82	8.19376435408162e-173	82	4.25700588445744e-172	85	6.9409794024422e-170	82	1.07457361674181e-170	82	7.3739711785844e-173	85	8.65480127928817e-168	85	9.25832736742677e-174	82	1.66148971741104e-179
<https://identifiers.org/wikipathways/WP2878_r116507>	WP2878	PPAR-alpha pathway	26	10	5.55507245191766e-41	10	7.1715646055023e-41	10	2.11684448461708e-41	10	1.18301132459424e-40	10	5.46504534643108e-41	10	4.5710164161742e-41	10	5.10334861672146e-42	10	5.10334861672146e-42
<https://identifiers.org/wikipathways/WP2879_r116462>	WP2879	Farnesoid X receptor pathway	19	7	1.44066789179143e-32	7	1.74496035848308e-32	7	6.98569275651409e-33	7	2.54023612181178e-32	7	1.42311533374315e-32	7	1.24461399275739e-32	7	2.40265872448331e-33	7	2.40265872448331e-33
<https://identifiers.org/wikipathways/WP288_r118398>	WP288	Nod-like receptor (NLR) signaling pathway	10	2	1.28978235336834e-24	2	1.46560387676551e-24	2	7.95934924629522e-25	2	1.88269734554945e-24	2	1.27928125518712e-24	2	1.169901489508e-24	2	3.90634999229351e-25	2	3.90634999229351e-25
<https://identifiers.org/wikipathways/WP2880_r117734>	WP2880	Glucocorticoid receptor pathway	71	36	2.66547697765738e-72	36	4.65615182007135e-72	36	3.24074897097997e-73	36	1.38913180158507e-71	36	2.5720390002997e-72	36	1.74116946479966e-72	36	1.44909970554991e-74	36	1.44909970554991e-74
<https://identifiers.org/wikipathways/WP2881_r117716>	WP2881	Estrogen receptor pathway	13	7	3.0278286963132e-17	7	3.33244952288668e-17	7	2.10802693019055e-17	7	4.02115536009718e-17	7	3.00931778331715e-17	7	2.81417154644173e-17	7	1.2359780842193e-17	7	1.2359780842193e-17
<https://identifiers.org/wikipathways/WP2882_r120815>	WP2882	Nuclear receptors meta-pathway	318	138	1.0173062307254e-257	138	1.73030380895754e-256	139	1.04750932914116e-260	138	4.45698013651389e-254	138	8.48623444019909e-258	139	5.14349880417093e-257	139	1.5598214035233e-267	138	3.10223458419986e-269
<https://identifiers.org/wikipathways/WP2884_r106658>	WP2884	NRF2 pathway	143	59	4.49262098273633e-150	59	1.70405002777383e-149	59	2.91744517574811e-152	59	2.3224234477461e-148	59	4.12533992655243e-150	59	1.62361217020678e-150	59	1.73046458885241e-155	59	1.73046458885241e-155
<https://identifiers.org/wikipathways/WP2889_r107138>	WP2889	Oxytocin signaling	5	2	2.97252206503549e-10	2	3.11850604989874e-10	2	2.48015034242795e-10	2	3.42571312551149e-10	2	2.96341941770944e-10	2	2.86569973100015e-10	2	1.89897225232792e-10	2	1.89897225232792e-10
<https://identifiers.org/wikipathways/WP289_r122789>	WP289	Myometrial relaxation and contraction pathways	156	56	6.76436908693204e-177	56	3.30033016107665e-176	57	1.88332940296859e-177	56	7.36595127493449e-175	56	6.11211217261358e-177	57	2.13596549651443e-175	57	2.99359123478281e-181	56	2.46974526534413e-183
<https://identifiers.org/wikipathways/WP2895_r118446>	WP2895	Differentiation of white and brown adipocyte	25	7	4.44705679969883e-47	7	5.92708276327367e-47	7	1.5023620894169e-47	7	1.04074640766904e-46	7	4.36607388902298e-47	7	3.57130725966339e-47	7	3.0326214207416e-48	7	3.0326214207416e-48
<https://identifiers.org/wikipathways/WP2911_r120808>	WP2911	miRNA targets in ECM and membrane receptors	41	17	3.26977500221748e-56	17	4.79501662641451e-56	17	7.69894866046359e-57	17	1.01536874620477e-55	17	3.19066468802885e-56	17	2.44111525596497e-56	17	9.12532987754724e-58	17	9.12532987754724e-58
<https://identifiers.org/wikipathways/WP2916_r104425>	WP2916	Interactome of polycomb repressive complex 2 (PRC2) 	16	4	5.20365079594436e-34	4	6.30274639286966e-34	4	2.52321203795662e-34	4	9.17525946990856e-34	4	5.14025146346838e-34	4	4.49550977776148e-34	4	8.6783338861625e-35	4	8.6783338861625e-35
<https://identifiers.org/wikipathways/WP2942_r119083>	WP2942	DDX1 as a regulatory component of the Drosha microprocessor	7	1	1.23512825607182e-19	1	1.35939083101438e-19	2	2.68079357133346e-16	1	1.6403314405991e-19	1	1.22757718433684e-19	2	3.4106250379574e-16	2	1.7180167397343e-16	1	5.0418686419202e-20
<https://identifiers.org/wikipathways/WP2943_r117758>	WP2943	Hypoxia-mediated EMT and stemness	2	1	0.000341005967604384	1	0.000346500346500379	1	0.000321027287319477	1	0.000357525920629227	1	0.00034065746891505	1	0.000336870473303061	1	0.000293685756240802	1	0.000293685756240802
<https://identifiers.org/wikipathways/WP299_r117807>	WP299	Nuclear receptors in lipid metabolism and toxicity	35	11	8.99983173770644e-59	11	1.31979548403089e-58	11	2.11908288657246e-59	11	2.7947329285262e-58	11	8.78208601638575e-59	11	6.71900254333531e-59	11	2.51168454689689e-60	11	2.51168454689689e-60
<https://identifiers.org/wikipathways/WP3_r120028>	WP3	Transcriptional activation by NRF2 in response to phytochemicals	15	6	2.19831795627744e-25	6	2.53818249246069e-25	6	1.27722164083707e-25	6	3.36412003372912e-25	6	2.17819448280709e-25	6	1.9698425416274e-25	6	5.73519557390131e-26	6	5.73519557390131e-26
<https://identifiers.org/wikipathways/WP304_r120696>	WP304	Kit receptor signaling pathway	58	27	3.04443891016223e-67	27	4.99053290726586e-67	27	4.70648718745328e-68	27	1.31448996030122e-66	27	2.94968982342355e-67	27	2.08762937432902e-67	27	2.99928703681801e-69	27	2.99928703681801e-69
<https://identifiers.org/wikipathways/WP306_r116784>	WP306	Focal adhesion	198	91	3.49897222485874e-174	91	1.90553617245326e-173	91	5.79047927553509e-177	91	5.2749727720959e-172	91	3.13942193212102e-174	91	9.59348019466191e-175	91	4.56563427635874e-181	91	4.56563427635874e-181
<https://identifiers.org/wikipathways/WP313_r118735>	WP313	Hepatocyte growth factor receptor signaling	34	13	3.36297657386758e-51	13	4.7016408920634e-51	13	9.48445102757902e-52	13	9.06627635344497e-51	13	3.29165533552846e-51	13	2.60394799736002e-51	13	1.46695237518225e-52	13	1.46695237518225e-52
<https://identifiers.org/wikipathways/WP314_r121827>	WP314	Fas ligand pathway and stress induction of heat shock proteins	43	14	3.39586742683246e-68	14	5.39233712268394e-68	14	5.92005426872328e-69	14	1.33450495711557e-67	14	3.2968827219913e-68	14	2.38584490460589e-68	14	4.50418539775051e-70	14	4.50418539775051e-70
<https://identifiers.org/wikipathways/WP322_r117584>	WP322	Osteoblast signaling	14	6	8.60714757147815e-23	6	9.78046320428196e-23	6	5.3115390636944e-23	6	1.25638669526333e-22	6	8.53707024294871e-23	6	7.8071426066501e-23	6	2.60683756152388e-23	6	2.60683756152388e-23
<https://identifiers.org/wikipathways/WP325_r116669>	WP325	Triacylglyceride synthesis	24	6	1.24517590391568e-47	6	1.65958317371661e-47	7	3.75410238903485e-45	6	2.91408994147335e-47	6	1.22250068892642e-47	7	8.50542536961436e-45	7	8.28148257576104e-46	6	8.49133997807617e-49
<https://identifiers.org/wikipathways/WP3286_r106367>	WP3286	Copper homeostasis	55	16	5.83254640970663e-88	16	1.0856855862479e-87	16	5.57799506236306e-89	16	3.66849996160926e-87	16	5.60525715275277e-88	16	3.62959762955541e-88	16	1.75047826817339e-90	16	1.75047826817339e-90
<https://identifiers.org/wikipathways/WP3287_r121705>	WP3287	Overview of nanoparticle effects	22	11	9.8762586208608e-29	11	1.17729567119591e-28	12	2.64492764859984e-26	11	1.66110273732138e-28	11	9.76589179192335e-29	12	4.28024985499934e-26	12	1.08665092850572e-26	11	1.91199576863172e-29
<https://identifiers.org/wikipathways/WP3297_r106734>	WP3297	EV release from cardiac cells and their functional effects	12	4	1.41876058870518e-23	4	1.61216426444208e-23	4	8.75528417092476e-24	4	2.07096708010441e-23	4	1.40720938070584e-23	4	1.28689163845881e-23	4	4.29698499152287e-24	4	4.29698499152287e-24
<https://identifiers.org/wikipathways/WP3298_r120642>	WP3298	Melatonin metabolism and effects	40	11	1.00161716503286e-69	11	1.59047946897097e-69	11	1.74613058408177e-70	11	3.93614621497501e-69	11	9.72421449481289e-70	11	7.03709217467423e-70	11	1.32851753081695e-71	11	1.32851753081695e-71
<https://identifiers.org/wikipathways/WP3299_r88676>	WP3299	let-7 inhibition of ES cell reprogramming	16	1	6.14937040670821e-44	1	7.81323698792234e-44	1	2.48877133487148e-44	1	1.24921716155813e-43	1	6.0558851126972e-44	1	5.1219968068944e-44	1	6.55724623105711e-45	1	6.55724623105711e-45
<https://identifiers.org/wikipathways/WP3300_r102277>	WP3300	Dual hijack model of Vif in HIV infection	9	3	1.48215390728618e-18	3	1.63126899721727e-18	4	1.60847614280008e-15	3	1.96839772871891e-18	3	1.47309262120421e-18	4	2.04637502277443e-15	4	1.03081004384058e-15	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP3301_r120029>	WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	13	3	2.13854560657372e-29	3	2.50889118784261e-29	3	1.16980435586016e-29	3	3.43093754236663e-29	3	2.11680707755789e-29	3	1.89307821981393e-29	3	4.80606337242684e-30	3	4.80606337242684e-30
<https://identifiers.org/wikipathways/WP3302_r87966>	WP3302	eIF5A regulation in response to inhibition of the nuclear export system	4	1	1.1890088260142e-10	1	1.2474024199595e-10	1	9.92060136971183e-11	1	1.37028525020459e-10	1	1.18536776708378e-10	1	1.14627989240006e-10	1	7.5958890093117e-11	1	7.5958890093117e-11
<https://identifiers.org/wikipathways/WP3303_r120561>	WP3303	RAC1/PAK1/p38/MMP2 pathway	68	25	1.26352153323591e-91	25	2.50612858086656e-91	25	9.50649826167778e-93	25	9.5899894391822e-91	25	1.20936085102195e-91	25	7.49085313837675e-92	25	2.09420297733166e-94	25	2.09420297733166e-94
<https://identifiers.org/wikipathways/WP334_r117741>	WP334	GPCRs, class B secretin-like	23	3	1.7985776804666e-54	3	2.47478171523472e-54	7	9.77005146746331e-43	3	4.62551668231956e-54	3	1.76222869106544e-54	7	2.10969988438809e-42	7	2.35539166925604e-43	3	9.10532829005252e-56
<https://identifiers.org/wikipathways/WP34_r116553>	WP34	Ovarian infertility	32	11	4.67579630591209e-52	11	6.53704081249452e-52	11	1.31869372575965e-52	11	1.2605517924576e-51	11	4.57663308683096e-52	11	3.62046245622247e-52	11	2.03961292806089e-53	11	2.03961292806089e-53
<https://identifiers.org/wikipathways/WP3407_r117112>	WP3407	FTO obesity variant mechanism	8	1	1.68302266199533e-22	1	1.88216106751731e-22	1	1.10316580553654e-22	1	2.3433306294272e-22	1	1.67102560399776e-22	1	1.54530987858568e-22	1	5.91768619943689e-23	1	5.91768619943689e-23
<https://identifiers.org/wikipathways/WP3408_r118453>	WP3408	Evolocumab mechanism to reduce LDL cholesterol	2	2	1	2	1	2	1	2	1	2	1	2	1	2	1	2	1
<https://identifiers.org/wikipathways/WP3413_r116601>	WP3413	NOTCH1 regulation of endothelial cell calcification	17	9	6.96769089119659e-22	9	7.91751783203769e-22	9	4.2998173372764e-22	9	1.01707494378461e-21	9	6.91096162524418e-22	9	6.32006782443105e-22	9	2.11029707361456e-22	9	2.11029707361456e-22
<https://identifiers.org/wikipathways/WP3414_r106735>	WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	32	8	2.26886514395966e-60	8	3.32721550596023e-60	8	5.34222576446847e-61	8	7.04554519796534e-60	8	2.21397126463498e-60	8	1.69386618739547e-60	8	6.3319778493199e-62	8	6.3319778493199e-62
<https://identifiers.org/wikipathways/WP35_r117729>	WP35	G protein signaling pathways	92	27	9.26620249779323e-132	27	2.60404486817836e-131	27	1.86878701880237e-133	27	1.97222690578644e-130	27	8.67349021058293e-132	27	4.21035813167073e-132	27	5.90185874263716e-136	27	5.90185874263716e-136
<https://identifiers.org/wikipathways/WP3527_r120810>	WP3527	Pre-implantation embryo	59	11	3.80803525375274e-109	11	8.17643049760663e-109	11	2.12328177667004e-110	11	3.65479800466195e-108	11	3.626359000646e-109	11	2.12498052748695e-109	11	3.00633365139808e-112	11	3.00633365139808e-112
<https://identifiers.org/wikipathways/WP3529_r120882>	WP3529	Zinc homeostasis	37	23	9.19934623479896e-33	23	1.15035604133247e-32	23	3.95431025795497e-33	23	1.78266114133909e-32	23	9.06873989002091e-33	23	7.75625546078308e-33	23	1.13863193774796e-33	23	1.13863193774796e-33
<https://identifiers.org/wikipathways/WP357_r121828>	WP357	Fatty acid biosynthesis	23	11	3.86579217630701e-31	11	4.68231029526297e-31	11	1.87449422299796e-31	11	6.81630026019497e-31	11	3.81869281221078e-31	11	3.33971421389899e-31	11	6.44713424403025e-32	11	6.44713424403025e-32
<https://identifiers.org/wikipathways/WP3580_r120915>	WP3580	Methionine de novo and salvage pathway	22	8	4.81682190189552e-37	8	6.02331952014958e-37	8	2.07049585603772e-37	8	9.33409941325873e-37	8	4.74843579205723e-37	8	4.06121263692309e-37	8	5.96193155030424e-38	8	5.96193155030424e-38
<https://identifiers.org/wikipathways/WP3584_r117155>	WP3584	MECP2 and associated Rett syndrome	73	21	7.83674643851993e-111	21	1.79279702426241e-110	21	3.43885884107273e-112	21	9.07352926017857e-110	21	7.43265942917976e-111	21	4.16648656725644e-111	21	3.41959212169179e-114	21	3.41959212169179e-114
<https://identifiers.org/wikipathways/WP3585_r106742>	WP3585	Cytosine methylation	9	3	1.48215390728618e-18	3	1.63126899721727e-18	3	1.03190129449887e-18	3	1.96839772871891e-18	3	1.47309262120421e-18	3	1.37756649126517e-18	3	6.0502423703042e-19	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP3591_r88424>	WP3591	Sleep regulation	39	10	2.75444720384037e-70	10	4.37381853966999e-70	10	4.80185910622475e-71	10	1.08244020911811e-69	10	2.67415898607352e-70	10	1.93520034803539e-70	10	3.6534232097468e-72	10	3.6534232097468e-72
<https://identifiers.org/wikipathways/WP3593_r117786>	WP3593	MicroRNA for targeting cancer growth and vascularization in glioblastoma	8	6	1.62771344918594e-06	6	1.68058370033078e-06	6	1.44258771384103e-06	6	1.78922712736696e-06	6	1.62438847575267e-06	6	1.58847646555818e-06	6	1.20734123840013e-06	6	1.20734123840013e-06
<https://identifiers.org/wikipathways/WP3594_r117682>	WP3594	Circadian rhythm genes	209	57	2.98761390543041e-255	57	3.28854061865561e-254	59	4.11413847193537e-255	57	3.61237907823791e-252	57	2.56259835789966e-255	59	5.18324797588264e-252	59	7.5991955722842e-261	57	5.36743450132653e-265
<https://identifiers.org/wikipathways/WP3595_r89883>	WP3595	mir-124 predicted interactions with cell cycle and differentiation 	6	4	8.71989347778175e-07	4	9.00312696605772e-07	4	7.72814846700547e-07	4	9.58514532518016e-07	4	8.70208112010357e-07	4	8.50969535120449e-07	4	6.46789949142924e-07	4	6.46789949142924e-07
<https://identifiers.org/wikipathways/WP3596_r105860>	WP3596	miR-517 relationship with ARCN1 and USP1	5	1	1.01312953818522e-13	1	1.08000209520309e-13	1	7.95812720175891e-14	1	1.22412475451539e-13	1	1.0089953754544e-13	1	9.6488206430979e-14	1	5.57455526883299e-14	1	5.57455526883299e-14
<https://identifiers.org/wikipathways/WP3599_r105845>	WP3599	Transcription factor regulation in adipogenesis	22	11	9.8762586208608e-29	11	1.17729567119591e-28	11	5.08639932423055e-29	11	1.66110273732138e-28	11	9.76589179192335e-29	11	8.6367913670747e-29	11	1.91199576863172e-29	11	1.91199576863172e-29
<https://identifiers.org/wikipathways/WP3601_r117687>	WP3601	Lipid particles composition	11	6	7.97522314945564e-15	6	8.63852091384699e-15	6	5.8977458569336e-15	6	1.01026373095056e-14	6	7.93456788867978e-15	6	7.50337508350628e-15	6	3.77963682741546e-15	6	3.77963682741546e-15
<https://identifiers.org/wikipathways/WP3611_r120501>	WP3611	Photodynamic therapy-induced AP-1 survival signaling	50	22	7.81370713774186e-63	22	1.22116680620552e-62	22	1.44654253341921e-63	22	2.9294156262639e-62	22	7.59367237753141e-63	22	5.55677251110198e-63	22	1.20258370818819e-64	22	1.20258370818819e-64
<https://identifiers.org/wikipathways/WP3612_r106540>	WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	23	10	7.23561578005384e-34	10	8.90480865281671e-34	10	3.30333810525122e-34	10	1.33748310492587e-33	10	7.1401701401188e-34	10	6.17529943736579e-34	10	1.039555506953e-34	10	1.039555506953e-34
<https://identifiers.org/wikipathways/WP3613_r106539>	WP3613	Photodynamic therapy-induced unfolded protein response	27	18	2.05856774334265e-22	18	2.37682660543994e-22	19	3.9267449506598e-20	18	3.15025811729917e-22	18	2.03972354782863e-22	19	5.77170899848773e-20	19	1.92719776869801e-20	18	5.37060099813182e-23
<https://identifiers.org/wikipathways/WP3614_r106542>	WP3614	Photodynamic therapy-induced HIF-1 survival signaling	37	26	1.19701454030413e-25	26	1.42689665262712e-25	26	6.16477775909677e-26	26	2.01327669297041e-25	26	1.18363794658814e-25	26	1.04678960371945e-25	26	2.31736209420231e-26	26	2.31736209420231e-26
<https://identifiers.org/wikipathways/WP3617_r106541>	WP3617	Photodynamic therapy-induced NF-kB survival signaling	35	19	4.24591954735843e-38	19	5.48145620191406e-38	20	5.05211739618737e-36	19	9.04213392591681e-38	19	4.17710895122562e-38	20	1.0397471559059e-35	20	1.33109769028735e-36	19	3.90065257227055e-39
<https://identifiers.org/wikipathways/WP3624_r122572>	WP3624	Lung fibrosis	64	36	9.8498722478796e-59	36	1.5393892837852e-58	39	8.14225983599434e-53	36	3.69278873279867e-58	36	9.57249887824103e-59	39	2.70857318020926e-52	39	8.83171425644369e-54	36	1.51596363726255e-60
<https://identifiers.org/wikipathways/WP363_r120695>	WP363	Wnt signaling pathway	51	13	1.41330078840944e-87	13	2.58930863307695e-87	13	1.43519439009101e-88	13	8.48115069337675e-87	13	1.35960623130765e-87	13	8.90225452529056e-88	13	4.92066829474168e-90	13	4.92066829474168e-90
<https://identifiers.org/wikipathways/WP3630_r121716>	WP3630	NAD metabolism, sirtuins and aging	11	4	6.94246848073074e-21	4	7.7639144035089e-21	4	4.55055894783824e-21	4	9.66623884638719e-21	4	6.89298061649074e-21	4	6.37440324916587e-21	4	2.44104555726771e-21	4	2.44104555726771e-21
<https://identifiers.org/wikipathways/WP3633_r118462>	WP3633	Caffeine and theobromine metabolism	4	1	1.1890088260142e-10	1	1.2474024199595e-10	1	9.92060136971183e-11	1	1.37028525020459e-10	1	1.18536776708378e-10	1	1.14627989240006e-10	1	7.5958890093117e-11	1	7.5958890093117e-11
<https://identifiers.org/wikipathways/WP3634_r116602>	WP3634	Insulin signaling in adipocytes (normal condition)	8	4	1.41838135345931e-12	4	1.51200293328433e-12	4	1.11413780824625e-12	4	1.71377465632155e-12	4	1.41259352563617e-12	4	1.35083489003371e-12	4	7.80437737636619e-13	4	7.80437737636619e-13
<https://identifiers.org/wikipathways/WP3635_r116600>	WP3635	Insulin signaling in adipocytes (diabetic condition)	8	4	1.41838135345931e-12	4	1.51200293328433e-12	4	1.11413780824625e-12	4	1.71377465632155e-12	4	1.41259352563617e-12	4	1.35083489003371e-12	4	7.80437737636619e-13	4	7.80437737636619e-13
<https://identifiers.org/wikipathways/WP364_r121718>	WP364	IL6 signaling pathway	44	27	2.074909268366e-38	27	2.72173573335496e-38	27	7.44470573210615e-39	27	4.63219254408349e-38	27	2.03920222586267e-38	27	1.68669850849345e-38	27	1.64228873943835e-39	27	1.64228873943835e-39
<https://identifiers.org/wikipathways/WP3640_r122579>	WP3640	Imatinib and chronic myeloid leukemia	20	10	1.38150046184662e-26	10	1.62074370734632e-26	10	7.55693613885664e-27	9	3.95500651743186e-29	9	2.3252123314103e-29	9	2.05637889692254e-29	10	3.10471693858776e-27	10	3.10471693858776e-27
<https://identifiers.org/wikipathways/WP3644_r118983>	WP3644	NAD+ metabolism	16	7	5.02472675720555e-25	7	5.80155998276729e-25	7	2.91936375048472e-25	7	7.68941721995219e-25	7	4.97873024641623e-25	7	4.50249723800548e-25	7	1.31090184546314e-25	7	1.31090184546314e-25
<https://identifiers.org/wikipathways/WP3645_r118940>	WP3645	NAD+ biosynthetic pathways	22	9	3.14591990437121e-34	9	3.87165593600724e-34	9	1.43623395880485e-34	9	5.81514393446031e-34	9	3.10442180005165e-34	9	2.68491279885469e-34	9	4.51980655196953e-35	9	4.51980655196953e-35
<https://identifiers.org/wikipathways/WP3646_r116732>	WP3646	Hepatitis C and hepatocellular carcinoma	56	24	2.74109483073348e-70	24	4.56529267318499e-70	25	9.99381126918402e-69	24	1.24053498975796e-69	24	2.65308653977269e-70	25	4.43289721953714e-68	25	6.36872202010368e-70	24	2.32740901187825e-72
<https://identifiers.org/wikipathways/WP3651_r122573>	WP3651	Pathways affected in adenoid cystic carcinoma	66	20	8.5699450393085e-100	20	1.78265587679914e-99	20	5.38671982606442e-101	20	7.4882489542052e-99	20	8.17765939145084e-100	20	4.89944891826145e-100	20	9.10172748627619e-103	20	9.10172748627619e-103
<https://identifiers.org/wikipathways/WP3655_r117757>	WP3655	Hypothetical craniofacial development pathway	8	5	1.66461235641988e-09	5	1.7463633879433e-09	5	1.38888419175966e-09	5	1.91839935028643e-09	5	1.65951487391729e-09	5	1.60479184936009e-09	5	1.06342446130364e-09	5	1.06342446130364e-09
<https://identifiers.org/wikipathways/WP3656_r117955>	WP3656	Interleukin-1 induced activation of NF-kB	10	5	4.35012171788489e-15	5	4.71192049846199e-15	5	3.21695228560015e-15	5	5.51052944154852e-15	5	4.32794612109808e-15	5	4.09275004554889e-15	5	2.06162008768117e-15	5	2.06162008768117e-15
<https://identifiers.org/wikipathways/WP3657_r120797>	WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	20	6	5.83857200229747e-38	6	7.30099335775709e-38	6	2.50969194671241e-38	6	1.13140598948591e-37	6	5.75567974794809e-38	6	4.92268198414912e-38	6	7.2265836973384e-39	6	7.2265836973384e-39
<https://identifiers.org/wikipathways/WP3658_r116670>	WP3658	Wnt/beta-catenin signaling pathway in leukemia	27	6	1.07272857407607e-54	6	1.49973822867297e-54	6	3.02536797483791e-55	6	2.89197783308539e-54	6	1.04997839172294e-54	6	8.30612215345807e-55	6	4.67931219591277e-56	6	4.67931219591277e-56
<https://identifiers.org/wikipathways/WP366_r120697>	WP366	TGF-beta signaling pathway	132	44	5.42369332718656e-163	44	2.19099978402202e-162	44	2.77575368081061e-165	44	3.37839306720274e-161	44	4.96025881607863e-163	44	1.86803171262828e-163	44	1.15853414921461e-168	44	1.15853414921461e-168
<https://identifiers.org/wikipathways/WP3664_r118061>	WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	18	5	5.41880940465855e-36	5	6.6688810380985e-36	5	2.47389581420932e-36	5	1.00165158679699e-35	5	5.34732941635697e-36	5	4.62473017984543e-36	5	7.78531272109585e-37	5	7.78531272109585e-37
<https://identifiers.org/wikipathways/WP3668_r117756>	WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	25	10	1.25630100066447e-38	10	1.59622478354007e-38	11	2.88614573871933e-36	10	2.55211943063428e-38	10	1.2372021888113e-38	11	5.66108428177158e-36	11	8.31057125193925e-37	10	1.33962901188939e-39
<https://identifiers.org/wikipathways/WP3670_r117829>	WP3670	Interactions between LOXL4 and oxidative stress pathway	18	9	2.13550887181237e-24	9	2.46566299267609e-24	9	1.24072959395602e-24	9	3.2680023184797e-24	9	2.11596035472688e-24	9	1.91356132615233e-24	9	5.57133284321839e-25	9	5.57133284321839e-25
<https://identifiers.org/wikipathways/WP3672_r117771>	WP3672	lncRNA-mediated mechanisms of therapeutic resistance	7	2	3.62510143157076e-16	2	3.926600415385e-16	2	2.68079357133346e-16	2	4.59210786795711e-16	2	3.60662176758171e-16	2	3.4106250379574e-16	2	1.7180167397343e-16	2	1.7180167397343e-16
<https://identifiers.org/wikipathways/WP3674_r117841>	WP3674	Tgif disruption of Shh signaling	9	1	2.5795647067367e-25	1	2.93120775353105e-25	1	1.59186984925905e-25	1	3.76539469109893e-25	1	2.55856251037422e-25	1	2.33980297901602e-25	1	7.81269998458703e-26	1	7.81269998458703e-26
<https://identifiers.org/wikipathways/WP3676_r116809>	WP3676	BDNF-TrkB signaling	33	11	2.62149639984879e-54	11	3.72384510292297e-54	11	6.9615890177681e-55	11	7.40840768496896e-54	11	2.56328737042476e-54	11	2.00529139065698e-54	11	9.85320255101876e-56	11	9.85320255101876e-56
<https://identifiers.org/wikipathways/WP3678_r117647>	WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	17	5	1.76924127062109e-33	5	2.14293377357574e-33	5	8.57892092905242e-34	5	3.1195882197689e-33	5	1.74768549757931e-33	5	1.52847332443889e-33	5	2.95063352129527e-34	5	2.95063352129527e-34
<https://identifiers.org/wikipathways/WP3679_r117678>	WP3679	Cell-type dependent selectivity of CCK2R signaling	13	4	3.14045422325347e-26	4	3.62597498922956e-26	4	1.82460234405296e-26	4	4.80588576247015e-26	4	3.11170640401015e-26	4	2.81406077375342e-26	4	8.19313653414472e-27	4	8.19313653414472e-27
<https://identifiers.org/wikipathways/WP368_r117795>	WP368	Mitochondrial long chain fatty acid beta-oxidation	17	12	1.06819655516951e-13	12	1.15703825573345e-13	12	7.89940505686255e-14	12	1.35314111842469e-13	12	1.06275121418075e-13	12	1.00499751118478e-13	12	5.06242265975041e-14	12	5.06242265975041e-14
<https://identifiers.org/wikipathways/WP3680_r117651>	WP3680	Physico-chemical features and toxicity-associated pathways	67	20	9.71386089720279e-102	20	2.0529038113706e-101	20	5.75064098703495e-103	20	8.89561489240662e-101	20	9.25981374391097e-102	20	5.48659664923157e-102	20	8.89462866949378e-105	20	8.89462866949378e-105
<https://identifiers.org/wikipathways/WP382_r119087>	WP382	MAPK signaling pathway	249	85	4.84425935572004e-258	85	6.42703959289965e-257	86	2.05735532878806e-260	85	1.01775801210598e-254	85	4.10576395280044e-258	86	4.7731276836551e-257	86	1.22740712756887e-266	85	1.51379625657413e-268
<https://identifiers.org/wikipathways/WP383_r118423>	WP383	Striated muscle contraction pathway	38	6	1.73759663165592e-79	6	2.89396670356236e-79	6	2.52960292009346e-80	6	7.86382651007381e-79	6	1.68180764244744e-79	6	1.1771281932055e-79	6	1.47535868302779e-81	6	1.47535868302779e-81
<https://identifiers.org/wikipathways/WP384_r121706>	WP384	Apoptosis modulation by HSP70	20	4	5.06695571777222e-44	4	6.54140888309723e-44	4	1.93084021096112e-44	4	1.0790617129166e-43	4	4.98483917278596e-44	4	4.16936736045077e-44	4	4.65492424754155e-45	4	4.65492424754155e-45
<https://identifiers.org/wikipathways/WP3844_r107714>	WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	30	13	3.62044798871812e-42	13	4.74907641113731e-42	13	1.2990047471149e-42	13	8.08257615658978e-42	13	3.55814382333353e-42	13	2.94307048300863e-42	13	2.86558118672646e-43	13	2.86558118672646e-43
<https://identifiers.org/wikipathways/WP3845_r116460>	WP3845	Canonical and non-canonical Notch signaling	29	9	1.01709567830385e-50	9	1.39948905996526e-50	9	3.04637747466314e-51	9	2.61572968385169e-50	9	9.96540324797498e-51	9	7.97170844653546e-51	9	5.14906314802465e-52	9	5.14906314802465e-52
<https://identifiers.org/wikipathways/WP3849_r116433>	WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	12	1	1.68003582840483e-33	1	2.002680351097e-33	1	8.65239908180607e-34	1	2.8256774356503e-33	1	1.66126148945724e-33	1	1.4691918768201e-33	1	3.25246788118213e-34	1	3.25246788118213e-34
<https://identifiers.org/wikipathways/WP3850_r121711>	WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	39	10	2.75444720384037e-70	10	4.37381853966999e-70	10	4.80185910622475e-71	10	1.08244020911811e-69	10	2.67415898607352e-70	10	1.93520034803539e-70	10	3.6534232097468e-72	10	3.6534232097468e-72
<https://identifiers.org/wikipathways/WP3851_r121712>	WP3851	TLR4 signaling and tolerance	29	11	3.20066806211053e-45	11	4.2658831124398e-45	12	5.62902057083125e-43	11	7.49053573592352e-45	11	3.14238245267226e-45	12	1.27533054263705e-42	12	1.24175184758146e-43	11	2.18266034436466e-46
<https://identifiers.org/wikipathways/WP3853_r120593>	WP3853	ERK pathway in Huntington's disease	15	2	6.64069779982673e-38	2	8.17264833100341e-38	2	3.03173506643298e-38	2	1.2275141995061e-37	2	6.55309977494717e-38	2	5.66756149490873e-38	2	9.54082441310752e-39	2	9.54082441310752e-39
<https://identifiers.org/wikipathways/WP3858_r117850>	WP3858	Toll-like receptor signaling related to MyD88	31	11	8.59908164384172e-50	11	1.18320438706151e-49	11	2.57557368312434e-50	11	2.2114805508928e-49	11	8.42529547328804e-50	11	6.73971714116193e-50	11	4.35329884333e-51	11	4.35329884333e-51
<https://identifiers.org/wikipathways/WP3859_r117840>	WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	19	6	1.71595631147523e-35	6	2.11181232873122e-35	6	7.83400341166293e-36	6	3.17189669152378e-35	6	1.69332098184633e-35	6	1.46449789028439e-35	6	2.46534902834702e-36	6	2.46534902834702e-36
<https://identifiers.org/wikipathways/WP3863_r121717>	WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	66	24	4.09549039553601e-90	24	7.99529827104829e-90	24	3.27177113132372e-91	24	2.96582421418093e-89	24	3.92391939864608e-90	24	2.45762790355334e-90	24	7.87394578614864e-93	24	7.87394578614864e-93
<https://identifiers.org/wikipathways/WP3865_r106524>	WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	60	19	1.88586700954861e-90	19	3.6236538242582e-90	22	4.26534586738507e-84	19	1.30301986223177e-89	19	1.80869864049106e-90	22	2.64571787710591e-83	22	1.46240483663117e-85	20	1.44051794373839e-90
<https://identifiers.org/wikipathways/WP3869_r118463>	WP3869	Cannabinoid receptor signaling	31	15	3.14308330129133e-39	15	4.05770134427403e-39	15	1.1977194912613e-39	15	6.693527711393e-39	15	3.09214558727091e-39	15	2.58630026736124e-39	15	2.8874960599925e-40	15	2.8874960599925e-40
<https://identifiers.org/wikipathways/WP3871_r106754>	WP3871	Valproic acid pathway	13	7	3.0278286963132e-17	7	3.33244952288668e-17	7	2.10802693019055e-17	7	4.02115536009718e-17	7	3.00931778331715e-17	7	2.81417154644173e-17	7	1.2359780842193e-17	7	1.2359780842193e-17
<https://identifiers.org/wikipathways/WP3872_r116648>	WP3872	Regulation of apoptosis by parathyroid hormone-related protein	22	9	3.14591990437121e-34	9	3.87165593600724e-34	9	1.43623395880485e-34	9	5.81514393446031e-34	9	3.10442180005165e-34	9	2.68491279885469e-34	9	4.51980655196953e-35	9	4.51980655196953e-35
<https://identifiers.org/wikipathways/WP3874_r116461>	WP3874	Canonical and non-canonical TGF-B signaling	17	9	6.96769089119659e-22	9	7.91751783203769e-22	9	4.2998173372764e-22	9	1.01707494378461e-21	9	6.91096162524418e-22	9	6.32006782443105e-22	9	2.11029707361456e-22	9	2.11029707361456e-22
<https://identifiers.org/wikipathways/WP3875_r117657>	WP3875	ATR signaling	9	3	1.48215390728618e-18	3	1.63126899721727e-18	3	1.03190129449887e-18	3	1.96839772871891e-18	3	1.47309262120421e-18	3	1.37756649126517e-18	3	6.0502423703042e-19	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP3876_r116398>	WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	13	4	3.14045422325347e-26	4	3.62597498922956e-26	4	1.82460234405296e-26	4	4.80588576247015e-26	4	3.11170640401015e-26	4	2.81406077375342e-26	4	8.19313653414472e-27	4	8.19313653414472e-27
<https://identifiers.org/wikipathways/WP3877_r117828>	WP3877	MYD88 distinct input-output pathway	18	8	3.27197477805779e-27	8	3.83860351739917e-27	8	1.78980066446605e-27	8	5.24933443982087e-27	8	3.23871482866358e-27	8	2.89640967631533e-27	8	7.35327695981312e-28	8	7.35327695981312e-28
<https://identifiers.org/wikipathways/WP3878_r117656>	WP3878	ATM signaling in development and disease 	46	14	1.50981012465035e-74	14	2.51458833991609e-74	16	3.58948808912034e-70	14	6.83293502479219e-74	14	1.46133467343432e-74	16	1.5176469012704e-69	16	2.49939809686554e-71	14	1.28194969795916e-76
<https://identifiers.org/wikipathways/WP3879_r120671>	WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	18	6	5.30772381186324e-33	6	6.42880132072716e-33	6	2.57367627871572e-33	6	9.35876465930646e-33	6	5.24305649273788e-33	6	4.58541997331669e-33	6	8.85190056388581e-34	6	8.85190056388581e-34
<https://identifiers.org/wikipathways/WP3888_r116782>	WP3888	VEGFA-VEGFR2 signaling pathway	435	188	1.35423393525086e-320	188	6.4692461600807e-319	193	2.71716342586852e-319	188	1.25971162787836e-315	188	1.04890136612097e-320	193	2.50809998853735e-314	193	0	188	0
<https://identifiers.org/wikipathways/WP3890_r116457>	WP3890	Nanomaterial-induced inflammasome activation	10	4	3.70538476821545e-18	4	4.07817249304314e-18	4	2.57975323624717e-18	4	4.92099432179726e-18	4	3.68273155301054e-18	4	3.44391622816294e-18	4	1.51256059257606e-18	4	1.51256059257606e-18
<https://identifiers.org/wikipathways/WP3891_r106161>	WP3891	Benzene metabolism	6	3	5.94504413007102e-10	3	6.23701209979749e-10	3	4.96030068485593e-10	3	6.85142625102298e-10	3	5.92683883541888e-10	3	5.73139946200029e-10	3	3.79794450465585e-10	3	3.79794450465585e-10
<https://identifiers.org/wikipathways/WP3892_r120069>	WP3892	Development of pulmonary dendritic cells and macrophage subsets	13	7	3.0278286963132e-17	7	3.33244952288668e-17	7	2.10802693019055e-17	7	4.02115536009718e-17	7	3.00931778331715e-17	7	2.81417154644173e-17	7	1.2359780842193e-17	7	1.2359780842193e-17
<https://identifiers.org/wikipathways/WP3893_r118859>	WP3893	Development and heterogeneity of the ILC family	32	14	4.36134988683187e-44	14	5.81285171365409e-44	14	1.47340747460266e-44	14	1.02068838599399e-43	14	4.28192773770727e-44	14	3.50247842884076e-44	14	2.9741745351782e-45	14	2.9741745351782e-45
<https://identifiers.org/wikipathways/WP391_r117794>	WP391	Mitochondrial gene expression	19	5	1.75157160068924e-38	5	2.19029800732716e-38	5	7.52907584013715e-39	5	3.3942179684577e-38	5	1.72670392438442e-38	5	1.47680459524474e-38	5	2.16797510920154e-39	5	2.16797510920154e-39
<https://identifiers.org/wikipathways/WP3915_r122574>	WP3915	Angiopoietin-like protein 8 regulatory pathway	134	51	1.23535173801074e-151	51	4.6124230063229e-151	52	1.03352748162205e-151	51	6.09509096281538e-150	51	1.13550345493161e-151	52	5.23021664560444e-150	52	7.30857671293553e-155	51	5.514306283701e-157
<https://identifiers.org/wikipathways/WP3924_r96137>	WP3924	Hfe effect on hepcidin production	7	1	1.23512825607182e-19	1	1.35939083101438e-19	1	8.59917745415729e-20	1	1.6403314405991e-19	1	1.22757718433684e-19	1	1.14797207605431e-19	1	5.0418686419202e-20	1	5.0418686419202e-20
<https://identifiers.org/wikipathways/WP3925_r117062>	WP3925	Amino acid metabolism	94	43	9.53714250954456e-100	43	2.14749531191977e-99	47	1.61287288640832e-92	43	1.05364546433214e-98	43	9.05455160371984e-100	47	1.53881680218859e-91	47	2.49466197734137e-94	43	4.82631916892594e-103
<https://identifiers.org/wikipathways/WP3926_r106298>	WP3926	ApoE and miR-146 in inflammation and atherosclerosis	9	6	2.49691853462982e-09	6	2.61954508191494e-09	6	2.08332628763949e-09	6	2.87759902542965e-09	6	2.48927231087593e-09	6	2.40718777404012e-09	6	1.59513669195546e-09	6	1.59513669195546e-09
<https://identifiers.org/wikipathways/WP3927_r117666>	WP3927	BMP signaling in eyelid development	20	7	4.90273231850068e-35	7	6.03374951066066e-35	7	2.23828668904652e-35	7	9.0625619757823e-35	7	4.83805994813244e-35	7	4.18427968652682e-35	7	7.04385436670573e-36	7	7.04385436670573e-36
<https://identifiers.org/wikipathways/WP3929_r119247>	WP3929	Chemokine signaling pathway	166	71	5.13370216146096e-163	71	2.31537557841261e-162	72	1.52180184042665e-163	71	4.4301178354922e-161	71	4.66207120946631e-163	72	1.36159119568337e-161	72	3.75069075232984e-167	71	3.911496728965e-169
<https://identifiers.org/wikipathways/WP3930_r116431>	WP3930	EDA signaling in hair follicle development	13	4	3.14045422325347e-26	4	3.62597498922956e-26	4	1.82460234405296e-26	4	4.80588576247015e-26	4	3.11170640401015e-26	4	2.81406077375342e-26	4	8.19313653414472e-27	4	8.19313653414472e-27
<https://identifiers.org/wikipathways/WP3931_r117717>	WP3931	Embryonic stem cell pluripotency pathways	116	47	8.59788595021748e-130	47	2.57389815094905e-129	48	1.79172942283472e-129	47	2.20640755313808e-128	47	8.01544123051515e-130	48	4.65715598471762e-128	48	4.34398162741465e-132	47	3.03156612555817e-134
<https://identifiers.org/wikipathways/WP3932_r120304>	WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	302	133	2.47413716764456e-245	133	3.54775025621804e-244	133	1.05366802208223e-249	133	6.54146689365678e-242	133	2.08656119948795e-245	133	3.23890228831631e-246	133	3.73403239517611e-256	133	3.73403239517611e-256
<https://identifiers.org/wikipathways/WP3933_r116372>	WP3933	Kennedy pathway from sphingolipids	14	3	5.09610867949464e-32	3	6.07479706499433e-32	3	2.62456105481452e-32	3	8.57122155480596e-32	3	5.03915985135365e-32	3	4.45654869302096e-32	3	9.86581923958582e-33	3	9.86581923958582e-33
<https://identifiers.org/wikipathways/WP3934_r107151>	WP3934	Leptin and adiponectin	10	2	1.28978235336834e-24	2	1.46560387676551e-24	2	7.95934924629522e-25	2	1.88269734554945e-24	2	1.27928125518712e-24	2	1.169901489508e-24	2	3.90634999229351e-25	2	3.90634999229351e-25
<https://identifiers.org/wikipathways/WP3935_r118425>	WP3935	Leptin-insulin signaling overlap	17	7	1.45421101247013e-27	7	1.70604600773297e-27	7	7.95466961984908e-28	7	2.33303752880929e-27	7	1.43942881273937e-27	7	1.28729318947348e-27	7	3.26812309325026e-28	7	3.26812309325026e-28
<https://identifiers.org/wikipathways/WP3937_r120792>	WP3937	Microglia pathogen phagocytosis pathway	40	24	6.57314377357005e-37	24	8.48588846346007e-37	24	2.50479597955081e-37	24	1.39982036051306e-36	24	6.46661751077094e-37	24	5.4087409939163e-37	24	6.03863306459303e-38	24	6.03863306459303e-38
<https://identifiers.org/wikipathways/WP3940_r119248>	WP3940	One-carbon metabolism and related pathways	52	18	8.66427979740656e-77	18	1.48964677520502e-76	19	3.68727125928315e-75	18	4.30800976668448e-76	18	8.36905820321319e-77	19	1.80006414035325e-74	19	1.96825038370845e-76	18	5.46496526237911e-79
<https://identifiers.org/wikipathways/WP3941_r117040>	WP3941	Oxidative damage response	40	14	9.3807449134841e-62	14	1.42015172807419e-61	14	1.95849532419848e-62	14	3.20080584015887e-61	14	9.13516062423946e-62	14	6.83523574335612e-62	14	1.94406770597861e-63	14	1.94406770597861e-63
<https://identifiers.org/wikipathways/WP3942_r106517>	WP3942	PPAR signaling pathway	68	29	2.69597692387332e-82	29	5.01836261814439e-82	29	2.57831569836862e-83	29	1.69569010634348e-81	29	2.59091704972096e-82	29	1.67770828808867e-82	29	8.09123268849308e-85	29	8.09123268849308e-85
<https://identifiers.org/wikipathways/WP3943_r117818>	WP3943	Robo4 and VEGF signaling pathways crosstalk	6	2	3.03938861455565e-13	2	3.24000628560928e-13	2	2.38743816052768e-13	2	3.67237426354619e-13	2	3.02698612636321e-13	2	2.89464619292938e-13	2	1.6723665806499e-13	2	1.6723665806499e-13
<https://identifiers.org/wikipathways/WP3944_r120596>	WP3944	Serotonin and anxiety-related events	13	4	3.14045422325347e-26	4	3.62597498922956e-26	4	1.82460234405296e-26	4	4.80588576247015e-26	4	3.11170640401015e-26	4	2.81406077375342e-26	4	8.19313653414472e-27	4	8.19313653414472e-27
<https://identifiers.org/wikipathways/WP3945_r116679>	WP3945	TYROBP causal network in microglia	60	30	2.60805683534231e-64	30	4.2077567580035e-64	30	4.28151226062552e-65	30	1.0743073908062e-63	30	2.52946073702787e-64	30	1.81023690670107e-64	30	2.98126176497114e-66	30	2.98126176497114e-66
<https://identifiers.org/wikipathways/WP3947_r106483>	WP3947	Serotonin and anxiety	17	3	1.02431087759606e-39	3	1.28087602767669e-39	3	4.40296832756565e-40	3	1.9849227885718e-39	3	1.00976837683301e-39	3	8.63628418271777e-40	3	1.26782170128746e-40	3	1.26782170128746e-40
<https://identifiers.org/wikipathways/WP395_r120704>	WP395	IL-4 signaling pathway	53	24	3.37622203588515e-64	24	5.36114197941736e-64	24	5.88580623547563e-65	24	1.32678472887682e-63	24	3.27780996624439e-64	24	2.37204258254814e-64	24	4.47812829012063e-66	24	4.47812829012063e-66
<https://identifiers.org/wikipathways/WP3953_r106206>	WP3953	mRNA, protein, and metabolite inducation pathway by cyclosporin A	8	3	9.66693715085535e-16	3	1.04709344410267e-15	3	7.14878285688919e-16	3	1.2245620981219e-15	3	9.61765804688458e-16	3	9.09500010121972e-16	3	4.5813779726248e-16	3	4.5813779726248e-16
<https://identifiers.org/wikipathways/WP3958_r117148>	WP3958	GPR40 pathway	15	3	1.30091269898605e-34	3	1.57568659821744e-34	3	6.30803009489147e-35	3	2.29381486747713e-34	3	1.28506286586711e-34	3	1.12387744444038e-34	3	2.16958347154066e-35	3	2.16958347154066e-35
<https://identifiers.org/wikipathways/WP3959_r118468>	WP3959	DNA IR-double strand breaks and cellular response via ATM	57	17	1.85492269844806e-89	17	3.50806117333596e-89	18	5.81861445721001e-88	17	1.22282055089827e-88	17	1.78082819066253e-89	18	3.78616850769296e-87	18	1.82598909542787e-89	17	4.79892009310893e-92
<https://identifiers.org/wikipathways/WP3963_r107557>	WP3963	Mevalonate pathway	7	6	0.00119352088661535	6	0.00121275121275133	6	0.00112359550561817	6	0.0012513407222023	6	0.00119230114120268	6	0.00117904665656071	6	0.0010279001468428	6	0.0010279001468428
<https://identifiers.org/wikipathways/WP3965_r117154>	WP3965	Lipid metabolism pathway	29	11	3.20066806211053e-45	11	4.2658831124398e-45	11	1.08129096926485e-45	11	7.49053573592352e-45	11	3.14238245267226e-45	11	2.57036723406863e-45	11	2.18266034436466e-46	11	2.18266034436466e-46
<https://identifiers.org/wikipathways/WP3967_r108139>	WP3967	miR-509-3p alteration of YAP1/ECM axis	18	10	1.25418436041539e-21	10	1.42515320976679e-21	10	7.73967120709751e-22	10	1.83073489881228e-21	10	1.24397309254395e-21	10	1.13761220839757e-21	10	3.79853473250619e-22	10	3.79853473250619e-22
<https://identifiers.org/wikipathways/WP3969_r106437>	WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	15	7	1.84438876531673e-22	7	2.09581354377469e-22	7	1.13818694222022e-22	7	2.69225720413575e-22	7	1.82937219491758e-22	7	1.67295912999645e-22	7	5.58608048897971e-23	7	5.58608048897971e-23
<https://identifiers.org/wikipathways/WP3971_r117820>	WP3971	OSX and miRNAs in tooth development	36	7	3.61673776628553e-72	7	5.74305968662206e-72	7	6.30510004099974e-73	7	1.4213023864118e-71	7	3.5113150052393e-72	7	2.54102245064284e-72	7	4.79714175697135e-74	7	4.79714175697135e-74
<https://identifiers.org/wikipathways/WP3972_r108157>	WP3972	PDGFR-beta pathway	29	12	1.56886079511119e-42	12	2.05793311149281e-42	12	5.62902057083125e-43	12	3.50244966785554e-42	12	1.54186232344452e-42	12	1.27533054263705e-42	12	1.24175184758146e-43	12	1.24175184758146e-43
<https://identifiers.org/wikipathways/WP3981_r108114>	WP3981	miRNA regulation of prostate cancer signaling pathways	35	10	1.68106892706363e-61	10	2.50478784063832e-61	10	3.72720047206539e-62	10	5.47206518579363e-61	10	1.63872682239597e-61	10	1.23987632908388e-61	10	4.04280509450774e-63	10	4.04280509450774e-63
<https://identifiers.org/wikipathways/WP3982_r108115>	WP3982	miRNA regulation of p53 pathway in prostate cancer	34	11	1.51402883633191e-56	11	2.18520423713112e-56	11	3.78589293992499e-57	11	4.48514710272336e-56	11	1.47890328515934e-56	11	1.14415014737938e-56	11	4.9035258596989e-58	11	4.9035258596989e-58
<https://identifiers.org/wikipathways/WP399_r119242>	WP399	Wnt signaling pathway and pluripotency	101	32	2.34754940754852e-136	32	7.02771950493018e-136	33	7.1157844562209e-136	32	6.02433060193031e-135	32	2.18851987812884e-136	33	1.84957157838162e-134	33	1.72519558748776e-138	32	8.27732689547755e-141
<https://identifiers.org/wikipathways/WP3995_r119304>	WP3995	Prion disease pathway	33	12	1.28584398412583e-51	12	1.79768622343596e-51	12	3.62640774583902e-52	12	3.46651742925842e-51	12	1.25857409887853e-51	12	9.95627175461194e-52	12	5.60893555216746e-53	12	5.60893555216746e-53
<https://identifiers.org/wikipathways/WP3996_r107156>	WP3996	Ethanol effects on histone modifications	31	10	1.60730498015731e-52	10	2.24710777929499e-52	10	4.53300968229890e-53	10	4.33314678657293e-52	10	1.57321762359816e-52	10	1.24453396932649e-52	10	7.01116944020931e-54	10	7.01116944020931e-54
<https://identifiers.org/wikipathways/WP3998_r119303>	WP3998	Prader-Willi and Angelman syndrome	74	17	1.14657184603032e-122	17	2.83913407031376e-122	17	3.7302731864822e-124	17	1.6780696708845e-121	17	1.0819560959293e-122	17	5.738264525877e-123	17	2.38558610160357e-126	17	2.38558610160357e-126
<https://identifiers.org/wikipathways/WP400_r116725>	WP400	p38 MAPK signaling pathway	34	8	7.3391318668795e-65	8	1.11107176449615e-64	8	1.53225096487786e-65	8	2.50418664592793e-64	8	7.14699622095525e-65	8	5.34762398128848e-65	8	1.52096335460629e-66	8	1.52096335460629e-66
<https://identifiers.org/wikipathways/WP4008_r117805>	WP4008	NO/cGMP/PKG mediated neuroprotection	47	14	1.2033419680951e-76	14	2.03627932419118e-76	16	2.69498307010639e-72	14	5.70828201502379e-76	14	1.16352244030853e-76	16	1.19539809552056e-71	16	1.7174226688988e-73	14	8.80614378896249e-79
<https://identifiers.org/wikipathways/WP4016_r120667>	WP4016	DNA IR-damage and cellular response via ATR	83	36	6.87285278864908e-95	36	1.4524920455541e-94	37	6.90148626372498e-94	36	6.29391878955459e-94	36	6.55160058247637e-95	37	6.27719289308341e-93	37	1.16611684384926e-95	36	6.29322100677095e-98
<https://identifiers.org/wikipathways/WP4018_r117168>	WP4018	Clear cell renal cell carcinoma pathways	86	44	4.25441052363745e-83	44	8.30554532396011e-83	44	3.39872791478361e-84	44	3.08090912917848e-82	44	4.07618193945728e-83	44	2.55299292789416e-83	44	8.17948391519932e-86	44	8.17948391519932e-86
<https://identifiers.org/wikipathways/WP4022_r120306>	WP4022	Pyrimidine metabolism	99	27	2.68670612978389e-144	27	8.43329624422493e-144	27	3.56763168969422e-146	27	7.93243749688376e-143	27	2.49712011557813e-144	27	1.12193260601164e-144	27	6.0812433664956e-149	27	6.0812433664956e-149
<https://identifiers.org/wikipathways/WP4030_r93221>	WP4030	SCFA and skeletal muscle substrate metabolism	6	3	5.94504413007102e-10	3	6.23701209979749e-10	3	4.96030068485593e-10	3	6.85142625102298e-10	3	5.92683883541888e-10	3	5.73139946200029e-10	3	3.79794450465585e-10	3	3.79794450465585e-10
<https://identifiers.org/wikipathways/WP405_r118377>	WP405	Eukaryotic transcription initiation	41	5	5.5086143317441e-89	5	9.77675540509395e-89	5	6.30730394710553e-90	5	3.00906555061135e-88	5	5.31011040146197e-89	5	3.55500885430725e-89	5	2.58133434198759e-91	5	2.58133434198759e-91
<https://identifiers.org/wikipathways/WP408_r116900>	WP408	Oxidative stress response	33	14	2.44644817721322e-46	14	3.31302429275634e-46	14	7.78208173205628e-47	14	6.00190961115497e-46	14	2.39945008226081e-46	14	1.94092003613346e-46	14	1.43743057499824e-47	14	1.43743057499824e-47
<https://identifiers.org/wikipathways/WP410_r117108>	WP410	Exercise-induced circadian regulation	48	16	1.41922151717138e-73	16	2.36371303952118e-73	16	2.06611064310986e-74	16	6.42295892330471e-73	16	1.37365459302823e-73	16	9.61446189426714e-74	16	1.20503271608161e-75	16	1.20503271608161e-75
<https://identifiers.org/wikipathways/WP411_r122796>	WP411	mRNA processing	127	20	2.95622589188747e-209	20	1.60995715567926e-208	20	4.89228369381111e-212	20	4.45674046140773e-207	20	2.65244757742264e-209	20	8.10537858611134e-210	20	3.85743166658157e-216	20	3.85743166658157e-216
<https://identifiers.org/wikipathways/WP4136_r120387>	WP4136	Fibrin complement receptor 3 signaling pathway	43	18	5.57085116696362e-58	18	8.3005521310719e-58	18	1.23514739729217e-58	18	1.81337363597738e-57	18	5.43053475316187e-58	18	4.10879434124848e-58	18	1.3397348030152e-59	18	1.3397348030152e-59
<https://identifiers.org/wikipathways/WP4141_r122432>	WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	22	13	2.18478984577726e-23	13	2.52256290789169e-23	13	1.26936181535501e-23	13	3.34341775659846e-23	13	2.16479020906675e-23	13	1.95772043367893e-23	13	5.69990206267732e-24	13	5.69990206267732e-24
<https://identifiers.org/wikipathways/WP4142_r119292>	WP4142	Metabolism of spingolipids in ER and Golgi apparatus	31	9	2.73072541650917e-55	9	3.87900531554467e-55	9	7.25165522684172e-56	9	7.7170913385094e-55	9	2.67009101085914e-55	9	2.08884519860107e-55	9	1.02637526573112e-56	9	1.02637526573112e-56
<https://identifiers.org/wikipathways/WP4146_r107552>	WP4146	Macrophage markers	9	6	2.49691853462982e-09	6	2.61954508191494e-09	6	2.08332628763949e-09	6	2.87759902542965e-09	6	2.48927231087593e-09	6	2.40718777404012e-09	6	1.59513669195546e-09	6	1.59513669195546e-09
<https://identifiers.org/wikipathways/WP4147_r94394>	WP4147	PTF1A related regulatory pathway	11	4	6.94246848073074e-21	4	7.7639144035089e-21	4	4.55055894783824e-21	4	9.66623884638719e-21	4	6.89298061649074e-21	4	6.37440324916587e-21	4	2.44104555726771e-21	4	2.44104555726771e-21
<https://identifiers.org/wikipathways/WP4148_r110682>	WP4148	Splicing factor NOVA regulated synaptic proteins	42	20	6.95941756749867e-51	20	9.88587778698463e-51	20	1.84812784449198e-51	20	1.96674703016711e-50	20	6.80488714663516e-51	20	5.32354731934664e-51	20	2.61577894723167e-52	20	2.61577894723167e-52
<https://identifiers.org/wikipathways/WP4149_r107159>	WP4149	White fat cell differentiation	32	11	4.67579630591209e-52	11	6.53704081249452e-52	11	1.31869372575965e-52	11	1.2605517924576e-51	11	4.57663308683096e-52	11	3.62046245622247e-52	11	2.03961292806089e-53	11	2.03961292806089e-53
<https://identifiers.org/wikipathways/WP4150_r116677>	WP4150	Wnt signaling in kidney disease	37	13	7.68447171450324e-58	13	1.12690229790328e-57	13	1.80937077238106e-58	13	2.38627196204928e-57	13	7.49855036783703e-58	13	5.73699447930935e-58	13	2.14459219004266e-59	13	2.14459219004266e-59
<https://identifiers.org/wikipathways/WP4153_r120394>	WP4153	Degradation pathway of sphingolipids, including diseases	19	2	5.16948381340487e-48	2	6.78100437086789e-48	2	1.85479367047176e-48	2	1.15407669830651e-47	2	5.08052234359035e-48	2	4.20228526166714e-48	2	4.09164158881468e-49	2	4.09164158881468e-49
<https://identifiers.org/wikipathways/WP4155_r119086>	WP4155	Endometrial cancer	63	21	1.81146690571785e-91	21	3.53638192757897e-91	21	1.44712953885464e-92	21	1.31180686396463e-90	21	1.73557973401651e-91	21	1.08702772657167e-91	21	3.48270679002726e-94	21	3.48270679002726e-94
<https://identifiers.org/wikipathways/WP4156_r121756>	WP4156	Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine	11	1	8.22517540989897e-31	1	9.64958149170228e-31	1	4.49924752253912e-31	1	1.3195913624487e-30	1	8.14156568291494e-31	1	7.28107007620751e-31	1	1.84848591247187e-31	1	1.84848591247187e-31
<https://identifiers.org/wikipathways/WP4157_r120415>	WP4157	GABA metabolism (aka GHB)	12	5	1.6661924353754e-20	5	1.86333945684214e-20	5	1.09213414748118e-20	5	2.31989732313294e-20	5	1.65431534795778e-20	5	1.52985677979982e-20	5	5.85850933744251e-21	5	5.85850933744251e-21
<https://identifiers.org/wikipathways/WP4159_r119288>	WP4159	GABA receptor signaling	43	9	1.14500856315668e-81	9	1.96860945580151e-81	9	1.4782658477425e-82	9	5.69315417825376e-81	9	1.10599421213329e-81	9	7.57083037909062e-82	9	7.22210289728997e-84	9	7.22210289728997e-84
<https://identifiers.org/wikipathways/WP4172_r122580>	WP4172	PI3K-Akt signaling pathway	340	138	1.55311757375918e-285	138	3.71322032728955e-284	139	4.42775586573868e-289	138	1.86314157951481e-281	138	1.26766769121904e-285	139	6.07627897953662e-285	139	9.83222885785721e-297	138	1.94933648729448e-298
<https://identifiers.org/wikipathways/WP4174_r117157>	WP4174	Metabolism of tetrahydrocannabinol (THC)	4	2	3.48795739111272e-07	2	3.60125078642309e-07	2	3.09125938680219e-07	2	3.83405813007207e-07	2	3.48083244804143e-07	2	3.4038781404818e-07	2	2.5871597965717e-07	2	2.5871597965717e-07
<https://identifiers.org/wikipathways/WP4186_r105819>	WP4186	Somatroph axis (GH) and its relationship to dietary restriction and aging	9	2	7.573601978979e-22	2	8.46972480382791e-22	2	4.96424612491445e-22	2	1.05449878324224e-21	2	7.5196152179899e-22	2	6.95389445363552e-22	2	2.66295878974659e-22	2	2.66295878974659e-22
<https://identifiers.org/wikipathways/WP4189_r120000>	WP4189	Mevalonate arm of cholesterol biosynthesis pathway with inhibitors	10	2	1.28978235336834e-24	2	1.46560387676551e-24	2	7.95934924629522e-25	2	1.88269734554945e-24	2	1.27928125518712e-24	2	1.169901489508e-24	2	3.90634999229351e-25	2	3.90634999229351e-25
<https://identifiers.org/wikipathways/WP4190_r118431>	WP4190	Mevalonate arm of cholesterol biosynthesis pathway	13	9	1.44877523960486e-11	9	1.54440299614041e-11	9	1.13801218985152e-11	9	1.75049839895701e-11	9	1.4428633868998e-11	9	1.379781351963e-11	9	7.97161403443121e-12	9	7.97161403443121e-12
<https://identifiers.org/wikipathways/WP4191_r106347>	WP4191	Caloric restriction and aging	9	4	2.17506085894246e-15	4	2.355960249231e-15	4	1.60847614280008e-15	4	2.75526472077428e-15	4	2.16397306054903e-15	4	2.04637502277443e-15	4	1.03081004384058e-15	4	1.03081004384058e-15
<https://identifiers.org/wikipathways/WP4194_r119287>	WP4194	Hormonal control of pubertal growth spurt	6	2	3.03938861455565e-13	2	3.24000628560928e-13	2	2.38743816052768e-13	2	3.67237426354619e-13	2	3.02698612636321e-13	2	2.89464619292938e-13	2	1.6723665806499e-13	2	1.6723665806499e-13
<https://identifiers.org/wikipathways/WP4197_r120647>	WP4197	Immune response to tuberculosis	23	16	5.15755983433488e-18	16	5.76781201036679e-18	16	3.38061024234902e-18	16	7.18104883898107e-18	16	5.12079529999102e-18	16	4.73554417380534e-18	16	1.81345274449419e-18	16	1.81345274449419e-18
<https://identifiers.org/wikipathways/WP4204_r108297>	WP4204	Tumor suppressor activity of SMARCB1	31	9	2.73072541650917e-55	9	3.87900531554467e-55	10	4.53300968229890e-53	9	7.7170913385094e-55	9	2.67009101085914e-55	10	1.24453396932649e-52	10	7.01116944020931e-54	9	1.02637526573112e-56
<https://identifiers.org/wikipathways/WP4205_r118937>	WP4205	MET in type 1 papillary renal cell carcinoma	59	23	1.06004391993503e-78	23	1.88137878234455e-78	23	1.21373884568079e-79	23	5.79046099348536e-78	23	1.02184504237596e-78	23	6.84104076701788e-79	23	4.96736131766423e-81	23	4.96736131766423e-81
<https://identifiers.org/wikipathways/WP4206_r119286>	WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	20	8	3.60166972947863e-32	8	4.36240089620771e-32	8	1.74642318912852e-32	8	6.35059030452945e-32	8	3.5577883343578e-32	8	3.11153498189349e-32	8	6.00664681120832e-33	8	6.00664681120832e-33
<https://identifiers.org/wikipathways/WP4210_r95880>	WP4210	Tryptophan catabolism leading to NAD+ production	16	9	2.40672240665333e-19	9	2.69149032654974e-19	9	1.57752710191726e-19	9	3.3509628000809e-19	9	2.38956661371681e-19	9	2.20979312637752e-19	9	8.46229126519476e-20	9	8.46229126519476e-20
<https://identifiers.org/wikipathways/WP4211_r107570>	WP4211	Transcriptional cascade regulating adipogenesis	13	4	3.14045422325347e-26	4	3.62597498922956e-26	4	1.82460234405296e-26	4	4.80588576247015e-26	4	3.11170640401015e-26	4	2.81406077375342e-26	4	8.19313653414472e-27	4	8.19313653414472e-27
<https://identifiers.org/wikipathways/WP4216_r119088>	WP4216	Chromosomal and microsatellite instability in colorectal cancer 	73	27	1.57240499247929e-96	27	3.27079927315098e-96	27	9.88349996264902e-98	27	1.37393647059722e-95	27	1.50042881196238e-96	27	8.98946014721816e-97	27	1.66997590695878e-99	27	1.66997590695878e-99
<https://identifiers.org/wikipathways/WP4217_r120623>	WP4217	Ebola virus infection in host	140	54	2.66318250610284e-155	54	1.04248095949707e-154	54	1.53527738962621e-157	54	1.51124972064232e-153	54	2.44053684176153e-155	54	9.39582679993114e-156	54	7.63869640957981e-161	54	7.63869640957981e-161
<https://identifiers.org/wikipathways/WP422_r116723>	WP422	MAPK cascade	33	7	1.7268545569128e-65	7	2.61428650469683e-65	7	3.60529638794797e-66	7	5.89220387277166e-65	7	1.6816461696366e-65	7	1.25826446618554e-65	7	3.57873730495604e-67	7	3.57873730495604e-67
<https://identifiers.org/wikipathways/WP4220_r120526>	WP4220	Neurotransmitter disorders	4	2	3.48795739111272e-07	2	3.60125078642309e-07	2	3.09125938680219e-07	2	3.83405813007207e-07	2	3.48083244804143e-07	2	3.4038781404818e-07	2	2.5871597965717e-07	2	2.5871597965717e-07
<https://identifiers.org/wikipathways/WP4222_r107160>	WP4222	Phosphodiesterases in neuronal function	52	9	1.75653084669519e-100	9	3.4839866533992e-100	11	4.72545760994501e-96	9	1.33318758931347e-99	9	1.68123738593132e-100	11	3.38373384098572e-95	11	1.24242603253543e-97	9	2.91133315275056e-103
<https://identifiers.org/wikipathways/WP4223_r119284>	WP4223	Ras signaling	184	68	2.20673188627324e-196	68	1.38398680039361e-195	69	1.96961617642897e-197	68	5.05153996940502e-194	68	1.96216888038404e-196	69	4.7645768415239e-195	69	7.71003670624771e-202	68	7.68220263871608e-204
<https://identifiers.org/wikipathways/WP4224_r120400>	WP4224	Purine metabolism and related disorders	24	9	5.02520400265779e-39	9	6.38489913416021e-39	10	1.26990412503651e-36	9	1.02084777225371e-38	9	4.94880875524508e-39	10	2.49087708397952e-36	10	3.65665135085334e-37	9	5.35851604755747e-40
<https://identifiers.org/wikipathways/WP4225_r120401>	WP4225	Pyrimidine metabolism and related diseases	24	7	1.04630352383315e-44	7	1.37247528466363e-44	7	3.75410238903485e-45	7	2.33585123737243e-44	7	1.02829772234268e-44	7	8.50542536961436e-45	7	8.28148257576104e-46	7	8.28148257576104e-46
<https://identifiers.org/wikipathways/WP4228_r119281>	WP4228	Vitamin B6-dependent and responsive disorders	6	3	5.94504413007102e-10	3	6.23701209979749e-10	3	4.96030068485593e-10	3	6.85142625102298e-10	3	5.92683883541888e-10	3	5.73139946200029e-10	3	3.79794450465585e-10	3	3.79794450465585e-10
<https://identifiers.org/wikipathways/WP4236_r120410>	WP4236	Krebs cycle disorders	11	2	2.41573401788731e-27	2	2.78921153017656e-27	2	1.40354026465612e-27	2	3.69683520190006e-27	2	2.39362031077702e-27	2	2.16466213365647e-27	2	6.30241271857283e-28	2	6.30241271857283e-28
<https://identifiers.org/wikipathways/WP4239_r118997>	WP4239	Epithelial to mesenchymal transition in colorectal cancer	161	59	9.90098632362453e-179	59	4.98489714836542e-178	59	2.20462579595911e-181	59	1.18321185398106e-176	59	8.92831095171807e-179	59	2.88237468279701e-179	59	2.69387898704116e-185	59	2.69387898704116e-185
<https://identifiers.org/wikipathways/WP4240_r106495>	WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	15	7	1.84438876531673e-22	7	2.09581354377469e-22	7	1.13818694222022e-22	7	2.69225720413575e-22	7	1.82937219491758e-22	7	1.67295912999645e-22	7	5.58608048897971e-23	7	5.58608048897971e-23
<https://identifiers.org/wikipathways/WP4241_r106520>	WP4241	Type 2 papillary renal cell carcinoma	34	13	3.36297657386758e-51	13	4.7016408920634e-51	14	4.23412992302631e-49	13	9.06627635344497e-51	13	3.29165533552846e-51	14	1.10797987287672e-48	14	7.15663194463912e-50	13	1.46695237518225e-52
<https://identifiers.org/wikipathways/WP4249_r117749>	WP4249	Hedgehog signaling pathway	43	11	3.62036156372029e-76	11	6.02971117081328e-76	12	2.74990563596756e-74	11	1.63846399803978e-75	11	3.50412266884115e-76	12	1.21975978126168e-73	12	1.75242298511252e-75	11	3.07397687784684e-78
<https://identifiers.org/wikipathways/WP4255_r119279>	WP4255	Non-small cell lung cancer	72	34	1.17679589798014e-78	34	2.15600798004136e-78	34	1.19502577576842e-79	34	7.06189611437875e-78	34	1.13208670722651e-78	34	7.41253149651701e-79	34	4.0972327420051e-81	34	4.0972327420051e-81
<https://identifiers.org/wikipathways/WP4258_r117770>	WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	98	32	4.90073915734975e-131	32	1.39917895383667e-130	32	9.31061928588421e-133	32	1.09302898737098e-129	32	4.58262684326744e-131	32	2.20007528128334e-131	32	2.69234433330798e-135	32	2.69234433330798e-135
<https://identifiers.org/wikipathways/WP4259_r119256>	WP4259	Disorders of folate metabolism and transport	15	6	2.19831795627744e-25	6	2.53818249246069e-25	6	1.27722164083707e-25	6	3.36412003372912e-25	6	2.17819448280709e-25	6	1.9698425416274e-25	6	5.73519557390131e-26	6	5.73519557390131e-26
<https://identifiers.org/wikipathways/WP4262_r108103>	WP4262	Breast cancer pathway	156	53	5.29812301270148e-183	53	2.70970413918636e-182	54	1.30358915786865e-183	53	6.63272736464008e-181	53	4.77283485266077e-183	54	1.70434020698502e-181	54	1.59288322152169e-187	53	1.24444001681379e-189
<https://identifiers.org/wikipathways/WP4263_r105482>	WP4263	Pancreatic adenocarcinoma pathway	89	35	4.08643944764963e-108	35	9.64938488723705e-108	35	1.59087171480844e-109	35	5.19640970740994e-107	35	3.86788233485047e-108	35	2.12067762103834e-108	35	1.32585306866091e-111	35	1.32585306866091e-111
<https://identifiers.org/wikipathways/WP4269_r117715>	WP4269	Ethanol metabolism production of ROS by CYP2E1	10	3	2.52453399299299e-21	3	2.82324160127598e-21	3	1.65474870830481e-21	3	3.51499594414078e-21	3	2.50653840599665e-21	3	2.31796481787851e-21	3	8.87652929915534e-22	3	8.87652929915534e-22
<https://identifiers.org/wikipathways/WP4271_r120408>	WP4271	Vitamin B12 disorders	16	4	5.20365079594436e-34	4	6.30274639286966e-34	4	2.52321203795662e-34	4	9.17525946990856e-34	4	5.14025146346838e-34	4	4.49550977776148e-34	4	8.6783338861625e-35	4	8.6783338861625e-35
<https://identifiers.org/wikipathways/WP428_r116549>	WP428	Wnt signaling	116	35	1.11642312214827e-155	35	4.03901736654846e-155	35	8.66839916193755e-158	35	5.01768960911496e-154	35	1.02825922309592e-155	35	4.18302590566978e-156	35	6.6931992228705e-161	35	6.6931992228705e-161
<https://identifiers.org/wikipathways/WP4288_r120407>	WP4288	MTHFR deficiency	27	8	6.63316733254407e-49	8	8.98275496506517e-49	9	1.46480303718147e-46	8	1.6273253256051e-48	8	6.50573923861034e-49	9	3.4820245781718e-46	9	2.95680588522308e-47	8	3.89737155345736e-50
<https://identifiers.org/wikipathways/WP4290_r118611>	WP4290	Metabolic reprogramming in colon cancer	42	25	7.6986591246985e-39	25	1.00986177844355e-38	26	6.63578257967145e-37	25	1.71870991857647e-38	25	7.56617316361311e-39	26	1.43290030638829e-36	26	1.59977325188141e-37	25	6.09348147508301e-40
<https://identifiers.org/wikipathways/WP4292_r121757>	WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	16	1	6.14937040670821e-44	1	7.81323698792234e-44	1	2.48877133487148e-44	1	1.24921716155813e-43	1	6.0558851126972e-44	1	5.1219968068944e-44	1	6.55724623105711e-45	1	6.55724623105711e-45
<https://identifiers.org/wikipathways/WP4297_r120409>	WP4297	Thiamine metabolic pathways	10	5	4.35012171788489e-15	5	4.71192049846199e-15	5	3.21695228560015e-15	5	5.51052944154852e-15	5	4.32794612109808e-15	5	4.09275004554889e-15	5	2.06162008768117e-15	5	2.06162008768117e-15
<https://identifiers.org/wikipathways/WP4298_r121698>	WP4298	Acute viral myocarditis	98	33	8.80647975851036e-129	33	2.47485077380124e-128	33	1.77607116377704e-130	33	1.87437910288861e-127	33	8.24317361867766e-129	33	4.00147025401861e-129	33	5.60905069439166e-133	33	5.60905069439166e-133
<https://identifiers.org/wikipathways/WP43_r122562>	WP43	Oxidation by cytochrome P450	64	22	5.26972190754272e-91	22	1.02876565165935e-90	22	4.20983138575907e-92	22	3.81616542244251e-90	22	5.04895922622984e-91	22	3.1622624772993e-91	22	1.01315106618973e-93	22	1.01315106618973e-93
<https://identifiers.org/wikipathways/WP430_r122069>	WP430	Statin inhibition of cholesterol production	31	17	3.99454918979248e-34	17	4.99508734163637e-34	17	1.71704449793952e-34	17	7.74068877946323e-34	17	3.93783717402543e-34	17	3.3679288914569e-34	17	4.94417882348821e-35	17	4.94417882348821e-35
<https://identifiers.org/wikipathways/WP4300_r105311>	WP4300	Extracellular vesicles in the crosstalk of cardiac cells	25	12	3.28891626366082e-33	12	4.04764029673487e-33	12	1.50151732056872e-33	12	6.07946865875397e-33	12	3.24553188187217e-33	12	2.80695428971174e-33	12	4.72525230433171e-34	12	4.72525230433171e-34
<https://identifiers.org/wikipathways/WP4301_r97800>	WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	18	4	4.60939894918227e-39	4	5.76394212454509e-39	4	1.98133574740453e-39	4	8.93215254857307e-39	4	4.54395769574853e-39	4	3.88632788222305e-39	4	5.70519765579351e-40	4	5.70519765579351e-40
<https://identifiers.org/wikipathways/WP4304_r119229>	WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	31	12	4.21641636603031e-47	12	5.70994717122778e-47	12	1.34122999548697e-47	12	1.0344200276801e-46	12	4.13541586147221e-47	12	3.34514627439664e-47	12	2.47738981675828e-48	12	2.47738981675828e-48
<https://identifiers.org/wikipathways/WP4312_r119230>	WP4312	Rett syndrome causing genes	49	12	4.25242808986291e-86	12	7.66811058996357e-86	12	4.5853616531414e-87	12	2.43468891845981e-85	12	4.09502733291583e-86	12	2.71124270958103e-86	12	1.71762198267943e-88	12	1.71762198267943e-88
<https://identifiers.org/wikipathways/WP4313_r120500>	WP4313	Ferroptosis	65	27	4.29751431568073e-81	27	7.87347676419762e-81	27	4.36408759393838e-82	27	2.57891786498287e-80	27	4.13424183348058e-81	27	2.70696560689866e-81	27	1.49625915536126e-83	27	1.49625915536126e-83
<https://identifiers.org/wikipathways/WP4316_r120818>	WP4316	miRNA degrading enzymes	3	1	1.74397869555636e-07	1	1.80062539321155e-07	1	1.54562969340109e-07	1	1.91702906503603e-07	1	1.74041622402071e-07	1	1.7019390702409e-07	1	1.29357989828585e-07	1	1.29357989828585e-07
<https://identifiers.org/wikipathways/WP4317_r114309>	WP4317	Mitochondrial fatty acid synthesis pathway	6	1	1.03574326616307e-16	1	1.12188583296715e-16	1	7.65941020380987e-17	1	1.31203081941631e-16	1	1.0304633621662e-16	1	9.74464296559259e-17	1	4.90861925638373e-17	1	4.90861925638373e-17
<https://identifiers.org/wikipathways/WP4320_r116686>	WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	26	7	1.96538291334641e-49	7	2.66155702668594e-49	8	4.88267679060479e-47	7	4.82170466845961e-49	7	1.92762644106971e-49	8	1.1606748593906e-46	8	9.85601961741005e-48	7	1.15477675657998e-50
<https://identifiers.org/wikipathways/WP4321_r106178>	WP4321	Thermogenesis	108	40	6.31232283152685e-131	40	1.86006182082432e-130	40	1.06423328178338e-132	40	1.54589066332742e-129	40	5.8906596807204e-131	40	2.766210307331e-131	40	2.58019417688418e-135	40	2.58019417688418e-135
<https://identifiers.org/wikipathways/WP4324_r98172>	WP4324	Mitochondrial complex I assembly model OXPHOS system	58	17	1.82193931430964e-91	17	3.50081810140194e-91	19	1.7762086237799e-87	17	1.25884969741033e-90	17	1.74738682216931e-91	19	1.15577775497995e-86	19	5.57407197551663e-89	17	4.06331920292433e-94
<https://identifiers.org/wikipathways/WP4329_r101725>	WP4329	miRNAs involvement in the immune response in sepsis	66	19	2.89965996931432e-102	19	6.12807107871827e-102	20	5.38671982606442e-101	19	2.65540743056917e-101	19	2.7641235056449e-102	20	4.89944891826145e-100	20	9.10172748627619e-103	19	2.65511303566985e-105
<https://identifiers.org/wikipathways/WP4331_r107654>	WP4331	Neovascularisation processes	41	13	1.55130594932744e-66	13	2.42446165205945e-66	13	2.87191469873415e-67	13	5.81595881310342e-66	13	1.50762102147494e-66	13	1.10322208185849e-66	13	2.38756742246652e-68	13	2.38756742246652e-68
<https://identifiers.org/wikipathways/WP4336_r108198>	WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	93	28	3.07770297248146e-131	28	8.64914902644908e-131	28	6.20704259816495e-133	28	6.55061079421936e-130	28	2.88083781994366e-131	28	1.39844037944776e-131	28	1.96026022523323e-135	28	1.96026022523323e-135
<https://identifiers.org/wikipathways/WP4337_r108190>	WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	18	10	1.25418436041539e-21	10	1.42515320976679e-21	10	7.73967120709751e-22	10	1.83073489881228e-21	10	1.24397309254395e-21	10	1.13761220839757e-21	10	3.79853473250619e-22	10	3.79853473250619e-22
<https://identifiers.org/wikipathways/WP4341_r122900>	WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	93	40	2.14616094093342e-104	40	4.98813061589749e-104	41	1.35912234669494e-103	40	2.6041346187441e-103	40	2.03343625077716e-104	41	1.646698879619e-102	41	1.35150766110645e-105	40	8.07516964520035e-108
<https://identifiers.org/wikipathways/WP4342_r106136>	WP4342	Vitamins A and D - action mechanisms	3	2	0.000511508951406576	2	0.000519750519750568	2	0.000481540930979215	2	0.000536288880943841	2	0.000510986203372576	2	0.000505305709954593	2	0.000440528634361202	2	0.000440528634361202
<https://identifiers.org/wikipathways/WP4352_r102218>	WP4352	Ciliary landscape	214	58	1.68102602410658e-260	58	1.96927435685362e-259	61	1.85251862943566e-258	58	2.44388308566947e-257	58	1.43614910779399e-260	61	2.68737312405584e-255	61	2.63574038948867e-264	58	1.68523104226194e-270
<https://identifiers.org/wikipathways/WP4357_r98705>	WP4357	NRF2-ARE regulation	23	8	1.88445150099671e-39	8	2.3943371753101e-39	8	7.62674642678861e-40	8	3.82817914595133e-39	8	1.8558032832169e-39	8	1.56961671398476e-39	8	2.00944351783405e-40	8	2.00944351783405e-40
<https://identifiers.org/wikipathways/WP437_r120689>	WP437	EGF/EGFR signaling pathway	162	61	2.61454209669202e-176	61	1.2958362716614e-175	61	6.17790360137486e-179	61	2.982566733236e-174	61	2.36005995262129e-176	61	7.70331172192939e-177	61	8.24048749745819e-183	61	8.24048749745819e-183
<https://identifiers.org/wikipathways/WP438_r119305>	WP438	Non-homologous end joining	10	3	2.52453399299299e-21	3	2.82324160127598e-21	3	1.65474870830481e-21	3	3.51499594414078e-21	3	2.50653840599665e-21	3	2.31796481787851e-21	3	8.87652929915534e-22	3	8.87652929915534e-22
<https://identifiers.org/wikipathways/WP4389_r116629>	WP4389	Bile acids synthesis and enterohepatic circulation 	13	4	3.14045422325347e-26	4	3.62597498922956e-26	4	1.82460234405296e-26	4	4.80588576247015e-26	4	3.11170640401015e-26	4	2.81406077375342e-26	4	8.19313653414472e-27	4	8.19313653414472e-27
<https://identifiers.org/wikipathways/WP4396_r98945>	WP4396	Nonalcoholic fatty liver disease	155	57	2.70539252821722e-173	57	1.27911065300545e-172	58	8.33370263472441e-174	57	2.6843272670026e-171	57	2.44944545010383e-173	58	8.59655055139462e-172	58	1.57863486982673e-177	57	1.32562360576149e-179
<https://identifiers.org/wikipathways/WP4399_r102102>	WP4399	MicroRNA network associated with chronic lymphocytic leukemia	9	2	7.573601978979e-22	2	8.46972480382791e-22	2	4.96424612491445e-22	2	1.05449878324224e-21	2	7.5196152179899e-22	2	6.95389445363552e-22	2	2.66295878974659e-22	2	2.66295878974659e-22
<https://identifiers.org/wikipathways/WP4462_r102079>	WP4462	Platelet-mediated interactions with vascular and circulating cells	19	14	2.00727044982403e-13	14	2.17421474429032e-13	14	1.48439369749836e-13	14	2.54271572802882e-13	14	1.99703799587811e-13	14	1.88851180673184e-13	14	9.51290411887163e-14	14	9.51290411887163e-14
<https://identifiers.org/wikipathways/WP4478_r121699>	WP4478	LTF danger signal response pathway	19	11	2.16631844071749e-21	11	2.46162827141537e-21	12	6.94828982617191e-19	11	3.16217846158487e-21	11	2.14868079621227e-21	12	9.73313427027186e-19	12	3.72725465271529e-19	11	6.56110544705622e-22
<https://identifiers.org/wikipathways/WP4479_r121700>	WP4479	Supression of HMGB1 mediated inflammation by THBD	9	2	7.573601978979e-22	2	8.46972480382791e-22	2	4.96424612491445e-22	2	1.05449878324224e-21	2	7.5196152179899e-22	2	6.95389445363552e-22	2	2.66295878974659e-22	2	2.66295878974659e-22
<https://identifiers.org/wikipathways/WP4480_r121701>	WP4480	Altered glycosylation of MUC1 in tumor microenvironment	9	3	1.48215390728618e-18	3	1.63126899721727e-18	3	1.03190129449887e-18	3	1.96839772871891e-18	3	1.47309262120421e-18	3	1.37756649126517e-18	3	6.0502423703042e-19	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP4481_r121702>	WP4481	Resistin as a regulator of inflammation	33	11	2.62149639984879e-54	11	3.72384510292297e-54	12	3.62640774583902e-52	11	7.40840768496896e-54	11	2.56328737042476e-54	12	9.95627175461194e-52	12	5.60893555216746e-53	11	9.85320255101876e-56
<https://identifiers.org/wikipathways/WP4482_r121703>	WP4482	Vitamin D in inflammatory diseases	22	9	3.14591990437121e-34	9	3.87165593600724e-34	9	1.43623395880485e-34	9	5.81514393446031e-34	9	3.10442180005165e-34	9	2.68491279885469e-34	9	4.51980655196953e-35	9	4.51980655196953e-35
<https://identifiers.org/wikipathways/WP4483_r107927>	WP4483	Relationship between inflammation, COX-2 and EGFR	26	9	9.44579570127149e-44	9	1.23904018754358e-43	9	3.38912021232319e-44	9	2.10875458929453e-43	9	9.28324332670476e-44	9	7.67850901423526e-44	9	7.47633843645104e-45	9	7.47633843645104e-45
<https://identifiers.org/wikipathways/WP4484_r107333>	WP4484	Control of immune tolerance by vasoactive intestinal peptide	15	7	1.84438876531673e-22	7	2.09581354377469e-22	7	1.13818694222022e-22	7	2.69225720413575e-22	7	1.82937219491758e-22	7	1.67295912999645e-22	7	5.58608048897971e-23	7	5.58608048897971e-23
<https://identifiers.org/wikipathways/WP4493_r120800>	WP4493	Cells and molecules involved in local acute inflammatory response 	17	13	4.82249660176162e-11	13	5.1408099731667e-11	14	1.686502232851e-08	13	5.82683383149328e-11	13	4.80281798716295e-11	14	1.9486758170801e-08	14	1.29130113158298e-08	13	2.6534883079645e-11
<https://identifiers.org/wikipathways/WP4494_r103559>	WP4494	Selective expression of chemokine receptors during T-cell polarization	29	17	1.48378199708254e-29	17	1.79718086332887e-29	17	7.19474988533034e-30	17	2.61625642339838e-29	17	1.46570415292208e-29	17	1.28186089680536e-29	17	2.47456182013511e-30	17	2.47456182013511e-30
<https://identifiers.org/wikipathways/WP4495_r117759>	WP4495	IL-10 anti-inflammatory signaling pathway 	13	10	8.50141310600155e-09	10	8.9189273027104e-09	10	7.09322997934397e-09	10	9.79753953896285e-09	10	8.47537953464899e-09	10	8.19590123066043e-09	10	5.43106064165789e-09	10	5.43106064165789e-09
<https://identifiers.org/wikipathways/WP4496_r102693>	WP4496	Signal transduction through IL1R	33	16	3.52735075472249e-41	16	4.62695730342233e-41	16	1.26560176790338e-41	16	7.87473848399181e-41	16	3.46664869644774e-41	16	2.86739152773127e-41	16	2.79189481335346e-42	16	2.79189481335346e-42
<https://identifiers.org/wikipathways/WP45_r106424>	WP45	G1 to S cell cycle control	66	25	9.67518651041403e-88	25	1.85906675398408e-87	25	8.20691070581192e-89	25	6.68496777876384e-87	25	9.27928459391822e-88	25	5.8766798429765e-88	25	2.15777610323612e-90	25	2.15777610323612e-90
<https://identifiers.org/wikipathways/WP4504_r119316>	WP4504	Cysteine and methionine catabolism	18	3	3.13617890742118e-42	3	3.98475086384034e-42	3	1.26927338078444e-42	3	6.3710075239464e-42	3	3.08850140747564e-42	3	2.6122183715161e-42	3	3.3441955778391e-43	3	3.3441955778391e-43
<https://identifiers.org/wikipathways/WP4506_r120405>	WP4506	Tyrosine metabolism	4	1	1.1890088260142e-10	1	1.2474024199595e-10	1	9.92060136971183e-11	1	1.37028525020459e-10	1	1.18536776708378e-10	1	1.14627989240006e-10	1	7.5958890093117e-11	1	7.5958890093117e-11
<https://identifiers.org/wikipathways/WP4507_r119314>	WP4507	Molybdenum cofactor (Moco) biosynthesis	8	4	1.41838135345931e-12	4	1.51200293328433e-12	5	1.38888419175966e-09	4	1.71377465632155e-12	4	1.41259352563617e-12	5	1.60479184936009e-09	5	1.06342446130364e-09	4	7.80437737636619e-13
<https://identifiers.org/wikipathways/WP4518_r122628>	WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	6	1	1.03574326616307e-16	1	1.12188583296715e-16	1	7.65941020380987e-17	1	1.31203081941631e-16	1	1.0304633621662e-16	1	9.74464296559259e-17	1	4.90861925638373e-17	1	4.90861925638373e-17
<https://identifiers.org/wikipathways/WP4519_r119988>	WP4519	Cerebral organic acidurias, including diseases	8	3	9.66693715085535e-16	3	1.04709344410267e-15	3	7.14878285688919e-16	3	1.2245620981219e-15	3	9.61765804688458e-16	3	9.09500010121972e-16	3	4.5813779726248e-16	3	4.5813779726248e-16
<https://identifiers.org/wikipathways/WP4521_r119311>	WP4521	Glycosylation and related congenital defects	25	7	4.44705679969883e-47	7	5.92708276327367e-47	7	1.5023620894169e-47	7	1.04074640766904e-46	7	4.36607388902298e-47	7	3.57130725966339e-47	7	3.0326214207416e-48	7	3.0326214207416e-48
<https://identifiers.org/wikipathways/WP4522_r119310>	WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	20	11	7.3772124662609e-24	11	8.51774488379013e-24	11	4.28615677912074e-24	11	1.1289462554748e-23	11	7.30968122542014e-24	11	6.61048458125352e-24	11	1.92464225493e-24	11	1.92464225493e-24
<https://identifiers.org/wikipathways/WP4523_r121849>	WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	25	2	1.5875994656497e-62	2	2.29138903827608e-62	2	3.9698594004285e-63	2	4.70309215569191e-62	2	1.55076707188415e-62	2	1.19974740177561e-62	2	5.14180103300935e-64	2	5.14180103300935e-64
<https://identifiers.org/wikipathways/WP453_r116780>	WP453	Inflammatory response pathway	33	17	1.22025586991311e-38	17	1.5753428748358e-38	17	4.64996978960264e-39	17	2.59866369971729e-38	18	3.92556976849879e-36	17	1.00409304497552e-38	17	1.12102788211474e-39	17	1.12102788211474e-39
<https://identifiers.org/wikipathways/WP4532_r103287>	WP4532	Intraflagellar transport proteins binding to dynein	27	8	6.63316733254407e-49	8	8.98275496506517e-49	9	1.46480303718147e-46	8	1.6273253256051e-48	8	6.50573923861034e-49	9	3.4820245781718e-46	9	2.95680588522308e-47	8	3.89737155345736e-50
<https://identifiers.org/wikipathways/WP4533_r103380>	WP4533	Transcription co-factors SKI and SKIL protein partners	18	9	2.13550887181237e-24	9	2.46566299267609e-24	9	1.24072959395602e-24	9	3.2680023184797e-24	9	2.11596035472688e-24	9	1.91356132615233e-24	9	5.57133284321839e-25	9	5.57133284321839e-25
<https://identifiers.org/wikipathways/WP4534_r103303>	WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	46	17	7.58077463813491e-67	17	1.20375996356386e-66	17	1.32156505587087e-67	17	2.97908606603149e-66	17	7.35980584115127e-67	17	5.32604788998795e-67	17	1.00549315202727e-68	17	1.00549315202727e-68
<https://identifiers.org/wikipathways/WP4535_r109210>	WP4535	Envelope proteins and their potential roles in EDMD physiopathology	46	11	1.60716577435789e-82	11	2.80745544161847e-82	12	1.02000343494228e-80	11	8.37585582728179e-82	11	1.55082676993462e-82	12	5.22387296157263e-80	12	4.98325099912993e-82	11	8.73743600081222e-85
<https://identifiers.org/wikipathways/WP4536_r110928>	WP4536	Genes related to primary cilium development (based on CRISPR)	103	31	3.77519995040863e-142	31	1.18499672182384e-141	32	9.87095805990392e-142	31	1.11461902412316e-140	31	3.50880493850409e-142	32	2.95982822943402e-140	32	1.83744249358284e-144	31	8.54500215007262e-147
<https://identifiers.org/wikipathways/WP4537_r103300>	WP4537	Hippo-Yap signaling pathway	23	10	7.23561578005384e-34	10	8.90480865281671e-34	10	3.30333810525122e-34	10	1.33748310492587e-33	10	7.1401701401188e-34	10	6.17529943736579e-34	10	1.039555506953e-34	10	1.039555506953e-34
<https://identifiers.org/wikipathways/WP4538_r104390>	WP4538	Regulatory circuits of the STAT3 signaling pathway	78	43	2.18529802808047e-70	43	3.81735782230915e-70	43	2.65693622385385e-71	43	1.13888321384632e-69	43	2.10869266649642e-70	43	1.42750218061335e-70	43	1.18804805127726e-72	43	1.18804805127726e-72
<https://identifiers.org/wikipathways/WP4539_r113659>	WP4539	Synaptic signaling pathways associated with autism spectrum disorder	50	16	9.99724592008503e-78	16	1.71882320215968e-77	16	1.29069665421548e-78	16	4.97078050002086e-77	16	9.65660561909169e-78	16	6.61020847829755e-78	16	6.30572914889895e-80	16	6.30572914889895e-80
<https://identifiers.org/wikipathways/WP4540_r120395>	WP4540	Hippo signaling regulation pathways	98	34	1.53569466141782e-126	34	4.2480085635016e-126	34	3.28782114847427e-128	34	3.11918734239532e-125	34	1.43891868902505e-126	34	7.06259499834324e-127	34	1.13401807274267e-130	34	1.13401807274267e-130
<https://identifiers.org/wikipathways/WP4541_r116745>	WP4541	Hippo-Merlin signaling dysregulation	120	49	2.04636063928292e-132	49	6.32268227123488e-132	50	3.63436174917734e-132	49	5.76600066743773e-131	49	1.90388273660483e-132	50	1.03908825697936e-130	50	7.38806131290657e-135	49	5.36923060530977e-137
<https://identifiers.org/wikipathways/WP4542_r120673>	WP4542	Leukocyte-intrinsic Hippo pathway functions	36	17	2.56877058607389e-45	17	3.47867550739418e-45	17	8.17118581865919e-46	17	6.30200509171259e-45	17	2.51942258637384e-45	17	2.03796603794012e-45	17	1.50930210374816e-46	17	1.50930210374816e-46
<https://identifiers.org/wikipathways/WP4545_r121824>	WP4545	Oxysterols derived from cholesterol	52	19	2.68957485500562e-74	19	4.55126291056062e-74	19	3.68727125928315e-75	19	1.27585110300708e-73	19	2.60057471746152e-74	19	1.80006414035325e-74	19	1.96825038370845e-76	19	1.96825038370845e-76
<https://identifiers.org/wikipathways/WP4549_r119333>	WP4549	Fragile X syndrome	112	33	2.7319158588864e-153	33	9.57674609043988e-153	33	2.38966281196127e-155	33	1.11844271394185e-151	33	2.52125844930092e-153	33	1.04854296375685e-153	33	2.19997120068041e-158	33	2.19997120068041e-158
<https://identifiers.org/wikipathways/WP455_r117740>	WP455	GPCRs, class A rhodopsin-like	262	55	0	55	0	55	0	55	0	55	0	55	0	55	0	55	0
<https://identifiers.org/wikipathways/WP4553_r103606>	WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	35	4	6.07211340697218e-79	4	9.9535851000311e-79	7	1.09603655712713e-70	4	2.62174159075167e-78	4	5.88313697589197e-79	7	4.21033303280123e-70	7	9.11190425949128e-72	4	5.98205829219618e-81
<https://identifiers.org/wikipathways/WP4558_r107928>	WP4558	Overview of interferons-mediated signaling pathway	37	10	6.45335309292748e-66	10	9.92644315296674e-66	10	1.26871163651973e-66	10	2.30812932845317e-65	10	6.27801262074782e-66	10	4.64542884841105e-66	10	1.15251465430965e-67	10	1.15251465430965e-67
<https://identifiers.org/wikipathways/WP4559_r104316>	WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	50	22	7.81370713774186e-63	22	1.22116680620552e-62	22	1.44654253341921e-63	22	2.9294156262639e-62	22	7.59367237753141e-63	22	5.55677251110198e-63	22	1.20258370818819e-64	22	1.20258370818819e-64
<https://identifiers.org/wikipathways/WP4560_r108134>	WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	18	4	4.60939894918227e-39	4	5.76394212454509e-39	4	1.98133574740453e-39	4	8.93215254857307e-39	4	4.54395769574853e-39	4	3.88632788222305e-39	4	5.70519765579351e-40	4	5.70519765579351e-40
<https://identifiers.org/wikipathways/WP4561_r107544>	WP4561	Cell migration and invasion through p75NTR	30	12	8.00167015527631e-45	12	1.06647077810993e-44	12	2.70322742316212e-45	12	1.87263393398089e-44	12	7.85595613168064e-45	12	6.42591808517143e-45	12	5.45665086091163e-46	12	5.45665086091163e-46
<https://identifiers.org/wikipathways/WP4562_r117956>	WP4562	Canonical NF-kB pathway	8	2	4.94051302428728e-19	2	5.4375633240575e-19	2	3.43967098166293e-19	2	6.56132576239643e-19	2	4.91030873734739e-19	2	4.59188830421729e-19	2	2.01674745676809e-19	2	2.01674745676809e-19
<https://identifiers.org/wikipathways/WP4564_r117803>	WP4564	Neural crest cell migration during development	39	16	1.99567925989001e-54	16	2.88037233506851e-54	16	4.99028013143882e-55	16	5.91198452477709e-54	16	1.94937939275066e-54	16	1.50813291301447e-54	16	6.46346002381573e-56	16	6.46346002381573e-56
<https://identifiers.org/wikipathways/WP4565_r117804>	WP4565	Neural crest cell migration in cancer	42	16	6.73068447542461e-61	16	1.01895886489323e-60	16	1.40522039511242e-61	16	2.29657819031393e-60	16	6.55447774789166e-61	16	4.90428164585813e-61	16	1.39486857903966e-62	16	1.39486857903966e-62
<https://identifiers.org/wikipathways/WP4566_r104315>	WP4566	Translation inhibitors in chronically activated PDGFRA cells	46	20	2.26696954823984e-59	20	3.43196702513112e-59	20	4.73293890973e-60	20	7.7351313103485e-59	20	2.20762115849276e-59	20	1.65181671904919e-59	20	4.6980728394343e-61	20	4.6980728394343e-61
<https://identifiers.org/wikipathways/WP4571_r120383>	WP4571	Urea cycle and related diseases	9	3	1.48215390728618e-18	3	1.63126899721727e-18	3	1.03190129449887e-18	3	1.96839772871891e-18	3	1.47309262120421e-18	3	1.37756649126517e-18	3	6.0502423703042e-19	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP4577_r118444>	WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	44	13	6.02056845068303e-73	13	9.86909110683389e-73	13	9.30737292173681e-74	13	2.59948615073615e-72	13	5.83319620273108e-73	13	4.12841772119322e-73	13	5.93127779576518e-75	13	5.93127779576518e-75
<https://identifiers.org/wikipathways/WP4582_r108125>	WP4582	Cancer immunotherapy by CTLA4 blockade	16	10	1.41298672494615e-16	10	1.55514311068044e-16	10	9.83745900755593e-17	10	1.87653916804536e-16	10	1.40434829888136e-16	10	1.31328005500613e-16	10	5.76789772635671e-17	10	5.76789772635671e-17
<https://identifiers.org/wikipathways/WP4583_r106803>	WP4583	Biomarkers for urea cycle disorders	12	5	1.6661924353754e-20	5	1.86333945684214e-20	5	1.09213414748118e-20	5	2.31989732313294e-20	5	1.65431534795778e-20	5	1.52985677979982e-20	5	5.85850933744251e-21	5	5.85850933744251e-21
<https://identifiers.org/wikipathways/WP4584_r119306>	WP4584	Biomarkers for pyrimidine metabolism disorders	19	6	1.71595631147523e-35	6	2.11181232873122e-35	6	7.83400341166293e-36	6	3.17189669152378e-35	6	1.69332098184633e-35	6	1.46449789028439e-35	6	2.46534902834702e-36	6	2.46534902834702e-36
<https://identifiers.org/wikipathways/WP4585_r108119>	WP4585	Cancer immunotherapy by PD-1 blockade	25	11	6.71435780264218e-36	11	8.39614236142071e-36	11	2.88614573871933e-36	11	1.30111688790881e-35	11	6.61903171014047e-36	11	5.66108428177158e-36	11	8.31057125193925e-37	11	8.31057125193925e-37
<https://identifiers.org/wikipathways/WP4586_r119267>	WP4586	Metabolism of alpha-linolenic acid	6	4	8.71989347778175e-07	4	9.00312696605772e-07	4	7.72814846700547e-07	4	9.58514532518016e-07	4	8.70208112010357e-07	4	8.50969535120449e-07	4	6.46789949142924e-07	4	6.46789949142924e-07
<https://identifiers.org/wikipathways/WP4589_r119266>	WP4589	Major receptors targeted by epinephrine and norepinephrine	21	3	1.23041097224866e-49	3	1.63990432185438e-49	3	4.1567330537225e-50	3	2.87953551528987e-49	3	1.20800463332651e-49	3	9.88108727970093e-50	3	8.39065215224926e-51	3	8.39065215224926e-51
<https://identifiers.org/wikipathways/WP4595_r121755>	WP4595	Urea cycle and associated pathways	24	9	5.02520400265779e-39	9	6.38489913416021e-39	9	2.03379904714365e-39	9	1.02084777225371e-38	9	4.94880875524508e-39	9	4.18564457062599e-39	9	5.35851604755747e-40	9	5.35851604755747e-40
<https://identifiers.org/wikipathways/WP4629_r119264>	WP4629	Aerobic glycolysis	13	8	2.2216693059198e-14	8	2.40644511171452e-14	8	1.64294348871722e-14	8	2.814306107648e-14	8	2.21034391184653e-14	8	2.0902259161196e-14	8	1.05289883049431e-14	8	1.05289883049431e-14
<https://identifiers.org/wikipathways/WP4630_r120771>	WP4630	Measles virus infection	150	54	2.01373615197676e-171	54	9.2262138723428e-171	56	8.31683417986423e-170	54	1.82052858345491e-169	54	1.82689594339629e-171	56	7.44126330671683e-168	56	2.04979861493203e-173	54	1.32433374768965e-177
<https://identifiers.org/wikipathways/WP465_r122957>	WP465	Tryptophan metabolism	56	16	5.53222559186284e-90	16	1.04626385871422e-89	17	1.83745719701372e-88	16	3.6470086605738e-89	16	5.3112419721515e-90	17	1.1956321603241e-87	17	5.76628135398295e-90	16	1.43125686987453e-92
<https://identifiers.org/wikipathways/WP4655_r105163>	WP4655	Cytosolic DNA-sensing pathway	74	23	6.78024150759103e-108	23	1.5267190184758e-107	25	2.07598027099176e-104	23	7.49068256492977e-107	23	6.43715311527804e-108	25	2.17935360305671e-103	25	2.69077013171533e-106	24	9.80744325599662e-109
<https://identifiers.org/wikipathways/WP4656_r120396>	WP4656	Joubert syndrome	76	24	2.72195293788511e-109	24	6.22695804375749e-109	25	3.00087531298153e-108	24	3.15152720845143e-108	24	2.58160058236844e-109	25	3.46622368774826e-107	25	3.25961670899023e-110	24	1.18773382487617e-112
<https://identifiers.org/wikipathways/WP4657_r120007>	WP4657	22q11.2 copy number variation syndrome	154	29	8.71018588863926e-232	29	6.28959327371064e-231	31	2.15394129060256e-230	29	3.02563789139632e-229	29	7.67534229075795e-232	31	7.60406010164747e-228	31	4.18951634933236e-235	29	8.10479063645425e-240
<https://identifiers.org/wikipathways/WP4658_r119261>	WP4658	Small cell lung cancer	96	44	3.34142923992886e-101	44	7.6441217603814e-101	44	1.46625944499981e-102	44	3.86876827228788e-100	44	3.1691347604434e-101	44	1.77650510359385e-101	44	1.4580445078442e-104	44	1.4580445078442e-104
<https://identifiers.org/wikipathways/WP4659_r116555>	WP4659	Gastrin signaling pathway	114	34	1.74137736987244e-154	34	6.2014358097183e-154	35	2.58686019694835e-154	34	7.46973747731705e-153	34	1.60547955234282e-154	35	1.13506978648033e-152	35	2.381515042619e-157	34	1.20994377256006e-159
<https://identifiers.org/wikipathways/WP466_r117096>	WP466	DNA replication	42	17	2.33198420942668e-58	17	3.47464972928587e-58	17	5.17038445378117e-59	17	7.59086638316121e-58	17	2.27324710597475e-58	17	1.71996042191796e-58	17	5.60819219866834e-60	17	5.60819219866834e-60
<https://identifiers.org/wikipathways/WP4661_r117646>	WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	6	2	3.03938861455565e-13	2	3.24000628560928e-13	2	2.38743816052768e-13	2	3.67237426354619e-13	2	3.02698612636321e-13	2	2.89464619292938e-13	2	1.6723665806499e-13	2	1.6723665806499e-13
<https://identifiers.org/wikipathways/WP4666_r119241>	WP4666	Hepatitis B infection	152	60	1.6162703965476e-162	60	6.95356230201945e-162	61	6.75625597331109e-163	60	1.21296093647293e-160	60	1.4722232095388e-162	61	5.24284599494658e-161	61	2.16680904620833e-166	60	1.91530722820902e-168
<https://identifiers.org/wikipathways/WP4673_r119920>	WP4673	Male infertility	145	41	1.22205328629007e-190	41	6.3490818213073e-190	41	2.41646787236805e-193	41	1.602665347638e-188	41	1.0997858032503e-190	41	3.47332163279357e-191	41	2.47801728431201e-197	41	2.47801728431201e-197
<https://identifiers.org/wikipathways/WP4674_r117748>	WP4674	Head and neck squamous cell carcinoma	74	30	1.66809323354638e-91	30	3.36148973967333e-91	30	1.18201624486178e-92	30	1.32693073565049e-90	30	1.59497083140412e-91	30	9.77030808134135e-92	30	2.38350573120935e-94	30	2.38350573120935e-94
<https://identifiers.org/wikipathways/WP4685_r119240>	WP4685	Melanoma	68	21	3.14544067147519e-101	21	6.64749805586665e-101	21	1.86211231961143e-102	21	2.88048482230307e-100	21	2.99841587898067e-101	21	1.77661224832251e-101	21	2.88016547393136e-104	21	2.88016547393136e-104
<https://identifiers.org/wikipathways/WP4686_r122622>	WP4686	Leucine, isoleucine and valine metabolism	25	10	1.25630100066447e-38	10	1.59622478354007e-38	10	5.08449761785905e-39	10	2.55211943063428e-38	10	1.2372021888113e-38	10	1.0464111426565e-38	10	1.33962901188939e-39	10	1.33962901188939e-39
<https://identifiers.org/wikipathways/WP4688_r120418>	WP4688	Serine metabolism	8	4	1.41838135345931e-12	4	1.51200293328433e-12	4	1.11413780824625e-12	4	1.71377465632155e-12	4	1.41259352563617e-12	4	1.35083489003371e-12	4	7.80437737636619e-13	4	7.80437737636619e-13
<https://identifiers.org/wikipathways/WP4698_r119119>	WP4698	Vitamin D-sensitive calcium signaling in depression	37	12	1.69635137185506e-60	12	2.52755863918959e-60	12	3.76108411272064e-61	12	5.52181123293712e-60	12	1.65362433896322e-60	12	1.25114793207553e-60	12	4.07955786809424e-62	12	4.07955786809424e-62
<https://identifiers.org/wikipathways/WP47_r120579>	WP47	Hedgehog signaling pathway	16	5	6.11533041539365e-31	5	7.28975647799305e-31	6	3.27545219640846e-28	5	1.02854658657672e-30	5	6.04699182162429e-31	6	5.30061901547899e-28	6	1.34569774427953e-28	5	1.18389830875028e-31
<https://identifiers.org/wikipathways/WP4705_r119081>	WP4705	Pathways of nucleic acid metabolism and innate immune sensing	20	5	5.95873992410031e-41	5	7.5710266412968e-41	7	2.23828668904652e-35	5	1.21049142954984e-40	5	5.86815267420367e-41	7	4.18427968652682e-35	7	7.04385436670573e-36	6	7.2265836973384e-39
<https://identifiers.org/wikipathways/WP4707_r116586>	WP4707	Aspirin and miRNAs	11	6	7.97522314945564e-15	6	8.63852091384699e-15	6	5.8977458569336e-15	6	1.01026373095056e-14	6	7.93456788867978e-15	6	7.50337508350628e-15	6	3.77963682741546e-15	6	3.77963682741546e-15
<https://identifiers.org/wikipathways/WP4718_r119764>	WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	47	31	1.57209763958942e-35	31	2.02956845046751e-35	31	5.99071613637644e-36	31	3.3479478928491e-35	31	1.54661977206211e-35	31	1.29360763169006e-35	31	1.44425880738607e-36	31	1.44425880738607e-36
<https://identifiers.org/wikipathways/WP4719_r116307>	WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	30	16	2.19055923311205e-34	16	2.73924144541352e-34	16	9.41605047257155e-35	16	4.24489384680246e-34	16	2.15945909543328e-34	16	1.84692874692799e-34	16	2.71132387094523e-35	16	2.71132387094523e-35
<https://identifiers.org/wikipathways/WP4720_r120365>	WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	9	5	2.55308643622674e-12	5	2.72160527991179e-12	5	2.00544805484324e-12	5	3.08479438137879e-12	5	2.54266834614509e-12	5	2.43150280206068e-12	5	1.40478792774592e-12	5	1.40478792774592e-12
<https://identifiers.org/wikipathways/WP4721_r116526>	WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	29	16	4.29203572407738e-32	16	5.28217058723902e-32	16	1.95948010334215e-32	16	7.9337065996738e-32	16	4.23541910584316e-32	16	3.66307534807385e-32	16	6.16645425715293e-33	16	6.16645425715293e-33
<https://identifiers.org/wikipathways/WP4722_r117144>	WP4722	Glycerolipids and glycerophospholipids	22	6	7.80311180536929e-43	6	1.00737696799698e-42	7	2.65278136583951e-40	6	1.66175503789159e-42	6	7.67665232609053e-43	7	5.45953639646864e-40	7	6.98936875768374e-41	6	7.16858334121406e-44
<https://identifiers.org/wikipathways/WP4723_r120315>	WP4723	Omega-3 / omega-6 fatty acid synthesis	14	9	3.45593003143077e-14	9	3.74335906266702e-14	9	2.5556898713379e-14	9	4.37780950078577e-14	9	3.43831275176123e-14	9	3.25146253618604e-14	9	1.63784262521336e-14	9	1.63784262521336e-14
<https://identifiers.org/wikipathways/WP4724_r117812>	WP4724	Omega-9 fatty acid synthesis	14	10	2.02828533544681e-11	10	2.16216419459659e-11	10	1.59321706579214e-11	10	2.45069775853982e-11	10	2.02000874165972e-11	10	1.9316938927482e-11	10	1.11602596482037e-11	10	1.11602596482037e-11
<https://identifiers.org/wikipathways/WP4725_r117175>	WP4725	Sphingolipid metabolism overview	23	9	1.23096559715107e-36	9	1.53929276626046e-36	9	5.2912671876521e-37	9	2.38538096116616e-36	9	1.21348914685908e-36	9	1.03786545165814e-36	9	1.52360472952219e-37	9	1.52360472952219e-37
<https://identifiers.org/wikipathways/WP4726_r120323>	WP4726	Sphingolipid metabolism: integrated pathway	26	9	9.44579570127149e-44	9	1.23904018754358e-43	10	2.11684448461708e-41	9	2.10875458929453e-43	9	9.28324332670476e-44	10	4.5710164161742e-41	10	5.10334861672146e-42	9	7.47633843645104e-45
<https://identifiers.org/wikipathways/WP474_r117098>	WP474	Endochondral ossification	64	33	2.06086563718009e-65	33	3.37823095923203e-65	33	3.18595248670423e-66	33	8.89814927985739e-65	33	1.99672733689689e-65	33	1.41317456768839e-65	33	2.0303010743902e-67	33	2.0303010743902e-67
<https://identifiers.org/wikipathways/WP4742_r122056>	WP4742	Ketogenesis and ketolysis	8	6	1.62771344918594e-06	6	1.68058370033078e-06	6	1.44258771384103e-06	6	1.78922712736696e-06	6	1.62438847575267e-06	6	1.58847646555818e-06	6	1.20734123840013e-06	6	1.20734123840013e-06
<https://identifiers.org/wikipathways/WP4746_r120402>	WP4746	Thyroid hormones production and peripheral downstream signaling effects	95	41	7.89868742840561e-106	41	1.86513164032085e-105	41	3.07499929338021e-107	41	1.00441512848975e-104	41	7.47623792404601e-106	41	4.09906224711854e-106	41	2.56274419320423e-109	41	2.56274419320423e-109
<https://identifiers.org/wikipathways/WP4747_r116543>	WP4747	Netrin-UNC5B signaling pathway	52	20	7.93021145998363e-72	20	1.32077649664469e-71	23	2.66527074813994e-65	20	3.58896915275877e-71	20	7.67559627858775e-72	23	1.07413249021047e-64	23	2.02783167854518e-66	20	6.73338456266671e-74
<https://identifiers.org/wikipathways/WP4751_r120779>	WP4751	HIPK2 in kidney fibrosis	2	1	0.000341005967604384	1	0.000346500346500379	1	0.000321027287319477	1	0.000357525920629227	1	0.00034065746891505	1	0.000336870473303061	1	0.000293685756240802	1	0.000293685756240802
<https://identifiers.org/wikipathways/WP4752_r119239>	WP4752	Base excision repair	31	11	8.59908164384172e-50	11	1.18320438706151e-49	11	2.57557368312434e-50	11	2.2114805508928e-49	11	8.42529547328804e-50	11	6.73971714116193e-50	11	4.35329884333e-51	11	4.35329884333e-51
<https://identifiers.org/wikipathways/WP4753_r119238>	WP4753	Nucleotide excision repair	43	13	8.06619341290386e-71	13	1.30137424095118e-70	13	1.32418532931983e-71	13	3.32261593448648e-70	13	7.82311154370794e-71	13	5.59869739599114e-71	13	9.22044093705354e-73	13	9.22044093705354e-73
<https://identifiers.org/wikipathways/WP4754_r115147>	WP4754	IL-18 signaling pathway	185	119	1.01161276843881e-105	119	2.88819145354709e-105	125	3.53270420974406e-97	119	2.25623532368591e-104	119	9.45947882308196e-106	125	6.27071755772394e-96	125	1.73383781670798e-99	119	5.55754921280338e-110
<https://identifiers.org/wikipathways/WP4756_r120634>	WP4756	Renin-angiotensin-aldosterone system (RAAS)	44	16	3.66883857015947e-65	16	5.73385180712068e-65	16	6.7920782625062e-66	16	1.37547425929899e-64	16	3.56552371578811e-65	16	2.60912022359525e-65	16	5.64659695413334e-67	16	5.64659695413334e-67
<https://identifiers.org/wikipathways/WP4758_r108284>	WP4758	Nephrotic syndrome	49	15	3.19911869442714e-78	15	5.50023424691091e-78	16	1.61672662907028e-76	15	1.59064976000665e-77	15	3.09011379810934e-78	16	7.89258892308702e-76	16	8.63002091318294e-78	15	2.01783332764775e-80
<https://identifiers.org/wikipathways/WP4760_r108400>	WP4760	PKC-gamma calcium signaling pathway in ataxia	22	8	4.81682190189552e-37	8	6.02331952014958e-37	8	2.07049585603772e-37	8	9.33409941325873e-37	8	4.74843579205723e-37	8	4.06121263692309e-37	8	5.96193155030424e-38	8	5.96193155030424e-38
<https://identifiers.org/wikipathways/WP4767_r116441>	WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	27	10	2.55036483934327e-43	10	3.34540850636763e-43	10	9.15062457327267e-44	10	5.69363739109539e-43	10	2.50647569821032e-43	10	2.07319743384351e-43	10	2.01861137784177e-44	10	2.01861137784177e-44
<https://identifiers.org/wikipathways/WP477_r117044>	WP477	Cytoplasmic ribosomal proteins	88	52	4.54411768739076e-70	52	8.06495508417958e-70	52	5.20296570058091e-71	52	2.48221188988614e-69	52	4.38036957102475e-70	52	2.93256663850967e-70	52	2.1293716230778e-72	52	2.1293716230778e-72
<https://identifiers.org/wikipathways/WP4784_r111633>	WP4784	Proteoglycan biosynthesis	18	8	3.27197477805779e-27	8	3.83860351739917e-27	8	1.78980066446605e-27	8	5.24933443982087e-27	8	3.23871482866358e-27	8	2.89640967631533e-27	8	7.35327695981312e-28	8	7.35327695981312e-28
<https://identifiers.org/wikipathways/WP4785_r111735>	WP4785	Somitogenesis in the context of spondylocostal dysostosis	9	1	2.5795647067367e-25	1	2.93120775353105e-25	1	1.59186984925905e-25	1	3.76539469109893e-25	1	2.55856251037422e-25	1	2.33980297901602e-25	1	7.81269998458703e-26	1	7.81269998458703e-26
<https://identifiers.org/wikipathways/WP4786_r117852>	WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	33	18	3.98616917504944e-36	18	5.06472734259713e-36	20	1.65494170957196e-31	18	8.09772482873005e-36	18	3.92556976849879e-36	20	3.09376766239795e-31	20	5.20807653669148e-32	18	4.25056405301839e-37
<https://identifiers.org/wikipathways/WP4787_r118872>	WP4787	Osteoblast differentiation and related diseases	118	42	8.40387752409387e-144	42	2.80981217251588e-143	42	8.79062132564532e-146	42	2.99093612430612e-142	42	7.77937485955855e-144	42	3.34419008313066e-144	42	1.05371145308797e-148	42	1.05371145308797e-148
<https://identifiers.org/wikipathways/WP4788_r117658>	WP4788	Autosomal recessive osteopetrosis pathways	11	3	4.72920196235064e-24	3	5.37388088147355e-24	3	2.91842805697492e-24	3	6.90322360034802e-24	3	4.6906979356861e-24	3	4.2896387948627e-24	3	1.43232833050762e-24	3	1.43232833050762e-24
<https://identifiers.org/wikipathways/WP4789_r117775>	WP4789	MED and pseudoachondroplasia genes	6	1	1.03574326616307e-16	1	1.12188583296715e-16	1	7.65941020380987e-17	1	1.31203081941631e-16	1	1.0304633621662e-16	1	9.74464296559259e-17	1	4.90861925638373e-17	1	4.90861925638373e-17
<https://identifiers.org/wikipathways/WP4790_r116413>	WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	23	9	1.23096559715107e-36	9	1.53929276626046e-36	9	5.2912671876521e-37	9	2.38538096116616e-36	9	1.21348914685908e-36	9	1.03786545165814e-36	9	1.52360472952219e-37	9	1.52360472952219e-37
<https://identifiers.org/wikipathways/WP4792_r119117>	WP4792	Purine metabolism	15	6	2.19831795627744e-25	6	2.53818249246069e-25	7	1.13818694222022e-22	6	3.36412003372912e-25	6	2.17819448280709e-25	7	1.67295912999645e-22	7	5.58608048897971e-23	6	5.73519557390131e-26
<https://identifiers.org/wikipathways/WP4799_r120793>	WP4799	Downregulation of ACE2 by SARS-CoV-2 spike protein	5	3	5.81326231852119e-07	3	6.00208464403848e-07	3	5.15209897800365e-07	3	6.39009688345344e-07	3	5.80138741340239e-07	3	5.67313023413633e-07	3	4.31193299428616e-07	3	4.31193299428616e-07
<https://identifiers.org/wikipathways/WP4803_r110008>	WP4803	Ciliopathies	184	41	1.64223955375033e-251	41	1.57101216299854e-250	42	4.90190674762525e-253	41	1.31105977817664e-248	41	1.42131874423561e-251	42	4.23868404389139e-250	42	1.8170489901177e-258	41	1.0977568697489e-260
<https://identifiers.org/wikipathways/WP4804_r117680>	WP4804	Cholesterol biosynthesis with skeletal dysplasias	7	4	1.04038272276242e-09	4	1.09147711746456e-09	4	8.68052619849782e-10	4	1.19899959392901e-09	4	1.0371967961983e-09	4	1.00299490585005e-09	4	6.6464028831477e-10	4	6.6464028831477e-10
<https://identifiers.org/wikipathways/WP4806_r116801>	WP4806	EGFR tyrosine kinase inhibitor resistance	85	38	3.49019693534526e-94	38	7.37609758553084e-94	38	2.06620928193445e-95	38	3.19620058018643e-93	38	3.32705747929446e-94	38	1.97133796883343e-94	38	3.19584622961191e-97	38	3.19584622961191e-97
<https://identifiers.org/wikipathways/WP4808_r117708>	WP4808	Endochondral ossification with skeletal dysplasias	64	33	2.06086563718009e-65	33	3.37823095923203e-65	33	3.18595248670423e-66	33	8.89814927985739e-65	33	1.99672733689689e-65	33	1.41317456768839e-65	33	2.0303010743902e-67	33	2.0303010743902e-67
<https://identifiers.org/wikipathways/WP481_r120562>	WP481	Insulin signaling	161	65	7.48822767391545e-167	65	3.43083625809278e-166	65	2.38140269887958e-169	65	6.76977095852332e-165	65	6.79344846010445e-167	65	2.34273518834222e-167	65	4.92463355202418e-173	65	4.92463355202418e-173
<https://identifiers.org/wikipathways/WP4814_r116554>	WP4814	Somatic sex determination	14	3	5.09610867949464e-32	3	6.07479706499433e-32	3	2.62456105481452e-32	3	8.57122155480596e-32	3	5.03915985135365e-32	3	4.45654869302096e-32	3	9.86581923958582e-33	3	9.86581923958582e-33
<https://identifiers.org/wikipathways/WP4815_r110276>	WP4815	Glycosaminoglycan degradation	17	4	1.5052248346274e-36	4	1.85246695502739e-36	4	6.8719328172481e-37	4	2.7823655188805e-36	4	1.48536928232135e-36	4	1.28464727217928e-36	4	2.16258686697106e-37	4	2.16258686697106e-37
<https://identifiers.org/wikipathways/WP4816_r116440>	WP4816	TGF-beta receptor signaling in skeletal dysplasias	59	25	6.14897909896874e-74	25	1.05719195360287e-73	25	7.93865311839065e-75	25	3.05736456265253e-73	25	5.93946238728497e-74	25	4.06572310992362e-74	25	3.87844782956098e-76	25	3.87844782956098e-76
<https://identifiers.org/wikipathways/WP4818_r117691>	WP4818	Conversion of angiotensinogen to angiotensin II 	5	2	2.97252206503549e-10	2	3.11850604989874e-10	2	2.48015034242795e-10	2	3.42571312551149e-10	2	2.96341941770944e-10	2	2.86569973100015e-10	2	1.89897225232792e-10	2	1.89897225232792e-10
<https://identifiers.org/wikipathways/WP4823_r119116>	WP4823	Genes controlling nephrogenesis	44	13	6.02056845068303e-73	13	9.86909110683389e-73	14	4.16172532071927e-71	13	2.59948615073615e-72	13	5.83319620273108e-73	14	1.75959061016859e-70	14	2.89785286593093e-72	13	5.93127779576518e-75
<https://identifiers.org/wikipathways/WP4829_r109219>	WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	38	16	3.01245225717244e-52	16	4.2791993100992e-52	16	7.99980291839865e-53	16	8.51325771567918e-52	16	2.9455622465332e-52	16	2.30434975093666e-52	16	1.13226561237713e-53	16	1.13226561237713e-53
<https://identifiers.org/wikipathways/WP4830_r118773>	WP4830	GDNF/RET signaling axis	23	4	2.64570776796633e-51	4	3.58286522823117e-51	4	8.41592079538919e-52	4	6.49075628446478e-51	4	2.5948817475939e-51	4	2.09900510643527e-51	4	1.55450717231917e-52	4	1.55450717231917e-52
<https://identifiers.org/wikipathways/WP4838_r110282>	WP4838	Regucalcin in proximal tubule epithelial kidney cells	44	7	1.7661918853854e-89	7	3.18485213953815e-89	7	1.90447160356262e-90	7	1.01121705537418e-88	7	1.70081748426709e-89	7	1.12608015274556e-89	7	7.13392429891962e-92	7	7.13392429891962e-92
<https://identifiers.org/wikipathways/WP4842_r119114>	WP4842	Mammalian disorder of sexual development	25	6	5.29141553593276e-50	6	7.16573045646219e-50	6	1.68318415907781e-50	6	1.29815125689299e-49	6	5.18976349518774e-50	6	4.1980102128706e-50	6	3.1090143446384e-51	6	3.1090143446384e-51
<https://identifiers.org/wikipathways/WP4844_r120398>	WP4844	Influence of laminopathies on Wnt signaling	39	11	1.47563248838465e-67	11	2.30619523000776e-67	11	2.73182129879581e-68	11	5.53225350514723e-67	11	1.43407853262249e-67	11	1.04940637054831e-67	11	2.27110071893163e-69	11	2.27110071893163e-69
<https://identifiers.org/wikipathways/WP4846_r122702>	WP4846	SARS-CoV-2 and COVID-19 pathway	50	6	5.65031045879929e-105	6	1.13863303628677e-104	6	4.00382821325549e-106	6	4.49469517828361e-104	6	5.40262389950638e-105	6	3.30948371634656e-105	6	8.07361788347283e-108	6	8.07361788347283e-108
<https://identifiers.org/wikipathways/WP4853_r122756>	WP4853	Linoleic acid metabolism affected by SARS-CoV-2	13	5	3.68877753063347e-23	5	4.19162708754937e-23	5	2.27637388444043e-23	5	5.38451440827145e-23	5	3.65874438983517e-23	5	3.3459182599929e-23	5	1.11721609779595e-23	5	1.11721609779595e-23
<https://identifiers.org/wikipathways/WP4856_r113654>	WP4856	Intracellular trafficking proteins involved in CMT neuropathy	27	10	2.55036483934327e-43	10	3.34540850636763e-43	10	9.15062457327267e-44	10	5.69363739109539e-43	10	2.50647569821032e-43	10	2.07319743384351e-43	10	2.01861137784177e-44	10	2.01861137784177e-44
<https://identifiers.org/wikipathways/WP4860_r120599>	WP4860	Hijack of ubiquitination by SARS-CoV-2	9	2	7.573601978979e-22	2	8.46972480382791e-22	3	1.03190129449887e-18	2	1.05449878324224e-21	2	7.5196152179899e-22	3	1.37756649126517e-18	3	6.0502423703042e-19	2	2.66295878974659e-22
<https://identifiers.org/wikipathways/WP4861_r118973>	WP4861	Endoplasmic reticulum stress response in coronavirus infection	54	15	1.69674077373283e-88	15	3.15835806908483e-88	15	1.62268947268738e-89	15	1.06719998883178e-87	15	1.63062026261897e-88	15	1.05588294677974e-88	15	5.09230041650431e-91	15	5.09230041650431e-91
<https://identifiers.org/wikipathways/WP4863_r116597>	WP4863	Host-pathogen interaction of human coronaviruses - autophagy	20	6	5.83857200229747e-38	6	7.30099335775709e-38	6	2.50969194671241e-38	6	1.13140598948591e-37	6	5.75567974794809e-38	6	4.92268198414912e-38	6	7.2265836973384e-39	6	7.2265836973384e-39
<https://identifiers.org/wikipathways/WP4864_r116596>	WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	32	9	1.48434199640382e-57	9	2.14235709522658e-57	9	3.71165974502455e-58	9	4.3972030418856e-57	9	1.44990518152879e-57	9	1.1217158307641e-57	9	4.8073782938225e-59	9	4.8073782938225e-59
<https://identifiers.org/wikipathways/WP4868_r120021>	WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	42	16	6.73068447542461e-61	16	1.01895886489323e-60	16	1.40522039511242e-61	16	2.29657819031393e-60	16	6.55447774789166e-61	16	4.90428164585813e-61	16	1.39486857903966e-62	16	1.39486857903966e-62
<https://identifiers.org/wikipathways/WP4871_r120412>	WP4871	Kisspeptin/kisspeptin receptor system in the ovary	39	11	1.47563248838465e-67	11	2.30619523000776e-67	11	2.73182129879581e-68	11	5.53225350514723e-67	11	1.43407853262249e-67	11	1.04940637054831e-67	11	2.27110071893163e-69	11	2.27110071893163e-69
<https://identifiers.org/wikipathways/WP4872_r110081>	WP4872	MAP3K1 role in promoting and blocking gonadal determination	17	5	1.76924127062109e-33	5	2.14293377357574e-33	5	8.57892092905242e-34	5	3.1195882197689e-33	5	1.74768549757931e-33	5	1.52847332443889e-33	5	2.95063352129527e-34	5	2.95063352129527e-34
<https://identifiers.org/wikipathways/WP4873_r110299>	WP4873	Peroxiredoxin 2 induced ovarian failure	8	1	1.68302266199533e-22	1	1.88216106751731e-22	1	1.10316580553654e-22	1	2.3433306294272e-22	1	1.67102560399776e-22	1	1.54530987858568e-22	1	5.91768619943689e-23	1	5.91768619943689e-23
<https://identifiers.org/wikipathways/WP4874_r121708>	WP4874	CAMKK2 pathway	47	9	4.04365771793804e-90	9	7.40838604501796e-90	9	4.10629847505015e-91	9	2.42657973019786e-89	9	3.89002983347333e-90	9	2.54706361968099e-90	9	1.40787428200894e-92	9	1.40787428200894e-92
<https://identifiers.org/wikipathways/WP4875_r116427>	WP4875	Disruption of postsynaptic signaling by CNV	33	10	4.89832858813272e-57	10	7.0697784142478e-57	10	1.22484771585811e-57	10	1.45107700382226e-56	10	4.78468709904502e-57	10	3.70166224152162e-57	10	1.58643483696143e-58	10	1.58643483696143e-58
<https://identifiers.org/wikipathways/WP4876_r120600>	WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	8	3	9.66693715085535e-16	3	1.04709344410267e-15	3	7.14878285688919e-16	3	1.2245620981219e-15	3	9.61765804688458e-16	3	9.09500010121972e-16	3	4.5813779726248e-16	3	4.5813779726248e-16
<https://identifiers.org/wikipathways/WP4877_r119237>	WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	42	13	1.10563125524784e-68	13	1.75564464459479e-68	13	1.92745952935175e-69	13	4.34489986037617e-68	13	1.07340367692738e-68	13	7.76786713127503e-69	13	1.46647896670953e-70	13	1.46647896670953e-70
<https://identifiers.org/wikipathways/WP4879_r120399>	WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	59	19	1.85600744856411e-88	19	3.51011267109811e-88	19	1.67165909719279e-89	19	1.22353565063562e-87	19	1.78186961065711e-88	19	1.14107910883231e-88	19	4.80172647912817e-91	19	4.80172647912817e-91
<https://identifiers.org/wikipathways/WP4880_r119113>	WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	43	12	1.77880431497457e-73	12	2.91586782701914e-73	12	2.74990563596756e-74	12	7.68029999081149e-73	12	1.72344433262511e-73	12	1.21975978126168e-73	12	1.75242298511252e-75	12	1.75242298511252e-75
<https://identifiers.org/wikipathways/WP4883_r120620>	WP4883	SARS-CoV-2 and ACE2 receptor: molecular mechanisms	7	4	1.04038272276242e-09	4	1.09147711746456e-09	4	8.68052619849782e-10	4	1.19899959392901e-09	4	1.0371967961983e-09	4	1.00299490585005e-09	4	6.6464028831477e-10	4	6.6464028831477e-10
<https://identifiers.org/wikipathways/WP4884_r120646>	WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	32	6	3.66302481769384e-66	6	5.54545622208424e-66	7	6.83367542624676e-64	6	1.24986142755764e-65	8	2.21397126463498e-60	7	2.27326446890851e-63	7	7.4123240846591e-65	6	7.59126094990676e-68
<https://identifiers.org/wikipathways/WP4891_r120510>	WP4891	COVID-19 adverse outcome pathway	15	12	1.35249753959115e-08	12	1.41892025270393e-08	13	5.40970392690382e-06	12	1.55869947210773e-08	12	1.3483558350578e-08	13	5.95678674584315e-06	13	4.52752964400048e-06	12	8.64032374809207e-09
<https://identifiers.org/wikipathways/WP49_r120703>	WP49	IL-2 signaling pathway	42	20	6.95941756749867e-51	20	9.88587778698463e-51	20	1.84812784449198e-51	20	1.96674703016711e-50	20	6.80488714663516e-51	20	5.32354731934664e-51	20	2.61577894723167e-52	20	2.61577894723167e-52
<https://identifiers.org/wikipathways/WP4900_r110333>	WP4900	Purinergic signaling	33	10	4.89832858813272e-57	10	7.0697784142478e-57	10	1.22484771585811e-57	10	1.45107700382226e-56	10	4.78468709904502e-57	10	3.70166224152162e-57	10	1.58643483696143e-58	10	1.58643483696143e-58
<https://identifiers.org/wikipathways/WP4904_r120598>	WP4904	LDLRAD4 and what we know about it	7	2	3.62510143157076e-16	2	3.926600415385e-16	2	2.68079357133346e-16	2	4.59210786795711e-16	2	3.60662176758171e-16	2	3.4106250379574e-16	2	1.7180167397343e-16	2	1.7180167397343e-16
<https://identifiers.org/wikipathways/WP4905_r115772>	WP4905	1q21.1 copy number variation syndrome	38	8	1.07845548426312e-73	8	1.73994611260784e-73	10	7.70513699660394e-69	7	6.31914630273793e-76	7	1.41800410081787e-76	8	7.48549607275365e-74	10	6.40566869442256e-70	8	1.23277915453671e-75
<https://identifiers.org/wikipathways/WP4906_r115773>	WP4906	3q29 copy number variation syndrome	75	16	4.16774676024609e-127	16	1.06520568614024e-126	18	1.5542804943676e-123	16	6.69873368640699e-126	16	3.92491429255938e-127	18	2.39094355244878e-122	18	9.93994209001513e-126	16	6.4492312069446e-131
<https://identifiers.org/wikipathways/WP4912_r115852>	WP4912	SARS coronavirus and innate immunity	32	10	8.73832133282937e-55	10	1.24128170097431e-54	10	2.32052967258934e-55	10	2.46946922832298e-54	10	8.54429123474919e-55	10	6.68430463552326e-55	10	3.28440085033957e-56	10	3.28440085033957e-56
<https://identifiers.org/wikipathways/WP4917_r119111>	WP4917	Proximal tubule transport	57	16	5.34016695573516e-92	16	1.02610185730748e-91	16	4.52976005296365e-93	16	3.68973187171988e-91	16	5.121651030496e-92	16	3.24360170970549e-92	16	1.1909728698226e-94	16	1.1909728698226e-94
<https://identifiers.org/wikipathways/WP4918_r117679>	WP4918	Cellular proteostasis	11	2	2.41573401788731e-27	2	2.78921153017656e-27	2	1.40354026465612e-27	2	3.69683520190006e-27	2	2.39362031077702e-27	2	2.16466213365647e-27	2	6.30241271857283e-28	2	6.30241271857283e-28
<https://identifiers.org/wikipathways/WP4919_r111814>	WP4919	Neuroinflammation	18	4	4.60939894918227e-39	4	5.76394212454509e-39	4	1.98133574740453e-39	4	8.93215254857307e-39	4	4.54395769574853e-39	4	3.88632788222305e-39	4	5.70519765579351e-40	4	5.70519765579351e-40
<https://identifiers.org/wikipathways/WP4921_r116643>	WP4921	Mitochondrial complex III assembly	16	5	6.11533041539365e-31	5	7.28975647799305e-31	6	3.27545219640846e-28	5	1.02854658657672e-30	5	6.04699182162429e-31	6	5.30061901547899e-28	6	1.34569774427953e-28	5	1.18389830875028e-31
<https://identifiers.org/wikipathways/WP4922_r117792>	WP4922	Mitochondrial complex IV assembly	35	14	8.40744143466909e-51	14	1.17541022301583e-50	14	2.37111275689477e-51	14	2.26656908836121e-50	14	8.22913833882112e-51	14	6.50986999340004e-51	14	3.66738093795559e-52	14	3.66738093795559e-52
<https://identifiers.org/wikipathways/WP4923_r110416>	WP4923	Autophagy	30	6	1.28081096836432e-61	6	1.87826681788077e-61	6	3.01577260897404e-62	6	3.97732390207717e-61	6	1.24982248810042e-61	6	9.56214783207122e-62	6	3.57450362461612e-63	6	3.57450362461612e-63
<https://identifiers.org/wikipathways/WP4925_r112845>	WP4925	Unfolded protein response	25	15	2.44419312480556e-25	15	2.86746963607424e-25	15	1.33699639379771e-25	15	3.92129769265255e-25	15	2.41934765833501e-25	15	2.16364278384579e-25	15	5.49296073750143e-26	15	5.49296073750143e-26
<https://identifiers.org/wikipathways/WP4928_r120795>	WP4928	MAPK pathway in congenital thyroid cancer	16	3	3.54170549324098e-37	3	4.35874577653509e-37	4	2.52321203795662e-34	3	6.54674239736591e-37	3	3.49498654663852e-37	4	4.49550977776148e-34	4	8.6783338861625e-35	3	5.08843968699069e-38
<https://identifiers.org/wikipathways/WP4932_r118797>	WP4932	7q11.23 copy number variation syndrome	117	32	4.09956534672519e-164	32	1.57965873687944e-163	37	4.80451880576875e-155	32	2.22038364945425e-162	32	3.76062453775271e-164	37	2.21081398221212e-153	37	4.05074225940903e-158	32	1.36261585738821e-169
<https://identifiers.org/wikipathways/WP4940_r115775>	WP4940	15q11.2 copy number variation syndrome	10	1	4.392243668886e-28	1	5.07129369123013e-28	1	2.55189139028388e-28	1	6.72151854890927e-28	1	4.35203692868553e-28	1	3.93574933392087e-28	1	1.1458932215587e-28	1	1.1458932215587e-28
<https://identifiers.org/wikipathways/WP4941_r120578>	WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	36	10	1.02747846136311e-63	10	1.55550047029463e-63	10	2.14515135082908e-64	10	3.50586130429918e-63	10	1.00057947093376e-63	10	7.48667357380385e-64	10	2.12934869644885e-65	10	2.12934869644885e-65
<https://identifiers.org/wikipathways/WP4942_r115789>	WP4942	15q13.3 copy number variation syndrome	34	6	1.1840797587067e-70	5	1.9143532288741e-73	6	2.19207311425426e-71	6	4.43920112022615e-70	6	1.15073595643925e-70	6	8.42066606560259e-71	6	1.82238085189827e-72	6	1.82238085189827e-72
<https://identifiers.org/wikipathways/WP4946_r117703>	WP4946	DNA repair pathways, full network	119	38	3.62373000099009e-154	38	1.31100011414282e-153	40	7.18011167041895e-152	38	1.62866139293303e-152	38	3.3375641561038e-154	40	3.15050957537693e-150	40	6.61015387339384e-155	38	2.17250488146879e-159
<https://identifiers.org/wikipathways/WP4947_r118070>	WP4947	Nitric oxide metabolism in cystic fibrosis	14	4	7.48490962300806e-29	4	8.78111915744915e-29	4	4.09431524551057e-29	4	1.20082813982831e-28	4	7.40882477145263e-29	4	6.62577376934876e-29	4	1.68212218034941e-29	4	1.68212218034941e-29
<https://identifiers.org/wikipathways/WP4949_r115778>	WP4949	16p11.2 proximal deletion syndrome	82	17	1.08412072452314e-137	17	3.04666232995907e-137	17	2.18643045766149e-139	16	6.93173524479423e-139	16	2.90619520344288e-140	16	1.39523649827015e-140	17	6.90501570370886e-142	17	6.90501570370886e-142
<https://identifiers.org/wikipathways/WP4950_r115784>	WP4950	16p11.2 distal deletion syndrome	34	13	3.36297657386758e-51	13	4.7016408920634e-51	13	9.48445102757902e-52	13	9.06627635344497e-51	13	3.29165533552846e-51	13	2.60394799736002e-51	13	1.46695237518225e-52	13	1.46695237518225e-52
<https://identifiers.org/wikipathways/WP496_r119106>	WP496	Steroid biosynthesis	11	3	4.72920196235064e-24	3	5.37388088147355e-24	3	2.91842805697492e-24	3	6.90322360034802e-24	3	4.6906979356861e-24	3	4.2896387948627e-24	3	1.43232833050762e-24	3	1.43232833050762e-24
<https://identifiers.org/wikipathways/WP4961_r120610>	WP4961	STING pathway in Kawasaki-like disease and COVID-19	21	9	8.40389603545e-32	9	1.01789354244847e-31	11	1.44268780832719e-26	9	1.48180440439021e-31	9	8.30150611350158e-32	11	2.33468173909052e-26	11	5.9271868827584e-27	10	9.55997884315872e-30
<https://identifiers.org/wikipathways/WP4962_r122013>	WP4962	Airway smooth muscle cell contraction	17	3	1.02431087759606e-39	3	1.28087602767669e-39	3	4.40296832756565e-40	3	1.9849227885718e-39	3	1.00976837683301e-39	3	8.63628418271777e-40	3	1.26782170128746e-40	3	1.26782170128746e-40
<https://identifiers.org/wikipathways/WP4963_r122690>	WP4963	p53 transcriptional gene network	98	38	1.06940480902845e-117	38	2.77681083118009e-117	39	4.68906316363271e-117	38	1.80123172252451e-116	38	1.00607728628294e-117	39	7.93553253317618e-116	39	2.51361754923449e-119	38	1.42715219711961e-121
<https://identifiers.org/wikipathways/WP4966_r112070>	WP4966	Fluoroacetic acid toxicity	6	2	3.03938861455565e-13	2	3.24000628560928e-13	2	2.38743816052768e-13	2	3.67237426354619e-13	2	3.02698612636321e-13	2	2.89464619292938e-13	2	1.6723665806499e-13	2	1.6723665806499e-13
<https://identifiers.org/wikipathways/WP4969_r120081>	WP4969	RAS and bradykinin pathways in COVID-19	31	18	1.30444222986668e-31	18	1.60536557063147e-31	18	5.9552826670203e-32	18	2.41122455480286e-31	18	1.28723521844253e-31	18	1.11328760578713e-31	18	1.87411845070337e-32	18	1.87411845070337e-32
<https://identifiers.org/wikipathways/WP497_r119105>	WP497	Urea cycle and metabolism of amino groups	37	9	1.09527377680374e-68	9	1.71175084548486e-68	10	1.26871163651973e-66	9	4.10626103620911e-68	9	1.06443075970629e-68	10	4.64542884841105e-66	10	1.15251465430965e-67	9	1.68570228800585e-70
<https://identifiers.org/wikipathways/WP4970_r113773>	WP4970	Galanin receptor pathway	20	5	5.95873992410031e-41	5	7.5710266412968e-41	5	2.41161942349047e-41	5	1.21049142954984e-40	5	5.86815267420367e-41	5	4.96321490588063e-41	5	6.35397159789422e-42	5	6.35397159789422e-42
<https://identifiers.org/wikipathways/WP4971_r122106>	WP4971	Phosphoinositides metabolism	54	15	1.69674077373283e-88	15	3.15835806908483e-88	15	1.62268947268738e-89	15	1.06719998883178e-87	15	1.63062026261897e-88	15	1.05588294677974e-88	15	5.09230041650431e-91	15	5.09230041650431e-91
<https://identifiers.org/wikipathways/WP500_r121748>	WP500	Glycogen synthesis and degradation	45	12	1.01298907582473e-77	12	1.71416668363914e-77	13	6.68953492218718e-76	12	4.80530678415511e-77	12	9.79468474265276e-78	13	3.11291550693202e-75	13	3.90158603726715e-77	12	7.41312751892318e-80
<https://identifiers.org/wikipathways/WP501_r117742>	WP501	GPCRs, class C metabotropic glutamate, pheromone	15	2	6.64069779982673e-38	2	8.17264833100341e-38	2	3.03173506643298e-38	2	1.2275141995061e-37	2	6.55309977494717e-38	2	5.66756149490873e-38	2	9.54082441310752e-39	2	9.54082441310752e-39
<https://identifiers.org/wikipathways/WP5027_r120060>	WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	17	7	1.45421101247013e-27	7	1.70604600773297e-27	7	7.95466961984908e-28	7	2.33303752880929e-27	7	1.43942881273937e-27	7	1.28729318947348e-27	7	3.26812309325026e-28	7	3.26812309325026e-28
<https://identifiers.org/wikipathways/WP5030_r120416>	WP5030	Ethylmalonic encephalopathy	4	1	1.1890088260142e-10	1	1.2474024199595e-10	1	9.92060136971183e-11	1	1.37028525020459e-10	1	1.18536776708378e-10	1	1.14627989240006e-10	1	7.5958890093117e-11	1	7.5958890093117e-11
<https://identifiers.org/wikipathways/WP5031_r122564>	WP5031	Biotin metabolism, including IMDs	9	3	1.48215390728618e-18	3	1.63126899721727e-18	3	1.03190129449887e-18	3	1.96839772871891e-18	3	1.47309262120421e-18	3	1.37756649126517e-18	3	6.0502423703042e-19	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP5033_r118996>	WP5033	Genes associated with the development of rheumatoid arthritis	18	12	3.27556013510245e-16	12	3.60510448385013e-16	12	2.28050186084251e-16	12	4.35015898046878e-16	12	3.25553469286132e-16	12	3.04442194569604e-16	12	1.33710356383724e-16	12	1.33710356383724e-16
<https://identifiers.org/wikipathways/WP5036_r119016>	WP5036	Angiotensin II receptor type 1 pathway	28	13	1.43903569167021e-37	13	1.82840293387314e-37	15	1.08109247080947e-32	13	2.92333680236283e-37	13	1.41715887082017e-37	15	2.02100708859245e-32	15	3.40218165911891e-33	13	1.53448414089145e-38
<https://identifiers.org/wikipathways/WP5037_r120417>	WP5037	Riboflavin and CoQ disorders	18	4	4.60939894918227e-39	4	5.76394212454509e-39	5	2.47389581420932e-36	4	8.93215254857307e-39	4	4.54395769574853e-39	5	4.62473017984543e-36	5	7.78531272109585e-37	4	5.70519765579351e-40
<https://identifiers.org/wikipathways/WP5038_r121595>	WP5038	Mitochondrial immune response to SARS-CoV-2	48	14	9.79322049314406e-79	14	1.68374517762578e-78	16	2.06611064310986e-74	14	4.86933600002028e-78	14	9.45953203502883e-79	16	9.61446189426714e-74	16	1.20503271608161e-75	14	6.17704079892157e-81
<https://identifiers.org/wikipathways/WP5039_r120358>	WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	86	39	7.69633170358188e-94	39	1.6265240829632e-93	40	7.1487662371416e-93	39	7.04803204861581e-93	39	7.336588287675e-94	40	6.50210446030533e-92	40	1.20789876315312e-94	39	7.04725066016994e-97
<https://identifiers.org/wikipathways/WP5043_r120456>	WP5043	Pentose phosphate pathway in senescent cells	10	2	1.28978235336834e-24	2	1.46560387676551e-24	2	7.95934924629522e-25	2	1.88269734554945e-24	2	1.27928125518712e-24	2	1.169901489508e-24	2	3.90634999229351e-25	2	3.90634999229351e-25
<https://identifiers.org/wikipathways/WP5044_r119244>	WP5044	Kynurenine pathway and links to cell senescence	23	12	1.89294956899828e-28	12	2.25648336979212e-28	12	9.74893203810852e-29	12	3.18378024653269e-28	12	1.8717959267853e-28	12	1.65538501202262e-28	12	3.66465855654409e-29	12	3.66465855654409e-29
<https://identifiers.org/wikipathways/WP5046_r118987>	WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	28	11	6.4918377728738e-43	11	8.51558528893588e-43	11	2.32924989137847e-43	11	1.44928951773336e-42	11	6.38011995908081e-43	11	5.27722983160165e-43	11	5.13828350723358e-44	11	5.13828350723358e-44
<https://identifiers.org/wikipathways/WP5049_r120508>	WP5049	Glycolysis in senescence	12	9	6.53954854307811e-09	9	6.86071330977721e-09	9	5.4563307533415e-09	9	7.53656887612527e-09	9	6.51952271896077e-09	9	6.30453940820032e-09	9	4.17773895512142e-09	9	4.17773895512142e-09
<https://identifiers.org/wikipathways/WP5050_r119012>	WP5050	TCA cycle in senescence	10	4	3.70538476821545e-18	4	4.07817249304314e-18	4	2.57975323624717e-18	4	4.92099432179726e-18	4	3.68273155301054e-18	4	3.44391622816294e-18	4	1.51256059257606e-18	4	1.51256059257606e-18
<https://identifiers.org/wikipathways/WP5052_r118777>	WP5052	Nephrogenesis	19	5	1.75157160068924e-38	5	2.19029800732716e-38	5	7.52907584013715e-39	5	3.3942179684577e-38	5	1.72670392438442e-38	5	1.47680459524474e-38	5	2.16797510920154e-39	5	2.16797510920154e-39
<https://identifiers.org/wikipathways/WP5053_r118778>	WP5053	Development of ureteric collection system	61	19	1.94781387711586e-92	19	3.80256121245066e-92	19	1.55605326758567e-93	19	1.41054501501577e-91	19	1.86621476775975e-92	19	1.16884701781896e-92	19	3.74484601078199e-95	19	3.74484601078199e-95
<https://identifiers.org/wikipathways/WP5055_r122621>	WP5055	Burn wound healing	109	53	2.46555722565269e-105	53	6.00930430580669e-105	54	9.91163475334967e-105	53	3.44331843963615e-104	53	2.32896690811865e-105	54	1.38586727483664e-103	54	7.56248330907217e-107	53	5.94863945651706e-109
<https://identifiers.org/wikipathways/WP5061_r115541>	WP5061	Fatty acid transporters	25	5	5.39573304139972e-53	5	7.42434514570418e-53	5	1.61611537117404e-53	5	1.38765500469589e-52	5	5.28668607319638e-53	5	4.22902304855995e-53	5	2.73159848701577e-54	5	2.73159848701577e-54
<https://identifiers.org/wikipathways/WP5063_r118833>	WP5063	FOXP3 in COVID-19	17	12	1.06819655516951e-13	12	1.15703825573345e-13	12	7.89940505686255e-14	12	1.35314111842469e-13	12	1.06275121418075e-13	12	1.00499751118478e-13	12	5.06242265975041e-14	12	5.06242265975041e-14
<https://identifiers.org/wikipathways/WP5064_r120384>	WP5064	7-oxo-C and 7-beta-HC pathways	29	12	1.56886079511119e-42	12	2.05793311149281e-42	12	5.62902057083125e-43	12	3.50244966785554e-42	12	1.54186232344452e-42	12	1.27533054263705e-42	12	1.24175184758146e-43	12	1.24175184758146e-43
<https://identifiers.org/wikipathways/WP5065_r118890>	WP5065	SARS-CoV-2 altering angiogenesis via NRP1	8	3	9.66693715085535e-16	3	1.04709344410267e-15	3	7.14878285688919e-16	3	1.2245620981219e-15	3	9.61765804688458e-16	3	9.09500010121972e-16	3	4.5813779726248e-16	3	4.5813779726248e-16
<https://identifiers.org/wikipathways/WP5066_r116631>	WP5066	FOXA2 pathway	21	9	8.40389603545e-32	9	1.01789354244847e-31	9	4.07498744129989e-32	9	1.48180440439021e-31	9	8.30150611350158e-32	9	7.26024829108474e-32	9	1.40155092261526e-32	9	1.40155092261526e-32
<https://identifiers.org/wikipathways/WP5072_r115764>	WP5072	Modulators of TCR signaling and T cell activation	64	23	1.35317293851944e-88	23	2.60009336221552e-88	23	1.14781967913456e-89	23	9.34960528498418e-88	23	1.29780204110745e-88	23	8.21913264751974e-89	23	3.01786867585469e-91	23	3.01786867585469e-91
<https://identifiers.org/wikipathways/WP5074_r120388>	WP5074	Kallmann syndrome	25	8	3.26969851197858e-44	8	4.28898526457392e-44	8	1.17315699657338e-44	8	7.29953511678893e-44	8	3.21343038232089e-44	8	2.65794542800451e-44	8	2.58796330492534e-45	8	2.58796330492534e-45
<https://identifiers.org/wikipathways/WP5076_r118892>	WP5076	Soluble ACE2-mediated cell entry of SARS-CoV-2	5	3	5.81326231852119e-07	3	6.00208464403848e-07	3	5.15209897800365e-07	3	6.39009688345344e-07	3	5.80138741340239e-07	3	5.67313023413633e-07	3	4.31193299428616e-07	3	4.31193299428616e-07
<https://identifiers.org/wikipathways/WP5083_r120385>	WP5083	Neuroinflammation and glutamatergic signaling	140	56	3.06063223170118e-151	56	1.16089704862203e-150	56	1.98753172667542e-153	56	1.58216864657498e-149	56	2.81041921730061e-151	56	1.10609814605157e-151	56	1.17889216936205e-156	56	1.17889216936205e-156
<https://identifiers.org/wikipathways/WP5085_r119785>	WP5085	Vasopressin-regulated water reabsorption	44	12	1.3274659066974e-75	12	2.2108940959649e-75	12	1.93253231085412e-76	12	6.00770132614592e-75	12	1.28484497857513e-75	12	8.99286702002553e-76	12	1.12712485521049e-77	12	1.12712485521049e-77
<https://identifiers.org/wikipathways/WP5087_r122659>	WP5087	Malignant pleural mesothelioma	438	170	0	170	0	171	0	170	0	170	0	171	0	171	0	170	0
<https://identifiers.org/wikipathways/WP5088_r119639>	WP5088	Prostaglandin signaling	35	21	3.49464654264888e-33	21	4.36997114800471e-33	22	4.26272864586719e-31	21	6.77197100238433e-33	21	3.44503182008302e-33	22	7.96879549405539e-31	22	1.34147425945081e-31	21	4.32543363739092e-34
<https://identifiers.org/wikipathways/WP5089_r118192>	WP5089	Kinin-Kallikrein pathway	8	3	9.66693715085535e-16	3	1.04709344410267e-15	3	7.14878285688919e-16	3	1.2245620981219e-15	3	9.61765804688458e-16	3	9.09500010121972e-16	3	4.5813779726248e-16	3	4.5813779726248e-16
<https://identifiers.org/wikipathways/WP5090_r118898>	WP5090	Complement system in neuronal development and plasticity	113	54	3.39725589154655e-110	54	8.68281232311571e-110	54	9.80667466306098e-112	54	5.46033955304515e-109	54	3.1993158344931e-110	54	1.65963185214819e-110	54	5.25696256853272e-114	54	5.25696256853272e-114
<https://identifiers.org/wikipathways/WP5092_r119997>	WP5092	Interactions of natural killer cells in pancreatic cancer	38	14	2.08578517965096e-57	14	3.05873480859465e-57	14	4.91114923932025e-58	13	1.61406789885857e-59	13	4.83367114466172e-60	13	3.65720164760541e-60	14	5.82103594440176e-59	14	5.82103594440176e-59
<https://identifiers.org/wikipathways/WP5095_r120801>	WP5095	Overview of proinflammatory and profibrotic mediators	130	55	7.62590129947118e-137	55	2.50977855405525e-136	56	9.5314255779699e-137	55	2.59023170937129e-135	55	7.06634153877434e-137	56	3.29680794465169e-135	56	1.36239644057032e-139	55	1.10828298477544e-141
<https://identifiers.org/wikipathways/WP5097_r119075>	WP5097	CCL18 signaling pathway	131	22	5.0442622222383e-211	22	2.83469204396613e-210	22	7.41392252455596e-214	22	8.34471371980891e-209	23	1.17418199060148e-208	22	1.35028329920589e-211	22	4.90650516531752e-218	22	4.90650516531752e-218
<https://identifiers.org/wikipathways/WP5098_r119538>	WP5098	T-cell activation SARS-CoV-2	92	37	3.90538840286685e-109	37	9.3690736627923e-109	37	1.43207739049589e-110	37	5.20446631077691e-108	37	3.69277122903035e-109	37	2.00236312163438e-109	37	1.09266146628994e-112	37	1.09266146628994e-112
<https://identifiers.org/wikipathways/WP51_r116716>	WP51	Regulation of actin cytoskeleton	151	47	1.69448566085735e-187	47	8.80356710015112e-187	47	3.35064780364922e-190	47	2.22223816358291e-185	47	1.52495091214855e-187	47	4.81606961688365e-188	47	3.4359915420469e-194	47	3.4359915420469e-194
<https://identifiers.org/wikipathways/WP5101_r119172>	WP5101	Congenital generalized lipodystrophy (CGL)	20	6	5.83857200229747e-38	6	7.30099335775709e-38	7	2.23828668904652e-35	6	1.13140598948591e-37	6	5.75567974794809e-38	7	4.18427968652682e-35	7	7.04385436670573e-36	6	7.2265836973384e-39
<https://identifiers.org/wikipathways/WP5102_r119174>	WP5102	Familial partial lipodystrophy (FPLD)	31	9	2.73072541650917e-55	9	3.87900531554467e-55	9	7.25165522684172e-56	9	7.7170913385094e-55	9	2.67009101085914e-55	9	2.08884519860107e-55	9	1.02637526573112e-56	9	1.02637526573112e-56
<https://identifiers.org/wikipathways/WP5103_r119170>	WP5103	Progeria-associated lipodystrophy	25	8	3.26969851197858e-44	8	4.28898526457392e-44	8	1.17315699657338e-44	8	7.29953511678893e-44	8	3.21343038232089e-44	8	2.65794542800451e-44	8	2.58796330492534e-45	8	2.58796330492534e-45
<https://identifiers.org/wikipathways/WP5104_r120389>	WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	10	5	4.35012171788489e-15	5	4.71192049846199e-15	5	3.21695228560015e-15	5	5.51052944154852e-15	5	4.32794612109808e-15	5	4.09275004554889e-15	5	2.06162008768117e-15	5	2.06162008768117e-15
<https://identifiers.org/wikipathways/WP5108_r120390>	WP5108	Familial  hyperlipidemia type 1	18	8	3.27197477805779e-27	8	3.83860351739917e-27	8	1.78980066446605e-27	8	5.24933443982087e-27	8	3.23871482866358e-27	8	2.89640967631533e-27	8	7.35327695981312e-28	8	7.35327695981312e-28
<https://identifiers.org/wikipathways/WP5109_r120391>	WP5109	Familial hyperlipidemia type 2	16	11	7.54021097766713e-14	11	8.16732886400083e-14	11	5.57605062837359e-14	11	9.5515843653508e-14	11	7.50177327657004e-14	11	7.09410007895139e-14	11	3.57347481864735e-14	11	3.57347481864735e-14
<https://identifiers.org/wikipathways/WP5110_r120392>	WP5110	Familial hyperlipidemia type 3	13	8	2.2216693059198e-14	8	2.40644511171452e-14	8	1.64294348871722e-14	8	2.814306107648e-14	8	2.21034391184653e-14	8	2.0902259161196e-14	8	1.05289883049431e-14	8	1.05289883049431e-14
<https://identifiers.org/wikipathways/WP5111_r119173>	WP5111	Familial hyperlipidemia type 4	22	9	3.14591990437121e-34	9	3.87165593600724e-34	9	1.43623395880485e-34	9	5.81514393446031e-34	9	3.10442180005165e-34	9	2.68491279885469e-34	9	4.51980655196953e-35	9	4.51980655196953e-35
<https://identifiers.org/wikipathways/WP5112_r119153>	WP5112	Familial hyperlipidemia type 5	15	7	1.84438876531673e-22	7	2.09581354377469e-22	7	1.13818694222022e-22	7	2.69225720413575e-22	7	1.82937219491758e-22	7	1.67295912999645e-22	7	5.58608048897971e-23	7	5.58608048897971e-23
<https://identifiers.org/wikipathways/WP5113_r119486>	WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	41	15	2.56407027635231e-61	15	3.88174805673613e-61	18	2.67452922077111e-54	15	8.74886929643411e-61	15	2.49694390395874e-61	18	8.08280384752852e-54	18	3.46407661407123e-55	15	5.31378506300807e-63
<https://identifiers.org/wikipathways/WP5114_r119169>	WP5114	Nucleotide excision repair in xeroderma pigmentosum 	61	17	1.90882495531802e-97	17	3.84660483784383e-97	18	4.71380932463765e-96	17	1.5184274183544e-96	17	1.82514985659152e-97	18	3.71434911165067e-95	18	1.03841322540652e-97	17	2.72748257074533e-100
<https://identifiers.org/wikipathways/WP5115_r120811>	WP5115	Network map of SARS-CoV-2 signaling pathway	285	105	9.55728841042173e-271	105	1.62556878552371e-269	106	1.29047567289907e-273	105	4.18719981433861e-267	107	2.57245229124323e-267	106	6.33651643542832e-270	106	1.92161684799952e-280	106	1.92161684799952e-280
<https://identifiers.org/wikipathways/WP5116_r120336>	WP5116	SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation	13	2	1.09202328846315e-32	2	1.30174222821305e-32	2	5.62405940317411e-33	2	1.8366903331727e-32	2	1.07981996814721e-32	2	9.54974719933072e-33	2	2.11410412276842e-33	2	2.11410412276842e-33
<https://identifiers.org/wikipathways/WP5117_r119395>	WP5117	Cohesin complex - Cornelia de Lange syndrome	36	10	1.02747846136311e-63	10	1.55550047029463e-63	13	3.05783660532413e-56	10	3.50586130429918e-63	10	1.00057947093376e-63	13	9.24121272883356e-56	13	3.96054011744923e-57	10	2.12934869644885e-65
<https://identifiers.org/wikipathways/WP5118_r119397>	WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	11	2	2.41573401788731e-27	2	2.78921153017656e-27	3	2.91842805697492e-24	2	3.69683520190006e-27	2	2.39362031077702e-27	3	4.2896387948627e-24	3	1.43232833050762e-24	2	6.30241271857283e-28
<https://identifiers.org/wikipathways/WP5120_r120422>	WP5120	Inclusion body myositis	12	2	4.93510524593939e-30	2	5.78974889502136e-30	2	2.6995485135235e-30	2	7.91754817469217e-30	2	4.88493940974894e-30	2	4.36864204572446e-30	2	1.10909154748312e-30	2	1.10909154748312e-30
<https://identifiers.org/wikipathways/WP5121_r119472>	WP5121	Sphingolipid metabolism in senescence	30	13	3.62044798871812e-42	13	4.74907641113731e-42	13	1.2990047471149e-42	13	8.08257615658978e-42	13	3.55814382333353e-42	13	2.94307048300863e-42	13	2.86558118672646e-43	13	2.86558118672646e-43
<https://identifiers.org/wikipathways/WP5122_r119484>	WP5122	Prostaglandin and leukotriene metabolism in senescence 	32	14	4.36134988683187e-44	14	5.81285171365409e-44	14	1.47340747460266e-44	14	1.02068838599399e-43	14	4.28192773770727e-44	14	3.50247842884076e-44	14	2.9741745351782e-45	14	2.9741745351782e-45
<https://identifiers.org/wikipathways/WP5124_r119432>	WP5124	Alzheimer's disease	267	86	7.93389079954421e-281	86	1.37053540980862e-279	86	1.67091830988566e-285	86	3.63910627231449e-277	86	6.61178452768813e-281	86	9.00945054354916e-282	86	2.09232083045096e-292	86	2.09232083045096e-292
<https://identifiers.org/wikipathways/WP5130_r122780>	WP5130	Th17 cell differentiation pathway	71	31	1.68380716282e-83	31	3.18444457885813e-83	31	1.51656264301315e-84	31	1.11001606922416e-82	31	1.61654783010537e-83	31	1.03520984157824e-83	31	4.35622251716362e-86	31	4.35622251716362e-86
<https://identifiers.org/wikipathways/WP5133_r121511>	WP5133	Non-classical role of vitamin D	8	6	1.62771344918594e-06	6	1.68058370033078e-06	6	1.44258771384103e-06	6	1.78922712736696e-06	6	1.62438847575267e-06	6	1.58847646555818e-06	6	1.20734123840013e-06	6	1.20734123840013e-06
<https://identifiers.org/wikipathways/WP5136_r120082>	WP5136	ALA oxylipin metabolism	3	3	1	3	1	3	1	3	1	3	1	3	1	3	1	3	1
<https://identifiers.org/wikipathways/WP5137_r120230>	WP5137	Linoleic acid oxylipin metabolism	3	3	1	3	1	3	1	3	1	3	1	3	1	3	1	3	1
<https://identifiers.org/wikipathways/WP5143_r120629>	WP5143	GDNF signaling	135	1	6.71457380711951e-276	1	5.58127880532552e-275	2	7.14932240745017e-276	1	3.53708053465239e-273	1	5.86378683533098e-276	2	4.04566846383639e-273	2	5.80802619730978e-281	1	1.67305954120985e-284
<https://identifiers.org/wikipathways/WP5144_r120537>	WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	57	25	6.24969621407234e-70	25	1.04088672948616e-69	26	2.19095093209033e-68	25	2.82841977664817e-69	25	6.04903731068178e-70	26	9.71827467360047e-68	26	1.39621982748425e-69	25	5.30649254708224e-72
<https://identifiers.org/wikipathways/WP5149_r120374>	WP5149	Lipid metabolism in senescent cells	20	7	4.90273231850068e-35	7	6.03374951066066e-35	7	2.23828668904652e-35	7	9.0625619757823e-35	7	4.83805994813244e-35	7	4.18427968652682e-35	7	7.04385436670573e-36	7	7.04385436670573e-36
<https://identifiers.org/wikipathways/WP5154_r122424>	WP5154	Docosahexaenoic acid (DHA) oxylipin metabolism	2	2	1	2	1	2	1	2	1	2	1	2	1	2	1	2	1
<https://identifiers.org/wikipathways/WP516_r117755>	WP516	Hypertrophy model	20	9	2.35149014782399e-29	9	2.80308493141883e-29	9	1.21104745815013e-29	9	3.95500651743186e-29	9	2.3252123314103e-29	9	2.05637889692254e-29	9	4.5523708776946e-30	9	4.5523708776946e-30
<https://identifiers.org/wikipathways/WP5166_r122169>	WP5166	Glyoxylate metabolism	14	3	5.09610867949464e-32	3	6.07479706499433e-32	3	2.62456105481452e-32	3	8.57122155480596e-32	3	5.03915985135365e-32	3	4.45654869302096e-32	3	9.86581923958582e-33	3	9.86581923958582e-33
<https://identifiers.org/wikipathways/WP5169_r122351>	WP5169	Hemesynthesis defects and porphyrias	9	2	7.573601978979e-22	2	8.46972480382791e-22	2	4.96424612491445e-22	2	1.05449878324224e-21	2	7.5196152179899e-22	2	6.95389445363552e-22	2	2.66295878974659e-22	2	2.66295878974659e-22
<https://identifiers.org/wikipathways/WP5171_r122629>	WP5171	Leukotriene metabolic pathway	14	6	8.60714757147815e-23	6	9.78046320428196e-23	6	5.3115390636944e-23	6	1.25638669526333e-22	6	8.53707024294871e-23	6	7.8071426066501e-23	6	2.60683756152388e-23	6	2.60683756152388e-23
<https://identifiers.org/wikipathways/WP5173_r122082>	WP5173	Disorders of galactose metabolism 	14	4	7.48490962300806e-29	4	8.78111915744915e-29	4	4.09431524551057e-29	4	1.20082813982831e-28	4	7.40882477145263e-29	4	6.62577376934876e-29	4	1.68212218034941e-29	4	1.68212218034941e-29
<https://identifiers.org/wikipathways/WP5174_r121476>	WP5174	Ulcerative colitis signaling	22	9	3.14591990437121e-34	9	3.87165593600724e-34	9	1.43623395880485e-34	9	5.81514393446031e-34	9	3.10442180005165e-34	9	2.68491279885469e-34	9	4.51980655196953e-35	9	4.51980655196953e-35
<https://identifiers.org/wikipathways/WP5175_r122904>	WP5175	Disorders in ketone body synthesis	5	3	5.81326231852119e-07	3	6.00208464403848e-07	3	5.15209897800365e-07	3	6.39009688345344e-07	3	5.80138741340239e-07	3	5.67313023413633e-07	3	4.31193299428616e-07	3	4.31193299428616e-07
<https://identifiers.org/wikipathways/WP5176_r122283>	WP5176	Disorders of bile acid synthesis and biliary transport	20	6	5.83857200229747e-38	6	7.30099335775709e-38	6	2.50969194671241e-38	6	1.13140598948591e-37	6	5.75567974794809e-38	6	4.92268198414912e-38	6	7.2265836973384e-39	6	7.2265836973384e-39
<https://identifiers.org/wikipathways/WP5178_r122450>	WP5178	Disorders of fructose metabolism	14	7	7.22016721996002e-20	7	8.07447097964934e-20	8	3.68904712783348e-17	7	1.00528884002427e-19	7	7.16869984115041e-20	8	4.92480020627302e-17	8	2.16296164738377e-17	7	2.53868737955843e-20
<https://identifiers.org/wikipathways/WP5179_r121899>	WP5179	Biosynthesis and turnover of 1-deoxy-sphingoid bases	10	3	2.52453399299299e-21	3	2.82324160127598e-21	3	1.65474870830481e-21	3	3.51499594414078e-21	3	2.50653840599665e-21	3	2.31796481787851e-21	3	8.87652929915534e-22	3	8.87652929915534e-22
<https://identifiers.org/wikipathways/WP5180_r122423>	WP5180	DYRK1A	62	17	2.00282868894428e-99	17	4.10057599632594e-99	17	1.33664600246121e-100	17	1.6697853837881e-98	17	1.91309029769526e-99	17	1.15896929144136e-99	17	2.46722963796634e-102	17	2.46722963796634e-102
<https://identifiers.org/wikipathways/WP5181_r122326>	WP5181	Roles of ceramides in the development of insulin resistance	23	7	2.56387959319274e-42	7	3.30995289484716e-42	7	9.77005146746331e-43	7	5.46005226735805e-42	7	2.52232862142971e-42	7	2.10969988438809e-42	7	2.35539166925604e-43	7	2.35539166925604e-43
<https://identifiers.org/wikipathways/WP5182_r122168>	WP5182	Pro-survival signaling of neuroprotectin D1	16	3	3.54170549324098e-37	3	4.35874577653509e-37	3	1.61692536876426e-37	3	6.54674239736591e-37	3	3.49498654663852e-37	3	3.02269946395126e-37	3	5.08843968699069e-38	3	5.08843968699069e-38
<https://identifiers.org/wikipathways/WP5183_r122816>	WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	33	10	4.89832858813272e-57	10	7.0697784142478e-57	11	6.9615890177681e-55	10	1.45107700382226e-56	10	4.78468709904502e-57	11	2.00529139065698e-54	11	9.85320255101876e-56	10	1.58643483696143e-58
<https://identifiers.org/wikipathways/WP5186_r122546>	WP5186	Activation of vitamin K-dependent proteins	11	4	6.94246848073074e-21	4	7.7639144035089e-21	4	4.55055894783824e-21	4	9.66623884638719e-21	4	6.89298061649074e-21	4	6.37440324916587e-21	4	2.44104555726771e-21	4	2.44104555726771e-21
<https://identifiers.org/wikipathways/WP5187_r122433>	WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	12	5	1.6661924353754e-20	5	1.86333945684214e-20	5	1.09213414748118e-20	5	2.31989732313294e-20	5	1.65431534795778e-20	5	1.52985677979982e-20	5	5.85850933744251e-21	5	5.85850933744251e-21
<https://identifiers.org/wikipathways/WP5188_r122585>	WP5188	Retinol metabolism	19	8	1.05817056652078e-29	8	1.26138821913846e-29	8	5.44971356167558e-30	8	1.77975293284435e-29	8	1.04634554913465e-29	8	9.25370503615148e-30	8	2.04856689496259e-30	8	2.04856689496259e-30
<https://identifiers.org/wikipathways/WP5190_r122630>	WP5190	Creatine pathway	5	2	2.97252206503549e-10	2	3.11850604989874e-10	2	2.48015034242795e-10	2	3.42571312551149e-10	2	2.96341941770944e-10	2	2.86569973100015e-10	2	1.89897225232792e-10	2	1.89897225232792e-10
<https://identifiers.org/wikipathways/WP5191_r122556>	WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	14	7	7.22016721996002e-20	7	8.07447097964934e-20	7	4.73258130575178e-20	7	1.00528884002427e-19	7	7.16869984115041e-20	7	6.62937937913252e-20	7	2.53868737955843e-20	7	2.53868737955843e-20
<https://identifiers.org/wikipathways/WP5192_r122557>	WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	14	8	5.29870021854809e-17	8	5.83178666505171e-17	8	3.68904712783348e-17	8	7.03702188017013e-17	8	5.26630612080505e-17	8	4.92480020627302e-17	8	2.16296164738377e-17	8	2.16296164738377e-17
<https://identifiers.org/wikipathways/WP5193_r122440>	WP5193	Cholesterol synthesis disorders	18	13	1.47904138408086e-13	13	1.60205296947708e-13	13	1.09376377710406e-13	13	1.8735800101265e-13	13	1.47150168117334e-13	13	1.39153501548661e-13	13	7.00950829811595e-14	13	7.00950829811595e-14
<https://identifiers.org/wikipathways/WP5194_r122165>	WP5194	Synthesis of ceramides and 1-deoxyceramides	22	8	4.81682190189552e-37	8	6.02331952014958e-37	8	2.07049585603772e-37	8	9.33409941325873e-37	8	4.74843579205723e-37	8	4.06121263692309e-37	8	5.96193155030424e-38	8	5.96193155030424e-38
<https://identifiers.org/wikipathways/WP5195_r122514>	WP5195	Disorders in ketolysis	5	4	0.00085251491901096	4	0.000866250866250947	4	0.000802568218298692	4	0.00089381480157307	4	0.000851643672287627	4	0.000842176183257654	4	0.000734214390602004	4	0.000734214390602004
<https://identifiers.org/wikipathways/WP5198_r121825>	WP5198	Inflammatory bowel disease signaling	43	24	2.39166135628281e-43	24	3.23883099066396e-43	24	7.60780642048785e-44	24	5.86750024570445e-43	24	2.34571575704077e-43	24	1.89745423152316e-43	24	1.40524013162575e-44	24	1.40524013162575e-44
<https://identifiers.org/wikipathways/WP5199_r122599>	WP5199	PtdIns(4,5)P2 in cytokinesis pathway	11	5	8.15184649007405e-18	5	8.97197948469494e-18	6	5.8977458569336e-15	5	1.08261875079541e-17	5	8.10200941662318e-18	6	7.50337508350628e-15	6	3.77963682741546e-15	5	3.32763330366732e-18
<https://identifiers.org/wikipathways/WP5200_r122392>	WP5200	Dravet syndrome	20	2	1.75772996035527e-50	2	2.34272045979197e-50	2	5.93819007674656e-51	2	4.11362216469982e-50	2	1.72572090475217e-50	2	1.41158389710016e-50	2	1.19866459317848e-51	2	1.19866459317848e-51
<https://identifiers.org/wikipathways/WP5202_r122439>	WP5202	Alstrom syndrome	33	14	2.44644817721322e-46	14	3.31302429275634e-46	14	7.78208173205628e-47	14	6.00190961115497e-46	14	2.39945008226081e-46	14	1.94092003613346e-46	14	1.43743057499824e-47	14	1.43743057499824e-47
<https://identifiers.org/wikipathways/WP5205_r122560>	WP5205	Clock-controlled autophagy in bone metabolism	80	24	8.42047210344774e-117	24	2.05232223943931e-116	24	2.90840660337958e-118	24	1.17597622811485e-115	24	7.95398325199054e-117	24	4.26545092086685e-117	24	2.03160373143695e-120	24	2.03160373143695e-120
<https://identifiers.org/wikipathways/WP521_r111034>	WP521	Amino acid conjugation of benzoic acid	4	1	1.1890088260142e-10	1	1.2474024199595e-10	1	9.92060136971183e-11	1	1.37028525020459e-10	1	1.18536776708378e-10	1	1.14627989240006e-10	1	7.5958890093117e-11	1	7.5958890093117e-11
<https://identifiers.org/wikipathways/WP5211_r122576>	WP5211	Glucose metabolism in triple-negative breast cancer cells	8	8	1	8	1	8	1	8	1	8	1	8	1	8	1	8	1
<https://identifiers.org/wikipathways/WP5213_r122577>	WP5213	Amino acid metabolism in triple-negative breast cancer cells	9	4	2.17506085894246e-15	4	2.355960249231e-15	4	1.60847614280008e-15	4	2.75526472077428e-15	4	2.16397306054903e-15	4	2.04637502277443e-15	4	1.03081004384058e-15	4	1.03081004384058e-15
<https://identifiers.org/wikipathways/WP5218_r122962>	WP5218	Extrafollicular B cell activation by SARS-CoV-2	76	40	4.56641036328768e-73	40	8.10452039524386e-73	40	5.22849057384429e-74	39	1.77221257781742e-74	39	2.98077462417257e-75	39	1.97351636794507e-75	40	2.13981796155816e-75	40	2.13981796155816e-75
<https://identifiers.org/wikipathways/WP5220_r122761>	WP5220	Metabolic reprogramming in pancreatic cancer	43	20	5.08331842028951e-53	20	7.3367750231332e-53	20	1.27110520334541e-53	20	1.50587824603252e-52	20	4.96538515705594e-53	20	3.84145888122013e-53	20	1.64634799079274e-54	20	1.64634799079274e-54
<https://identifiers.org/wikipathways/WP5221_r122738>	WP5221	2q11.2 copy number variation syndrome	65	15	1.97685366865094e-110	15	4.38132961771165e-110	16	3.83732956962376e-109	15	2.08392943462976e-109	15	1.87872628326236e-110	16	4.02840920047891e-108	16	4.97373310130684e-111	15	1.16022349644135e-113
<https://identifiers.org/wikipathways/WP5222_r122737>	WP5222	2q13 copy number variation syndrome	68	19	3.77910086997717e-106	19	8.2439655361242e-106	20	6.22978472388707e-105	19	3.80124358347205e-105	19	3.59515698373879e-106	20	6.23476891958128e-104	20	8.820690528301e-107	19	2.57237985660566e-109
<https://identifiers.org/wikipathways/WP5223_r122632>	WP5223	2q21.1 copy number variation syndrome	42	7	3.25008245572896e-85	6	6.84372878356587e-88	7	3.9515259228614e-86	6	2.10634588542804e-87	6	3.71707728102341e-88	6	2.48850619801517e-88	7	1.76692335709049e-87	7	1.76692335709049e-87
<https://identifiers.org/wikipathways/WP5224_r122740>	WP5224	2q37 copy number variation syndrome	172	48	2.56680113764618e-218	48	1.82469601375182e-217	52	3.88610042947611e-213	48	8.51278348860213e-216	48	2.26410949641951e-218	52	1.19065836330742e-210	52	9.82438578230929e-218	48	2.76526097287235e-226
<https://identifiers.org/wikipathways/WP524_r117113>	WP524	G13 signaling pathway	38	12	1.09442023990649e-62	12	1.65684368275321e-62	12	2.28491121156492e-63	12	3.73427348018531e-62	12	1.0657687394946e-62	12	7.97444170058187e-63	12	2.26807899030839e-64	12	2.26807899030839e-64
<https://identifiers.org/wikipathways/WP528_r120525>	WP528	Acetylcholine synthesis	7	4	1.04038272276242e-09	4	1.09147711746456e-09	4	8.68052619849782e-10	4	1.19899959392901e-09	4	1.0371967961983e-09	4	1.00299490585005e-09	4	6.6464028831477e-10	4	6.6464028831477e-10
<https://identifiers.org/wikipathways/WP53_r120698>	WP53	ID signaling pathway	16	5	6.11533041539365e-31	5	7.28975647799305e-31	5	3.14947326577743e-31	5	1.02854658657672e-30	5	6.04699182162429e-31	5	5.34785843162519e-31	5	1.18389830875028e-31	5	1.18389830875028e-31
<https://identifiers.org/wikipathways/WP530_r117693>	WP530	Cytokines and inflammatory response	30	16	2.19055923311205e-34	16	2.73924144541352e-34	16	9.41605047257155e-35	16	4.24489384680246e-34	16	2.15945909543328e-34	16	1.84692874692799e-34	16	2.71132387094523e-35	16	2.71132387094523e-35
<https://identifiers.org/wikipathways/WP531_r117702>	WP531	DNA mismatch repair	23	8	1.88445150099671e-39	8	2.3943371753101e-39	8	7.62674642678861e-40	8	3.82817914595133e-39	8	1.8558032832169e-39	8	1.56961671398476e-39	8	2.00944351783405e-40	8	2.00944351783405e-40
<https://identifiers.org/wikipathways/WP534_r117147>	WP534	Glycolysis and gluconeogenesis	46	23	4.35713007453379e-52	23	6.28866430554264e-52	24	2.83819633261269e-50	23	1.2907527823136e-51	23	4.25604442033367e-52	24	8.17544766899661e-50	24	4.01708909753431e-51	23	1.41115542067952e-53
<https://identifiers.org/wikipathways/WP536_r116854>	WP536	Calcium regulation in cardiac cells	152	52	1.04659629720443e-178	52	5.10633479892169e-178	52	2.62432697505142e-181	52	1.13967425944097e-176	52	9.45677843084292e-179	52	3.12084180799022e-179	52	3.82123774816052e-185	52	3.82123774816052e-185
<https://identifiers.org/wikipathways/WP545_r116815>	WP545	Complement activation	22	12	4.83525161646323e-26	12	5.67260297571213e-26	12	2.64492764859984e-26	12	7.75734978329091e-26	12	4.78610080235841e-26	12	4.28024985499934e-26	12	1.08665092850572e-26	12	1.08665092850572e-26
<https://identifiers.org/wikipathways/WP550_r119093>	WP550	Biogenic amine synthesis	15	6	2.19831795627744e-25	6	2.53818249246069e-25	6	1.27722164083707e-25	6	3.36412003372912e-25	6	2.17819448280709e-25	6	1.9698425416274e-25	6	5.73519557390131e-26	6	5.73519557390131e-26
<https://identifiers.org/wikipathways/WP554_r121084>	WP554	ACE inhibitor pathway	17	7	1.45421101247013e-27	7	1.70604600773297e-27	7	7.95466961984908e-28	7	2.33303752880929e-27	7	1.43942881273937e-27	7	1.28729318947348e-27	7	3.26812309325026e-28	7	3.26812309325026e-28
<https://identifiers.org/wikipathways/WP558_r119232>	WP558	Complement and coagulation cascades	60	30	2.60805683534231e-64	30	4.2077567580035e-64	30	4.28151226062552e-65	30	1.0743073908062e-63	30	2.52946073702787e-64	30	1.81023690670107e-64	30	2.98126176497114e-66	30	2.98126176497114e-66
<https://identifiers.org/wikipathways/WP560_r117838>	WP560	TGF-beta receptor signaling	55	24	2.88598127178657e-68	24	4.73078453258791e-68	24	4.4615228880286e-69	24	1.24607309239082e-67	24	2.79616370673904e-68	24	1.97897197300759e-68	24	2.84317947326052e-70	24	2.84317947326052e-70
<https://identifiers.org/wikipathways/WP561_r117151>	WP561	Heme biosynthesis	9	2	7.573601978979e-22	2	8.46972480382791e-22	2	4.96424612491445e-22	2	1.05449878324224e-21	2	7.5196152179899e-22	2	6.95389445363552e-22	2	2.66295878974659e-22	2	2.66295878974659e-22
<https://identifiers.org/wikipathways/WP58_r113950>	WP58	Monoamine GPCRs	34	5	1.20557925542854e-73	5	1.9143532288741e-73	5	2.10170001366661e-74	5	4.7376746213726e-73	5	1.17043833507976e-73	5	8.47007483547653e-74	5	1.59904725232373e-75	5	1.59904725232373e-75
<https://identifiers.org/wikipathways/WP581_r117099>	WP581	EPO receptor signaling	26	11	2.96943872884328e-38	11	3.7728949429129e-38	11	1.2017903460394e-38	11	6.03228229059007e-38	11	2.92429608264481e-38	11	2.47333542809717e-38	11	3.16639584628403e-39	11	3.16639584628403e-39
<https://identifiers.org/wikipathways/WP585_r107188>	WP585	Interferon type I signaling pathways	54	28	7.58888217069675e-57	28	1.14888148310851e-56	29	3.41737264245503e-55	28	2.58940399683259e-56	28	7.39020815799938e-57	29	1.13681018201061e-54	29	3.70674226736515e-56	28	1.57272166428079e-58
<https://identifiers.org/wikipathways/WP61_r120637>	WP61	Notch signaling pathway	60	20	5.56802234569245e-88	20	1.0530338013294e-87	20	5.01497729157825e-89	20	3.67060695190663e-87	20	5.34560883197125e-88	20	3.42323732649692e-88	20	1.44051794373839e-90	20	1.44051794373839e-90
<https://identifiers.org/wikipathways/WP619_r120967>	WP619	Type II interferon signaling	37	26	1.19701454030413e-25	26	1.42689665262712e-25	26	6.16477775909677e-26	26	2.01327669297041e-25	26	1.18363794658814e-25	26	1.04678960371945e-25	26	2.31736209420231e-26	26	2.31736209420231e-26
<https://identifiers.org/wikipathways/WP623_r107189>	WP623	Oxidative phosphorylation	62	12	2.05922257151141e-112	12	4.56388501844973e-112	19	1.53819041119755e-95	12	2.17075982773927e-111	12	1.95700654506492e-112	19	1.21205076274921e-94	19	3.38850631448462e-97	12	1.20856614212635e-115
<https://identifiers.org/wikipathways/WP673_r118930>	WP673	ErbB signaling pathway	92	33	5.03487293804672e-118	33	1.28682849297798e-117	33	1.45338951346393e-119	33	8.09244776543975e-117	33	4.74151763352179e-118	33	2.45964265461835e-118	33	7.79103471083561e-122	33	7.79103471083561e-122
<https://identifiers.org/wikipathways/WP678_r116938>	WP678	Arachidonate epoxygenase / epoxide hydrolase	7	6	0.00119352088661535	6	0.00121275121275133	6	0.00112359550561817	6	0.0012513407222023	6	0.00119230114120268	6	0.00117904665656071	6	0.0010279001468428	6	0.0010279001468428
<https://identifiers.org/wikipathways/WP688_r117673>	WP688	Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs)	5	5	1	5	1	5	1	5	1	5	1	5	1	5	1	5	1
<https://identifiers.org/wikipathways/WP69_r120966>	WP69	T-cell receptor signaling pathway	89	40	3.7503639270847e-97	40	8.18127698269055e-97	40	1.96954837625037e-98	40	3.77233826351969e-96	40	3.56781878227627e-97	40	2.06762193752708e-97	40	2.552819031007e-100	40	2.552819031007e-100
<https://identifiers.org/wikipathways/WP690_r117170>	WP690	Polyol pathway	4	3	0.000682011935208769	3	0.000693000693000758	3	0.000642054574638953	3	0.000715051841258455	3	0.000681314937830102	3	0.000673740946606124	3	0.000587371512481603	3	0.000587371512481603
<https://identifiers.org/wikipathways/WP691_r114497>	WP691	Tamoxifen metabolism	21	13	5.83239580193168e-21	13	6.62746073073368e-21	13	3.59921772917471e-21	13	8.51355739657474e-21	13	5.78490983595616e-21	13	5.29029453555522e-21	13	1.76645146651513e-21	13	1.76645146651513e-21
<https://identifiers.org/wikipathways/WP692_r117833>	WP692	Sulfation biotransformation reaction	18	5	5.41880940465855e-36	5	6.6688810380985e-36	5	2.47389581420932e-36	5	1.00165158679699e-35	5	5.34732941635697e-36	5	4.62473017984543e-36	5	7.78531272109585e-37	5	7.78531272109585e-37
<https://identifiers.org/wikipathways/WP694_r106139>	WP694	Arylamine metabolism	7	3	7.0919067672965e-13	3	7.56001466642164e-13	3	5.57068904123124e-13	3	8.56887328160778e-13	3	7.0629676281808e-13	3	6.75417445016854e-13	3	3.90218868818311e-13	3	3.90218868818311e-13
<https://identifiers.org/wikipathways/WP696_r106311>	WP696	Benzo(a)pyrene metabolism	9	3	1.48215390728618e-18	3	1.63126899721727e-18	3	1.03190129449887e-18	3	1.96839772871891e-18	3	1.47309262120421e-18	3	1.37756649126517e-18	3	6.0502423703042e-19	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP697_r106826>	WP697	Estrogen metabolism	18	9	2.13550887181237e-24	9	2.46566299267609e-24	9	1.24072959395602e-24	9	3.2680023184797e-24	9	2.11596035472688e-24	9	1.91356132615233e-24	9	5.57133284321839e-25	9	5.57133284321839e-25
<https://identifiers.org/wikipathways/WP698_r106827>	WP698	Glucuronidation	26	8	1.44529345990212e-46	8	1.92630189806396e-46	8	4.88267679060479e-47	8	3.38242582492442e-46	8	1.41897401393247e-46	8	1.1606748593906e-46	8	9.85601961741005e-48	8	9.85601961741005e-48
<https://identifiers.org/wikipathways/WP699_r106828>	WP699	Aflatoxin B1 metabolism	8	2	4.94051302428728e-19	2	5.4375633240575e-19	2	3.43967098166293e-19	2	6.56132576239643e-19	2	4.91030873734739e-19	2	4.59188830421729e-19	2	2.01674745676809e-19	2	2.01674745676809e-19
<https://identifiers.org/wikipathways/WP702_r106643>	WP702	Metapathway biotransformation Phase I and II	190	61	3.68878268935019e-219	61	2.83565982429413e-218	61	1.65888560241351e-222	61	1.54198055011351e-216	61	3.23753616183837e-219	61	7.77348840369597e-220	61	1.91063677528275e-227	61	1.91063677528275e-227
<https://identifiers.org/wikipathways/WP704_r117787>	WP704	Methylation pathways	9	3	1.48215390728618e-18	3	1.63126899721727e-18	3	1.03190129449887e-18	3	1.96839772871891e-18	3	1.47309262120421e-18	3	1.37756649126517e-18	3	6.0502423703042e-19	3	6.0502423703042e-19
<https://identifiers.org/wikipathways/WP706_r117178>	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	166	66	1.06478044447087e-172	66	5.19505510513979e-172	68	2.34701933697598e-171	66	1.15947559508943e-170	66	9.6210857689358e-173	68	2.53860667664625e-169	68	4.07257168949023e-175	66	3.88763006211948e-179
<https://identifiers.org/wikipathways/WP707_r116541>	WP707	DNA damage response	68	27	6.27922360989268e-87	27	1.20653961982212e-86	28	1.19271263762473e-85	27	4.33856313390989e-86	27	6.02228213816122e-87	28	8.14148934982799e-85	28	3.42598551564184e-87	27	1.40040283851046e-89
<https://identifiers.org/wikipathways/WP710_r116542>	WP710	DNA damage response (only ATM dependent)	114	45	1.39345048158689e-130	45	4.1714901067104e-130	46	3.0300911378674e-130	45	3.575901896465e-129	45	1.29905426839385e-130	46	7.87596994117203e-129	46	7.34634374171449e-133	45	4.91322785866324e-135
<https://identifiers.org/wikipathways/WP712_r109450>	WP712	Estrogen signaling pathway	23	4	2.64570776796633e-51	4	3.58286522823117e-51	4	8.41592079538919e-52	4	6.49075628446478e-51	4	2.5948817475939e-51	4	2.09900510643527e-51	4	1.55450717231917e-52	4	1.55450717231917e-52
<https://identifiers.org/wikipathways/WP716_r116512>	WP716	Vitamin A and carotenoid metabolism	43	20	5.08331842028951e-53	20	7.3367750231332e-53	20	1.27110520334541e-53	20	1.50587824603252e-52	20	4.96538515705594e-53	20	3.84145888122013e-53	20	1.64634799079274e-54	20	1.64634799079274e-54
<https://identifiers.org/wikipathways/WP722_r120570>	WP722	Serotonin HTR1 group and FOS pathway	34	10	2.82851854613641e-59	10	4.14792866409705e-59	10	6.65997478637051e-60	10	8.78344634679658e-59	10	2.76008417657837e-59	10	2.11168651361965e-59	10	7.89386571881874e-61	10	7.89386571881874e-61
<https://identifiers.org/wikipathways/WP727_r116775>	WP727	Monoamine transport	32	12	2.29308843835777e-49	12	3.1552116988307e-49	13	3.30148921966021e-47	12	5.89728146904737e-49	12	2.24674545954351e-49	13	8.23420621389945e-47	13	6.09819031817438e-48	12	1.16087969155465e-50
<https://identifiers.org/wikipathways/WP732_r120591>	WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	20	6	5.83857200229747e-38	6	7.30099335775709e-38	6	2.50969194671241e-38	6	1.13140598948591e-37	6	5.75567974794809e-38	6	4.92268198414912e-38	6	7.2265836973384e-39	6	7.2265836973384e-39
<https://identifiers.org/wikipathways/WP733_r120590>	WP733	Serotonin receptor 2 and STAT3 signaling	4	2	3.48795739111272e-07	2	3.60125078642309e-07	2	3.09125938680219e-07	2	3.83405813007207e-07	2	3.48083244804143e-07	2	3.4038781404818e-07	2	2.5871597965717e-07	2	2.5871597965717e-07
<https://identifiers.org/wikipathways/WP734_r117826>	WP734	Serotonin receptor 4/6/7 and NR3C signaling	19	7	1.44066789179143e-32	7	1.74496035848308e-32	7	6.98569275651409e-33	7	2.54023612181178e-32	7	1.42311533374315e-32	7	1.24461399275739e-32	7	2.40265872448331e-33	7	2.40265872448331e-33
<https://identifiers.org/wikipathways/WP75_r119233>	WP75	Toll-like receptor signaling pathway	104	42	1.23868731345358e-119	42	3.31975750663159e-119	43	4.3723966496542e-119	42	2.29113527671791e-118	42	1.1629789031394e-119	43	8.14040689673496e-118	43	1.9647832926286e-121	42	1.22959804370596e-123
<https://identifiers.org/wikipathways/WP78_r119082>	WP78	TCA cycle (aka Krebs or citric acid cycle)	18	5	5.41880940465855e-36	5	6.6688810380985e-36	5	2.47389581420932e-36	5	1.00165158679699e-35	5	5.34732941635697e-36	5	4.62473017984543e-36	5	7.78531272109585e-37	5	7.78531272109585e-37
<https://identifiers.org/wikipathways/WP80_r111167>	WP80	Nucleotide GPCRs	11	4	6.94246848073074e-21	4	7.7639144035089e-21	4	4.55055894783824e-21	4	9.66623884638719e-21	4	6.89298061649074e-21	4	6.37440324916587e-21	4	2.44104555726771e-21	4	2.44104555726771e-21
<https://identifiers.org/wikipathways/WP98_r117172>	WP98	Prostaglandin synthesis and regulation	46	22	1.70200393536477e-54	22	2.49593233869685e-54	22	4.00750538168344e-55	22	5.28526152629737e-54	22	1.66082493497918e-54	22	1.27066473060494e-54	22	4.74997434152331e-56	22	4.74997434152331e-56
